S-1 1 a2050360zs-1.txt S-1 AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JULY 11, 2001 REGISTRATION NO. 333- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ------------------------ FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ------------------------ CROSS COUNTRY, INC. (Exact name of registrant as specified in its charter) DELAWARE 7363 13-4066229 (State or other jurisdiction of (Primary Standard (I.R.S. Employer incorporation or organization) Industrial Identification Number) Classification Code Number)
6551 PARK OF COMMERCE BLVD, N.W. SUITE 200 BOCA RATON, FL 33487 (561) 998-2232 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) ------------------------------ JOSEPH A. BOSHART PRESIDENT AND CHIEF EXECUTIVE OFFICER CROSS COUNTRY, INC. 6551 PARK OF COMMERCE BLVD, N.W. SUITE 200 BOCA RATON, FL 33487 (561) 998-2232 (Name, address, including zip code, and telephone number, including area code, of agent for service) ------------------------------ COPIES OF COMMUNICATIONS TO: JULIE M. ALLEN, ESQ. MICHAEL W. BLAIR, ESQ. PROSKAUER ROSE LLP DEBEVOISE & PLIMPTON 1585 BROADWAY 875 THIRD AVENUE NEW YORK, NEW YORK 10036-8299 NEW YORK, NEW YORK 10022 (212) 969-3000 (212) 909-6000
------------------------------ APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO PUBLIC: As soon as practicable after the effective date of this registration statement. If any securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, check the following box. / / If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. / / __________________ If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. / / __________________ If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. / / __________________ If delivery of the prospectus is expected to be made pursuant to Rule 434, please check the following box. / / CALCULATION OF REGISTRATION FEE
PROPOSED TITLE OF EACH CLASS OF MAXIMUM AGGREGATE AMOUNT OF SECURITIES TO BE REGISTERED OFFERING PRICE(1) REGISTRATION FEE Common Stock, par value $.01 per share...................... $143,750,000 $35,938
(1) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. ------------------------------ THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(A), MAY DETERMINE. -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- EXPLANATORY NOTE This registration statement contains two separate prospectuses. The first prospectus relates to a public offering in the United States and Canada of an aggregate of shares of common stock. The second prospectus relates to a concurrent offering outside the United States and Canada of an aggregate of shares of common stock. The prospectuses for each of the U.S. offering and the international offering will be identical with the exception of an alternate front cover page, an alternate back cover page, and an alternate "Underwriting" section for the international offering. These alternate pages appear in this registration statement immediately following the complete prospectus for the U.S. offering. SUBJECT TO COMPLETION PRELIMINARY PROSPECTUS DATED JULY 11, 2001 The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted. PROSPECTUS SHARES [LOGO] CROSS COUNTRY, INC. COMMON STOCK ------------------ This is Cross Country, Inc.'s initial public offering. We are selling all of the shares. The U.S. underwriters are offering shares in the U.S. and Canada and the international managers are offering shares outside the U.S. and Canada. We expect the public offering price to be between $ and $ per share. Currently, no public market exists for the shares. After pricing of the offering, we expect that the shares will be quoted on the Nasdaq National Market under the symbol CCRN. INVESTING IN THE COMMON STOCK INVOLVES RISKS WHICH ARE DESCRIBED IN THE "RISK FACTORS" SECTION BEGINNING ON PAGE 9 OF THIS PROSPECTUS. ------------------------
PER SHARE TOTAL --------- -------- Public offering price....................................... $ $ Underwriting discount....................................... $ $ Proceeds, before expenses, to Cross Country, Inc............ $ $
The U.S. underwriters may also purchase up to an additional shares from us at the public offering price, less the underwriting discount, within 30 days from the date of this prospectus to cover over-allotments. The international managers may similarly purchase up to an additional shares from us. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. The shares will be ready for delivery on or about , 2001. ------------------------ MERRILL LYNCH & CO. SALOMON SMITH BARNEY BANC OF AMERICA SECURITIES LLC ROBINSON-HUMPHREY CIBC WORLD MARKETS ------------------------ The date of this prospectus is , 2001. [DESCRIPTION OF INSIDE FRONT COVER ARTWORK TO BE PROVIDED BY AMENDMENT.] TABLE OF CONTENTS
PAGE -------- Prospectus Summary.......................................... 1 Risk Factors................................................ 9 Special Note Regarding Forward-Looking Statements........... 14 Use of Proceeds............................................. 15 Dividend Policy............................................. 15 Capitalization.............................................. 16 Dilution.................................................... 17 Selected Consolidated Financial and Other Data.............. 18 Unaudited Pro Forma Condensed Consolidated Statement of Operations................................................ 22 Management's Discussion and Analysis of Financial Condition and Results of Operations................................. 25 Business of Cross Country, Inc.............................. 36 Management.................................................. 45 Related Party Transactions.................................. 50 Principal Stockholders...................................... 51 Description of Capital Stock................................ 53 Shares Eligible for Future Sale............................. 55 United States Federal Tax Considerations for Non-United States Holders............................................ 57 Underwriting................................................ 60 Legal Matters............................................... 65 Experts..................................................... 65 Where You Can Find More Information......................... 65
------------------------ You should rely on only the information contained in this prospectus. We have not, and the underwriters have not, authorized any other person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not, and the underwriters are not, making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus is accurate only as of the date of the front cover of this prospectus or other date stated in this prospectus. Our business, financial condition, results of operations and prospects may have changed since that date. PROSPECTUS SUMMARY THE FOLLOWING SUMMARY HIGHLIGHTS INFORMATION CONTAINED ELSEWHERE IN THIS PROSPECTUS. IT IS NOT COMPLETE AND DOES NOT CONTAIN ALL OF THE INFORMATION THAT YOU SHOULD CONSIDER BEFORE INVESTING IN OUR COMMON STOCK. YOU SHOULD READ THE ENTIRE PROSPECTUS CAREFULLY, ESPECIALLY THE RISKS OF INVESTING IN OUR COMMON STOCK DISCUSSED UNDER RISK FACTORS AND OUR CONSOLIDATED FINANCIAL STATEMENTS AND ACCOMPANYING NOTES. UNLESS OTHERWISE SPECIFIED, ALL INFORMATION IN THIS PROSPECTUS ASSUMES NO EXERCISE OF THE UNDERWRITERS' OVER-ALLOTMENT OPTION. THE INFORMATION IN THIS PROSPECTUS WILL BE ADJUSTED TO REFLECT A FOR STOCK SPLIT, WHICH WILL BE APPROVED AND CONSUMMATED PRIOR TO THIS OFFERING. CROSS COUNTRY, INC. We are the largest provider of healthcare staffing services in the United States. Approximately 80% of our revenue is derived from travel nurse staffing. We also provide complementary services, including staffing of clinical trials and allied health professionals, search and recruitment, consulting and education and training. Our active client base includes over 2,500 hospitals, pharmaceutical companies and other healthcare providers across all 50 states. Our fees are paid directly by our clients rather than by government or other third-party payors. We are well positioned to take advantage of current industry dynamics, including the growing shortage of nurses in the United States, the growing demand for healthcare services and the trend among healthcare providers toward outsourcing staffing services. For the year ended December 31, 2000, our revenue and EBITDA, pro forma for the acquisitions of ClinForce, Inc. and Heritage Professional Education, LLC, were $407.3 million and $51.1 million, respectively. INDUSTRY DYNAMICS The STAFFING INDUSTRY REPORT, an independent staffing industry publication, estimates that the healthcare segment of the temporary staffing market generated $7.2 billion in revenue in 2000 and that this segment will grow 18% to $8.5 billion in 2001. Several trends are driving demand for our healthcare staffing services, including: - A growing shortage of registered nurses throughout the country. A recent study published in the JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION projects that by 2020, the nationwide registered nurse workforce will be nearly 20% below projected requirements. - Increasing demand for healthcare services as a result of the aging of the baby boomers and technological advances in healthcare delivery. - Greater use of temporary staffing by healthcare providers to manage seasonal fluctuations in demand for their services. The use of temporary personnel enables providers to vary their staffing levels to match these changes in demand while avoiding the more costly alternative of hiring permanent staff. OUR COMPETITIVE STRENGTHS Our competitive strengths include: - LEADER IN THE RAPIDLY GROWING NURSE STAFFING INDUSTRY. We have operated in the travel nurse staffing industry since the 1970s and have the leading brand name. Our Cross Country TravCorps brand is well recognized among leading healthcare providers and professionals. We believe that through our relationships with existing travel nurse staffing clients, we are positioned to market complementary services, including staffing of clinical trials and allied health professionals, search and recruitment, consulting, and education and training to our existing client base. 1 - STRONG AND DIVERSE CLIENT RELATIONSHIPS. We provide staffing solutions to an active client base of over 2,500 hospitals, pharmaceutical companies and other healthcare providers across all 50 states. We do not rely on any geographic region or client for a significant portion of our revenue. No single client accounted for more than 3% of our revenue in 2000. In 2000, we worked with over 75% of the nation's top hospitals, as identified by U.S. NEWS AND WORLD REPORT. We provide temporary staffing to our clients through assignments that typically have terms of 13 weeks or longer. Our fees are paid directly by our clients rather than by government or other third-party payors. - LEADER IN RECRUITING AND EMPLOYEE RETENTION. We are a leader in the recruitment and retention of highly qualified healthcare professionals. We recruit healthcare professionals from all 50 states and Canada. In 2000, we received approximately 28,000 requests for applications from potential field employees and approximately 12,500 completed applications were added to our database. Employee referrals generate a majority of our new candidates. We believe we offer appealing assignments, competitive compensation packages, attractive housing options and other valuable benefits. Historically, approximately 70% of our nurses have accepted new assignments with us within 35 days of completion of previous assignments. In 2000, we were recognized by WORKING MOTHER MAGAZINE as a top 100 national employer of working mothers. - SCALABLE AND EFFICIENT OPERATING STRUCTURE. We have an efficient centralized operating structure that includes a database of more than 146,000 nurses and other healthcare professionals who have completed job applications with us. Our size and centralized structure provide us with operating efficiencies in key areas such as recruiting, advertising, marketing, training, housing and insurance benefits. Our fully integrated proprietary information system enables us to manage virtually all aspects of our travel staffing operations. This system is designed to accommodate significant future growth of our business. - STRONG MANAGEMENT TEAM WITH EXTENSIVE HEALTHCARE STAFFING AND ACQUISITION EXPERIENCE. Our management team, which averages 15 years of experience in the healthcare industry, has played a key role in the development of the travel nurse staffing industry. Our management team has consistently demonstrated the ability to successfully identify and integrate strategic acquisitions. GROWTH STRATEGY We intend to continue to grow our business by: - ENHANCING OUR ABILITY TO FILL UNMET DEMAND FOR OUR TRAVEL STAFFING SERVICES. There is substantial unmet demand for our travel staffing services. We are striving to meet a greater portion of this demand by recruiting additional healthcare personnel. Our recruitment strategy for nurses and other healthcare professionals is focused on: - increasing referrals from existing field employees by providing them with superior service; - expanding our advertising presence to reach more nursing professionals; - using the internet to accelerate the recruitment-to-placement cycle; - increasing the number of staff dedicated to the recruitment of new nurses; and - developing Assignment America, our recruitment program for foreign-trained nurses residing abroad. - INCREASING OUR MARKET PRESENCE IN THE PER DIEM STAFFING MARKET. We intend to use our existing brand recognition, client relationships and database of nurses who have expressed an interest in temporary assignments to expand our per diem services to the acute care hospital market. While 2 we have not historically had a significant presence in per diem staffing services, we believe that this market presents a substantial growth opportunity. - EXPANDING THE RANGE OF SERVICES WE OFFER OUR CLIENTS. We plan to utilize our relationships with existing travel staffing clients to more effectively market complementary services, including staffing of clinical trials and allied health professionals, search and recruitment, consulting, and education and training. - ACQUIRING COMPLEMENTARY BUSINESSES. We intend to continue to evaluate opportunities to acquire complementary businesses to strengthen and broaden our market presence. - INCREASING OPERATING EFFICIENCIES. We seek to increase our operating margins by increasing the productivity of our administrative personnel, using our purchasing power to achieve greater savings in key areas such as housing and benefits and continuing to invest in our information systems. RECENT DEVELOPMENTS In May 2001, we acquired Gill/Balsano Consulting, L.L.C., or Gill/Balsano, a management consulting firm focused on the rehabilitation services sector. In March 2001, we acquired ClinForce, Inc., or ClinForce, the clinical trials staffing subsidiary of Edgewater Technology, Inc. These acquisitions broaden the array of services that complement our core travel nurse staffing business. ------------------------ In July 1999, an affiliate of Charterhouse Group International, Inc., or Charterhouse, and certain members of management acquired the assets of Cross Country Staffing, a Delaware partnership, our predecessor, from W. R. Grace & Co. In December 1999, we acquired TravCorps Corporation, or TravCorps, which was owned by funds managed by Morgan Stanley Private Equity and certain members of TravCorps' management. We were incorporated in Delaware in 1999. Our principal executive offices are located at 6551 Park of Commerce Blvd, N.W., Suite 200, Boca Raton, FL 33487. Our telephone number at that address is (561) 998-2232. Our World Wide Web site address is www.crosscountry.com. Our website address is included in this prospectus as an inactive textual reference only. The information in our website is not intended to be incorporated into this prospectus by reference and should not be considered a part of this prospectus. 3 THE OFFERING Common stock offered by Cross Country, Inc.: U.S. offering...................................... shares International offering............................. shares Total............................................ shares Common stock outstanding after the offering.......... shares Use of proceeds...................................... We estimate that our net proceeds from this offering will be approximately $114.8 million. We intend to use these proceeds as follows: - approximately $75.6 million to repay indebtedness outstanding under our credit facility; and - approximately $39.2 million to redeem all of our senior subordinated notes and pay a redemption premium. Risk factors......................................... See "Risk Factors" and other information included in this prospectus for a discussion of factors you should carefully consider before deciding to invest in shares of our common stock. Nasdaq National Market symbol........................ CCRN
The number of shares outstanding after the offering excludes shares reserved for issuance under our stock option plans, of which options to purchase shares at a weighted average exercise price of $ have been granted. 4 SUMMARY CONSOLIDATED FINANCIAL AND OTHER DATA The summary consolidated financial data for the five-month period July 30, 1999 to December 31, 1999 and for the year ended December 31, 2000 are derived from the audited consolidated financial statements of Cross Country, Inc., or Cross Country, included elsewhere in this prospectus. The summary financial data for the year ended December 31, 1998 and for the seven-month period January 1, 1999 to July 29, 1999 were derived from the audited financial statements of Cross Country Staffing, our predecessor company, included elsewhere in this prospectus. The data for the three month periods ended March 31, 2000 and 2001 are derived from our unaudited consolidated financial statements included elsewhere in this prospectus. The unaudited consolidated financial statements include all adjustments, consisting of normal recurring accruals, which we consider necessary for a fair presentation of our financial position and results of operations for these periods. Operating results for the three months ended March 31, 2001 are not necessarily indicative of the results that may be expected for the entire year ending December 31, 2001. The pro forma as adjusted consolidated statement of operations for the year ended December 31, 2000 and the three months ended March 31, 2001 are pro forma for the Heritage Professional Education, LLC, or Heritage, and ClinForce acquisitions and as adjusted for the offering and expected use of proceeds as if these events had occurred on January 1, 2000 and January 1, 2001, respectively. The as adjusted consolidated balance sheet data as of March 31, 2001 are as adjusted for the offering and expected use of proceeds as if these events had occurred on March 31, 2001. The summary data below should be read in conjunction with the consolidated financial statements and related notes of Cross Country, Inc., Cross Country Staffing, TravCorps Corporation and Subsidiary, ClinForce, Inc., the "Pro Forma Condensed Consolidated Statement of Operations" and related notes, "Management's Discussion and Analysis of Financial Condition and Results of Operations", "Use of Proceeds" and other financial information included elsewhere in this prospectus. 5
YEAR ENDED PREDECESSOR(A) DECEMBER 31, ------------------------- ------------------------ PERIOD FROM PERIOD FROM JANUARY 1 JULY 30 PRO YEAR ENDED THROUGH THROUGH FORMA DECEMBER 31, JULY 29, DECEMBER 31, AS ADJUSTED 1998 1999 1999(B) 2000 2000(C) ------------ ---------- ------------ ---------- ----------- (DOLLARS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA) CONSOLIDATED STATEMENT OF OPERATIONS DATA Revenue from services.... $ 158,592 $ 106,047 $ 87,727 $ 367,690 $ 407,276 Operating expenses: Direct operating expenses............. 121,951 80,187 68,036 273,095 297,796 Selling, general and administrative expenses(e).......... 19,070 12,688 9,257 49,027 57,840 Bad debt expense....... 722 157 511 433 543 Depreciation........... 264 212 155 1,324 1,459 Amortization........... 859 496 4,422 13,701 15,215 Non-recurring indirect transaction costs(f)............. -- -- -- 1,289 1,289 ---------- ---------- ---------- ---------- ---------- Total operating expenses........... 142,866 93,740 82,381 338,869 374,142 ---------- ---------- ---------- ---------- ---------- Income from operations... 15,726 12,307 5,346 28,821 33,134 Other expenses: Interest expense, net.................. 850 230 4,821 15,435 4,404 Other expenses......... 183 190 -- -- -- ---------- ---------- ---------- ---------- ---------- Income before income taxes and discontinued operations........... 14,693 11,887 525 13,386 28,730 Income tax expense(g)........... -- -- 672 6,730 12,673 ---------- ---------- ---------- ---------- ---------- Income (loss) before discontinued operations........... 14,693 11,887 (147) 6,656 16,057 Discontinued operations: Loss from discontinued operations, net of income taxes(h)...... -- -- (195) (1,604) -- Loss on disposal(h).... -- -- -- (454) -- ---------- ---------- ---------- ---------- ---------- Net income (loss)...... $ 14,693 $ 11,887 $ (342) $ 4,598 $ 16,057 ========== ========== ========== ========== ========== Basic and diluted income (loss) per common share(i): Income (loss) before discontinued operations........... $ (.06) $ 1.66 $ Discontinued operations........... (.07) (.51) ---------- ---------- ---------- ---------- ---------- Net income (loss)...... $ (.13) $ 1.15 $ ========== ========== ========== ========== ========== Weighted-average number of shares outstanding: Basic and diluted.... 2,635,895 3,999,998 THREE MONTHS ENDED MARCH 31, ------------------------------------- PRO FORMA AS ADJUSTED 2000 2001 2001(D) ---------- ---------- ----------- (DOLLARS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA) CONSOLIDATED STATEMENT OF OPERATIONS DATA Revenue from services.... $ 89,584 $ 103,872 $ 111,565 Operating expenses: Direct operating expenses............. 67,063 79,002 84,352 Selling, general and administrative expenses(e).......... 12,054 14,175 15,781 Bad debt expense....... 234 420 420 Depreciation........... 309 518 553 Amortization........... 3,435 3,592 3,853 Non-recurring indirect transaction costs(f)............. 267 -- -- ---------- ---------- ---------- Total operating expenses........... 83,362 97,707 104,959 ---------- ---------- ---------- Income from operations... 6,222 6,165 6,606 Other expenses: Interest expense, net.................. 3,833 4,008 1,796 Other expenses......... -- -- -- ---------- ---------- ---------- Income before income taxes and discontinued operations........... 2,389 2,157 4,810 Income tax expense(g)........... 1,202 1,085 2,106 ---------- ---------- ---------- Income (loss) before discontinued operations........... 1,187 1,072 2,704 Discontinued operations: Loss from discontinued operations, net of income taxes(h)...... (286) (440) -- Loss on disposal(h).... -- (623) -- ---------- ---------- ---------- Net income (loss)...... $ 901 $ 9 $ 2,704 ========== ========== ========== Basic and diluted income (loss) per common share(i): Income (loss) before discontinued operations........... $ .30 $ .27 $ Discontinued operations........... (.07) (.27) ---------- ---------- ---------- Net income (loss)...... $ .23 $ -- $ ========== ========== ========== Weighted-average number of shares outstanding: Basic and diluted.... 3,999,998 3,999,998
6
YEAR ENDED THREE MONTHS PREDECESSOR(A) DECEMBER 31, ENDED MARCH 31, ------------------------- ------------------------ ------------------------------------- PERIOD FROM PERIOD FROM JANUARY 1 JULY 30 PRO PRO YEAR ENDED THROUGH THROUGH FORMA FORMA DECEMBER 31, JULY 29, DECEMBER 31, AS ADJUSTED AS ADJUSTED 1998 1999 1999(B) 2000 2000(C) 2000 2001 2001(D) ------------ ---------- ------------ ---------- ----------- ---------- ---------- ----------- (DOLLARS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA) OTHER OPERATING DATA EBITDA(j)............. $ 16,849 $ 13,015 $ 9,923 $ 45,135 $ 51,097 $ 10,233 $ 10,275 $ 11,012 EBITDA as a % of revenue............. 10.6% 12.3% 11.3% 12.3% 12.5% 11.4% 9.9% 9.9% FTE's(k).............. 2,264 2,466 2,789 4,167 4,452 4,289 4,361 4,631 Weeks worked(l)....... 117,728 73,980 61,358 216,684 231,504 55,757 56,687 60,203 Average contract revenue per week(m)............. $ 1,347 $ 1,429 $ 1,417 $ 1,616 $ 1,638 $ 1,544 $ 1,698 $ 1,727 Net cash flow provided by (used in) operating activities.......... $ 14,434 $ 12,178 $ 6,301 $ 10,397 $ 3,286 $ 5,009 Net cash flow provided by (used in) investing activities.......... $ (977) $ (202) $ 1,380 $ (9,584) $ (506) $ (32,605) Net cash flow provided by (used in) financing activities.......... $ (13,458) $ (11,977) $ (3,111) $ (5,641) $ (7,417) $ 27,596
AS OF MARCH 31, 2001 ---------------------------- ACTUAL AS ADJUSTED(N) ---------- --------------- (DOLLARS IN THOUSANDS) CONSOLIDATED BALANCE SHEET DATA Working capital............................................. $ 37,691 $ 37,691 Cash and cash equivalents................................... -- -- Total assets................................................ 349,926 342,872 Total debt.................................................. 186,883 75,799 Stockholders' equity........................................ $ 122,424 $ 231,937
------------------------------ (a) On July 29, 1999, we acquired the assets of Cross Country Staffing which, for accounting and reporting purposes, is our predecessor. Financial data for periods prior to July 30, 1999 is that of Cross Country Staffing. (b) Includes TravCorps results from December 16, 1999, the date of its acquisition, through December 31, 1999. (c) Reflects the following adjustments as if the offering and the Heritage and ClinForce acquisitions had occurred on January 1, 2000: - additional amortization expense of $0.9 million related to $34.0 million of goodwill and other intangibles acquired in the Heritage and ClinForce acquisitions; - a reduction in interest expense of $11.0 million as a result of the repayment of $35.5 million of senior subordinated debt (12.00% interest rate) and $77.3 million of borrowings outstanding under our credit facility using the weighted average rate in effect during the year ended December 31, 2000 (9.74%); and - additional income tax expense of $5.9 million as a result of the above adjustments. (d) Reflects the following adjustments as if the offering and the Heritage and ClinForce acquisitions had occurred on January 1, 2001: - additional amortization expense of $0.2 million related to $34.0 million of goodwill and other intangibles acquired in the Heritage and ClinForce acquisitions; - a reduction in interest expense of $2.2 million as a result of the repayment of $36.6 million of senior subordinated debt (12.0% interest rate) and $75.6 million of borrowings outstanding under our credit facility using the weighted average interest rate in effect during the three months ended March 31, 2001 (9.27%); and - additional income tax expense of $1.0 million as a result of the above adjustments. (e) Includes expenses related to a discontinued management incentive compensation plan of $2.1 million and $2.7 million for the seven-month period January 1-July 29, 1999 and the year ended December 31, 1998, respectively. The management incentive compensation plan was discontinued on July 30, 1999. (f) Non-recurring indirect transaction costs consist of non-capitalizable transition bonuses and integration costs related to the TravCorps acquisition. 7 (g) Prior to July 30, 1999, our predecessor, Cross Country Staffing, operated as a partnership under the applicable provisions of the Internal Revenue Code, and, accordingly, income related to the operations of Cross Country Staffing was taxed directly to its partners. (h) Reflects the operating results of HospitalHub, Inc., which began operations in 1999. We completed the divestiture of HospitalHub, Inc. during the second quarter of 2001. (i) The financial data contained herein for periods prior to July 30, 1999, is that of our predecessor, Cross Country Staffing, a partnership, for which share and per share amounts were not applicable. (j) We define EBITDA as income before interest, income taxes, depreciation, amortization and non-recurring indirect transaction costs. EBITDA should not be considered a measure of financial performance under generally accepted accounting principles. Items excluded from EBITDA are significant components in understanding and assessing financial performance. EBITDA is a key measure used by management to evaluate our operations and provide useful information to investors. EBITDA should not be considered in isolation or as an alternative to net income, cash flows generated by operations, investing or financing activities, or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, EBITDA as presented may not be comparable to other similarly titled measures of other companies. (k) FTE's represent the average number of contract staffing personnel on a full-time equivalent basis. (l) Weeks worked is calculated by multiplying the FTE's by the number of weeks during the respective period. (m) Average contract revenue per week is calculated by dividing the revenue received under our staffing contracts by the number of weeks worked during the respective period. (n) Reflects the following adjustments as if the offering had occurred on March 31, 2001: - increase in stockholders' equity of $114.8 million from the offering. - repayment of $36.6 million of senior subordinated debt, plus a $1.5 million redemption premium, and repayment of $75.6 million of borrowings outstanding under our credit facility. 8 RISK FACTORS RISKS RELATED TO OUR BUSINESS CURRENTLY WE ARE UNABLE TO RECRUIT ENOUGH NURSES TO MEET OUR CLIENTS' DEMANDS FOR OUR NURSE STAFFING SERVICES, LIMITING THE POTENTIAL GROWTH OF OUR STAFFING BUSINESS. We rely significantly on our ability to attract, develop and retain nurses and other healthcare personnel who possess the skills, experience and, as required, licensure necessary to meet the specified requirements of our healthcare staffing clients. We compete for healthcare staffing personnel with other temporary healthcare staffing companies, as well as actual and potential clients, some of which seek to fill positions with either regular or temporary employees. Currently, there is a shortage of qualified nurses in most areas of the United States and competition for nursing personnel is increasing. At this time we do not have enough nurses to meet our clients' demands for our nurse staffing services. This shortage of nurses limits our ability to grow our staffing business. Furthermore, we believe that the aging of the existing nurse population and declining enrollments in nursing schools will further exacerbate the existing nurse shortage. THE COSTS OF ATTRACTING AND RETAINING QUALIFIED NURSES AND OTHER HEALTHCARE PERSONNEL MAY RISE MORE THAN WE ANTICIPATE. We compete with other healthcare staffing companies for qualified nurses and other healthcare personnel. Because there is currently a shortage of qualified healthcare personnel, competition for these employees is intense. To induce healthcare personnel to sign on with them, our competitors may increase hourly wages or other benefits. If we do not raise wages in response to such increases by our competitors, we could face difficulties attracting and retaining qualified healthcare personnel. In addition, if we raise wages in response to our competitors' wage increases and are unable to pass such cost increases on to our clients, our margins could decline. OUR COSTS OF PROVIDING HOUSING FOR NURSES AND OTHER HEALTHCARE PERSONNEL MAY BE HIGHER THAN WE ANTICIPATE AND, AS A RESULT, OUR MARGINS COULD DECLINE. We currently have approximately 2,900 apartments on lease throughout the U.S. If the costs of renting apartments and furniture for our nurses and other healthcare personnel increase more than we anticipate and we are unable to pass such increases on to our clients, our margins may decline. To the extent the length of a nurse's housing lease exceeds the term of the nurse's staffing contract, we bear the risk that we will be obligated to pay rent for housing we do not use. To limit the costs of unutilized housing, we try to secure leases with term lengths that match the term lengths of our staffing contracts, typically 13 weeks. In some housing markets we have had, and believe we will continue to have, difficulty identifying short-term leases. If we cannot identify a sufficient number of appropriate short-term leases in regional markets, or, if for any reason, we are unable to efficiently utilize the apartments we do lease, we may be required to pay rent for unutilized housing or, to avoid such risk, we may forego otherwise profitable opportunities. DECREASES IN PATIENT OCCUPANCY AT OUR CLIENTS' FACILITIES MAY ADVERSELY AFFECT THE PROFITABILITY OF OUR BUSINESS. Demand for our temporary healthcare staffing services is significantly affected by the general level of patient occupancy at our clients' facilities. When a hospital's occupancy increases, temporary employees are often added before full-time employees are hired. As occupancy decreases, clients may reduce their use of temporary employees before undertaking layoffs of their regular employees. We also may experience more competitive pricing pressure during periods of occupancy downturn. In addition, if a trend emerges toward providing healthcare in alternative settings, as opposed to acute care hospitals, occupancy at our clients' facilities could decline. This reduction in occupancy could adversely affect the demand for our services and our profitability. 9 WE ARE DEPENDENT ON THE PROPER FUNCTIONING OF OUR INFORMATION SYSTEMS. Our company is dependent on the proper functioning of our information systems in operating our business. Critical information systems used in daily operations identify and match staffing resources and client assignments and perform billing and accounts receivable functions. Our information systems are protected through physical and software safeguards and we have backup remote processing capabilities. However, they are still vulnerable to fire, storm, flood, power loss, telecommunications failures, physical or software break-ins and similar events. In the event that critical information systems fail or are otherwise unavailable, these functions would have to be accomplished manually, which could temporarily impact our ability to identify business opportunities quickly, to maintain billing and clinical records reliably and to bill for services efficiently. WE MAY EXPERIENCE DIFFICULTIES WITH OUR RECENTLY IMPLEMENTED FINANCIAL PLANNING AND REPORTING SYSTEM. In March 2001, we implemented a new financial planning and reporting system. We may face difficulties or incur additional costs integrating data, including data from companies acquired by us, to make it compatible with the new system. If we experience difficulties with our system, our ability to generate timely and accurate financial reports could be adversely affected. IF REGULATIONS THAT APPLY TO US CHANGE, WE MAY FACE INCREASED COSTS THAT REDUCE OUR REVENUE AND PROFITABILITY. The temporary healthcare staffing industry is regulated in many states. In some states, firms such as our company must be registered to establish and advertise as a nurse staffing agency or must qualify for an exemption from registration in those states. If we were to lose any required state licenses, we could be required to cease operating in those states. The introduction of new regulatory provisions could substantially raise the costs associated with hiring temporary employees. For example, some states could impose sales taxes or increase sales tax rates on temporary healthcare staffing services. These increased costs may not be able to be passed on to clients without a decrease in demand for temporary employees. In addition, if government regulations were implemented that limited the amounts we could charge for our services, our profitability could be adversely affected. FUTURE CHANGES IN REIMBURSEMENT TRENDS COULD HAMPER OUR CLIENTS' ABILITY TO PAY US. Many of our clients are reimbursed under the federal Medicare program and state Medicaid programs for the services they provide. In recent years, federal and state governments have made significant changes in these programs that have reduced reimbursement rates. In addition, insurance companies and managed care organizations seek to control costs by requiring that healthcare providers, such as hospitals, discount their services in exchange for exclusive or preferred participation in their benefit plans. Future federal and state legislation or evolving commercial reimbursement trends may further reduce, or change conditions for, our clients' reimbursement. Limitations on reimbursement could reduce our clients' cash flows, hampering their ability to pay us. COMPETITION FOR ACQUISITION OPPORTUNITIES MAY RESTRICT OUR FUTURE GROWTH BY LIMITING OUR ABILITY TO MAKE ACQUISITIONS AT REASONABLE VALUATIONS. Our business strategy includes increasing our market share and presence in the temporary healthcare staffing industry through strategic acquisitions of companies that complement or enhance our business. We have historically faced competition for acquisitions. In the future, this could limit our ability to grow by acquisitions or could raise the prices of acquisitions and make them less accretive to us. In addition, restrictive covenants in our credit facility, including a covenant that requires us to obtain bank approval for any acquisition over $10 million, may limit our ability to complete desirable acquisitions. If we are unable to secure necessary financing under our credit facility or otherwise, we may be unable to complete desirable acquisitions. 10 WE MAY FACE DIFFICULTIES INTEGRATING OUR ACQUISITIONS INTO OUR OPERATIONS AND OUR ACQUISITIONS MAY BE UNSUCCESSFUL, INVOLVE SIGNIFICANT CASH EXPENDITURES OR EXPOSE US TO UNFORESEEN LIABILITIES. We expect to continue pursuing acquisitions of temporary healthcare staffing companies and travel healthcare companies that complement or enhance our business. These acquisitions involve numerous risks, including: - potential loss of key employees or clients of acquired companies; - difficulties integrating acquired personnel and distinct cultures into our business; - difficulties integrating acquired companies into our operating, financial planning and financial reporting systems; - diversion of management attention from existing operations; and - assumption of liabilities and exposure to unforeseen liabilities of acquired companies, including liabilities for their failure to comply with healthcare regulations. These acquisitions may also involve significant cash expenditures, debt incurrence and integration expenses that could have a material adverse effect on our financial condition and results of operations. Any acquisition may ultimately have a negative impact on our business and financial condition. SIGNIFICANT LEGAL ACTIONS COULD SUBJECT US TO SUBSTANTIAL UNINSURED LIABILITIES. In recent years, healthcare providers have become subject to an increasing number of legal actions alleging malpractice, product liability or related legal theories. Many of these actions involve large claims and significant defense costs. In addition, we may be subject to claims related to torts or crimes committed by our employees or temporary staffing personnel. In some instances, we are required to indemnify clients against some or all of these risks. A failure of any of our employees or personnel to observe our policies and guidelines intended to reduce these risks, relevant client policies and guidelines or applicable federal, state or local laws, rules and regulations could result in negative publicity, payment of fines or other damages. To protect ourselves from the cost of these claims, we maintain professional malpractice liability insurance and general liability insurance coverage in amounts and with deductibles that we believe are appropriate for our operations. However, our insurance coverage may not cover all claims against us or continue to be available to us at a reasonable cost. If we are unable to maintain adequate insurance coverage, we may be exposed to substantial liabilities. IF WE BECOME SUBJECT TO MATERIAL LIABILITIES UNDER OUR SELF-INSURED PROGRAMS, OUR FINANCIAL RESULTS MAY BE ADVERSELY AFFECTED. We provide workers compensation coverage through a program that is partially self-insured. In addition, we provide medical coverage to our employees through a partially self-insured preferred provider organization. If we become subject to substantial uninsured workers compensation or medical coverage liabilities, our financial results may be adversely affected. OUR CLIENTS MAY TERMINATE OR NOT RENEW THEIR STAFFING CONTRACTS WITH US. Our travel staffing arrangements with clients are generally terminable upon 30 or 90 days' notice. We may have fixed costs, including housing costs, associated with terminated arrangements that we will be obligated to pay post-termination. Our clinical trials staffing business is conducted under long-term contracts with individual clients that may conduct numerous clinical trials. Some of these long-term contracts are terminable by the clients without cause upon 30 to 60 days notice. 11 OUR INDEMNITY FROM W. R. GRACE, IN CONNECTION WITH OUR ACQUISITION OF THE ASSETS OF CROSS COUNTRY STAFFING, MAY BE MATERIALLY IMPAIRED BY GRACE'S FINANCIAL CONDITION. In connection with our acquisition from W. R. Grace & Co. of the assets of Cross Country Staffing, our predecessor, Grace agreed to indemnify us against damages arising out of the breach of any representation or warranty of Grace, as well as against any liabilities retained by Grace. In March 2001, Grace filed a voluntary petition under Chapter 11 of the United States Bankruptcy Code. This bankruptcy filing could materially impair Grace's obligations to indemnify us. RISKS RELATED TO THIS OFFERING BECAUSE OUR PRINCIPAL STOCKHOLDERS CONTROL US, THEY WILL BE ABLE TO DETERMINE THE OUTCOME OF ALL MATTERS SUBMITTED TO OUR STOCKHOLDERS FOR APPROVAL, REGARDLESS OF THE PREFERENCES OF OTHER STOCKHOLDERS. Following this offering, Charterhouse Equity Partners III, or CEP III, and investment funds managed by Morgan Stanley Private Equity together will own approximately % of our outstanding common stock. Accordingly, acting together, they will be able to: - elect our entire board of directors; - control our management and policies; and - determine, without the consent of our other stockholders, the outcome of any corporate transaction or other matter submitted to our stockholders for approval, including mergers, consolidations and the sale of all or substantially all of our assets. CEP III and investment funds managed by Morgan Stanley Private Equity, acting together, will also be able to prevent or cause a change in control of us and will be able to amend our certificate of incorporation and bylaws at any time. Their interests may conflict with the interests of the other holders of common stock. YOU WILL EXPERIENCE IMMEDIATE AND SIGNIFICANT DILUTION IN BOOK VALUE PER SHARE. The initial public offering price of our common stock is substantially higher than the net tangible book value per share of our outstanding common stock will be immediately after this offering. Net tangible book value per share represents the amount of total tangible assets less total liabilities, divided by the number of shares outstanding. If you purchase our common stock in this offering, you will incur immediate dilution of approximately $ in the net tangible book value per share of common stock in this offering, based on an assumed initial public offering price of $ per share. We also have a significant number of outstanding options to purchase our common stock with exercise prices significantly below the initial public offering price of the common stock. To the extent these options are exercised, there will be further dilution. AN AGGREGATE OF APPROXIMATELY MILLION SHARES WILL BECOME ELIGIBLE FOR RESALE IN THE PUBLIC MARKET 180 DAYS AFTER THIS OFFERING, AND FUTURE SALES OF THIS STOCK MAY CAUSE OUR STOCK PRICE TO DECLINE. Sales of substantial amounts of our common stock in the public market after the completion of this offering, or the perception that these sales could occur, could adversely affect the market price of our common stock and could materially impair our future ability to raise capital through offerings of our common stock. An aggregate of shares of common stock will be outstanding after this offering. Of these, the shares offered by this prospectus will be freely tradable without restriction or further registration. In connection with this offering, we and our officers, directors and substantially all of our existing stockholders, who together hold shares, have agreed not to sell or transfer any shares of our common stock for 180 days after completion of this offering without the underwriters' consent. While 12 the underwriters may release these shares from the restrictions at any time, this will be done, if at all, only on a case-by-case basis. The underwriters do not currently have any intention of consenting to a waiver of these restrictions. CEP III and investment funds managed by Morgan Stanley Private Equity each have demand rights to cause us to file, at our expense, a registration statement under the Securities Act covering resales of their shares. These shares, along with shares held by others who can participate in the registrations, will represent % of our outstanding common stock after the offering. CEP III and the investment funds of Morgan Stanley Private Equity have informed us that they do not presently intend to exercise their demand registration rights, although they retain the right to do so. These shares may also be sold under Rule 144 of the Securities Act, depending on their holding period and subject to significant restrictions in the case of shares held by persons deemed to be our affiliates. In addition, after this offering, we also intend to register shares of common stock for issuance under our stock option plans. As of March 31, 2001, options to purchase shares of common stock were issued and outstanding, of which shares have vested. We cannot predict what effect, if any, market sales of shares held by any stockholder or the availability of these shares for future sale will have on the market price of our common stock. See "Shares Eligible for Future Sale" for a more detailed description of the restrictions on selling shares of our common stock after this offering. IF OUR STOCK PRICE DECLINES AFTER THE INITIAL OFFERING, YOU COULD LOSE A SIGNIFICANT PART OF YOUR INVESTMENT. Prior to this offering, there has been no public market for our common stock. We do not know if an active trading market will develop for our common stock or how the common stock will trade in the future. Negotiations between the underwriters and us will determine the initial public offering price. You may not be able to resell your shares at or above the initial public offering price due to fluctuations in the market price of our common stock due to changes in our operating performance or prospects. In addition, the stock market in general has experienced extreme volatility that often has been unrelated to the operating performance or prospects of particular companies. IF PROVISIONS IN OUR CORPORATE DOCUMENTS AND DELAWARE LAW DELAY OR PREVENT A CHANGE IN CONTROL OF OUR COMPANY, WE MAY BE UNABLE TO CONSUMMATE A TRANSACTION THAT OUR STOCKHOLDERS CONSIDER FAVORABLE. Our certificate of incorporation and by-laws may discourage, delay or prevent a merger or acquisition involving us that our stockholders may consider favorable. For example, our certificate of incorporation authorizes our board of directors, which is controlled by CEP III and investment funds managed by Morgan Stanley Private Equity, to issue up to shares of "blank check" preferred stock. Without stockholder approval, the board of directors has the authority to attach special rights, including voting and dividend rights, to this preferred stock. With these rights, preferred stockholders could make it more difficult for a third party to acquire us. Delaware law may also discourage, delay or prevent someone from acquiring or merging with us. 13 SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS Some of the matters discussed in this prospectus include forward-looking statements. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates" and similar expressions are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results and performance to be materially different from any future results or performance expressed or implied by these forward-looking statements. These factors include the following: - our ability to attract and retain qualified nurses and other healthcare personnel; - costs and availability of short-term leases for our travel nurses; - demand for the healthcare services we provide, both nationally and in the regions in which we operate; - the functioning of our information systems; - the effect of existing or future government regulation and federal and state legislative and enforcement initiatives on our business; - our clients' ability to pay us for our services; - our ability to successfully implement our acquisition and development strategies; - the effect of liabilities and other claims asserted against us; and - the effect of competition in the markets we serve. Although we believe that these statements are based upon reasonable assumptions, we can not guarantee future results. Given these uncertainties, the forward-looking statements discussed in this prospectus might not occur. These forward-looking statements are made as of the date of this prospectus. Except as may be required under applicable statutes, regulations or court decisions, we undertake no obligation to update or revise them. 14 USE OF PROCEEDS We estimate that our net proceeds from the offering will be $114.8 million, assuming an initial offering price of $ per share and after deducting estimated expenses and underwriting discounts and commissions of $10.3 million. We intend to use the net proceeds of this offering to make the following payments: - approximately $75.6 million to repay a portion of the outstanding balances under our credit facility, which becomes due on July 29, 2005. As of July 1, 2001, the outstanding balance of principal and interest on our credit facility was approximately $146.9 million and the effective interest rate was 7.86%. On March 16, 2001, to finance our acquisition of ClinForce, we amended our credit facility to provide for an additional term loan in the aggregate principal amount of $30.0 million; and - approximately $39.2 million to redeem all of our outstanding senior subordinated notes and pay a redemption premium. The senior subordinated notes accrue interest at a rate of 12.00% per annum, compounded quarterly, and become due on January 1, 2006. As of July 1, 2001, the outstanding balance of principal and interest on the senior subordinated notes was $37.7 million. If the underwriters' over-allotment option is exercised in full, we estimate that our net proceeds will be $132.2 million. Any additional net proceeds will be used to repay additional indebtedness under our credit facility. DIVIDEND POLICY We have not declared or paid any cash dividends on our capital stock. We currently intend to retain future earnings, if any, for use in the operation and expansion of our business and do not anticipate declaring or paying any cash dividends in the foreseeable future. In addition, covenants in our credit facility limit our ability to declare and pay cash dividends on our common stock. 15 CAPITALIZATION The following table shows our capitalization as of March 31, 2001: - on an actual basis; and - on an as adjusted basis to give effect to the sale of shares of our common stock at an assumed public offering price of per share and the application of the net proceeds of the offering to repay a portion of our outstanding debt. See "Use of Proceeds." In addition, you should read the following table in conjunction with our consolidated financial statements and the accompanying notes which are contained elsewhere in this prospectus.
AS OF MARCH 31, 2001 ---------------------------- ACTUAL AS ADJUSTED(A) ----------- -------------- (IN THOUSANDS) Long term debt: Revolving loan facility................................... $ 9,150 $ -- Term loan................................................. 141,780 75,337 12.00% senior subordinated pay-in-kind notes due 2006(b)................................................. 36,554 -- Note payable.............................................. 462 462 ---------- ---------- Total debt.................................................. 187,946 75,799 Less current maturities................................... 12,861 12,861 Total long-term debt.................................... 175,085 62,938 Stockholders' equity: Undesignated preferred stock, $ par value, shares authorized, none issued and outstanding--actual and as adjusted................................................ -- -- Common stock, $ par value; shares authorized, shares issued and outstanding--actual, shares authorized, shares issued and outstanding--as adjusted(c)............................................. 40 40 Additional paid-in capital................................ 119,043 233,793 Retained earnings(d)...................................... 4,265 (972) Accumulated other comprehensive earnings.................. (924) (924) ---------- ---------- Total stockholders' equity.............................. 122,424 231,937 ---------- ---------- Total capitalization.................................. $ 297,509 $ 294,875 ========== ==========
------------------------ (a) As adjusted amounts do not include the use of $1.1 million of proceeds to repay pay-in-kind notes issued between March 31, 2001 and July 1, 2001, and a related redemption premium. (b) Actual amount includes $1.1 million of interest accrued between January 1, 2001 and March 31, 2001. (c) Gives effect to conversion of 131,053 shares of Class B common stock ($.01 par value) into a like amount of Class A common shares. (d) As adjusted amount includes the effects of a $1.5 million redemption premium associated with the prepayment of our pay-in-kind notes and the write-off of $7.1 million of related debt issuance costs as of March 31, 2001, net of taxes. 16 DILUTION Our net tangible book deficit as of March 31, 2001, was approximately $137.5 million, or $ per share of common stock. Net tangible book deficit is the difference between our total tangible assets and our total liabilities. We determined the net tangible book deficit per share by dividing our net tangible book deficit by the total number of shares of common stock outstanding. After giving effect to the issuance and sale of the shares of common stock offered by us in the offering at an assumed initial offering price of $ per share, and after deducting estimated underwriting discounts and commissions and offering expenses payable by us, our pro forma net tangible book deficit as of March 31, 2001 would have been approximately $24.2 million, or $ per share of common stock. This represents an immediate decrease in net tangible book deficit of $ per share to existing stockholders and an immediate dilution of $ per share to new investors purchasing shares of common stock in the offering. The following table illustrates this dilution on a per share basis: Assumed initial public offering price per share............. $ Net tangible book deficit per share as of March 31, 2001.................................................. $ Decrease in net tangible book deficit per share attributable to new investors......................... ---------- Pro forma net tangible book deficit per share after the offering.................................................. ---------- Dilution per share to new investors......................... $ ==========
If the underwriters' over-allotment option is exercised in full, the pro forma net tangible book deficit per share after the offering would be $ per share, the decrease in net tangible book deficit per share to existing shareholders would be $ per share and the dilution in net tangible book value to new investors would be $ per share. The following table sets forth, as of March 31, 2001, the number of shares of common stock purchased from us, the total consideration paid and the average price per share paid by our existing stockholders and to be paid by new investors in the offering at $ , before deduction of estimated underwriting discounts and commissions and other expenses of the offering:
SHARES PURCHASED TOTAL CONSIDERATION -------------------- --------------------- AVERAGE PRICE NUMBER PERCENT AMOUNT PERCENT PER SHARE --------- -------- ---------- -------- ------------- Existing stockholders.......... % $ % $ New investors.................. --------- ----- ---------- ----- ---------- Total...................... 100.0% $ 100.0% $ ========= ===== ========== ===== ==========
The foregoing discussion and table assume no exercise of any outstanding stock options to purchase common stock. As of March 31, 2001 there were shares of common stock issuable upon the exercise of stock options outstanding at a weighted average exercise price of $ . To the extent these options are exercised, there will be further dilution to new investors. 17 SELECTED CONSOLIDATED FINANCIAL AND OTHER DATA The selected consolidated financial data as of December 31, 1999 and 2000 and for the five-month period July 30, 1999 to December 31, 1999 and for the year ended December 31, 2000 are derived from the audited consolidated financial statements of Cross Country, Inc. included elsewhere in this prospectus. The selected financial data as of December 31, 1998 and July 29, 1999 and for the year ended December 31, 1998 and for the seven-month period January 1, 1999 to July 29, 1999 have been derived from the audited financial statements of Cross Country Staffing, included elsewhere in this prospectus. The selected financial data as of December 31, 1996 and 1997 and for the period from July 1, 1996 to December 31, 1996 and for the year ended December 31, 1997 were derived from the financial statements of Cross Country Staffing that have been audited but not included in this prospectus. The selected financial data as of June 30, 1996 and for the period from January 1, 1996 to June 30, 1996 are derived from the unaudited consolidated financial statements of Cross Country Staffing. The data as of March 31, 2001 and for the three month periods ended March 31, 2000 and 2001 are derived from our unaudited consolidated financial statements included elsewhere in this prospectus. The unaudited consolidated financial statements include all adjustments, consisting of normal recurring accruals, which we consider necessary for a fair presentation of our financial position and results of operations for these periods. Operating results for the three months ended March 31, 2001 are not necessarily indicative of the results that may be expected for the entire year ending December 31, 2001. The pro forma as adjusted consolidated statement of operations for the year ended December 31, 2000 and the three months ended March 31, 2001 are pro forma for the Heritage and ClinForce acquisitions and as adjusted for the offering and expected use of proceeds as if these events had occurred on January 1, 2000 and January 1, 2001, respectively. The as adjusted consolidated balance sheet data as of March 31, 2001 are as adjusted for the offering and expected use of proceeds as if these events had occurred on March 31, 2001. The selected consolidated financial data below should be read in conjunction with the consolidated financial statements and related notes of Cross Country, Inc., Cross Country Staffing, TravCorps Corporation and Subsidiary, ClinForce, Inc., the "Pro Forma Condensed Consolidated Statement of Operations" and related notes, "Management's Discussion and Analysis of Financial Condition and Results of Operations" and other financial information included elsewhere in this prospectus. 18
PREDECESSOR(A) ------------------------------------------------------------ PERIOD FROM PERIOD FROM YEAR ENDED DECEMBER JANUARY 1 THROUGH JULY 1 THROUGH 31, JUNE 30, DECEMBER 31, ----------------------- 1996 1996 1997 1998 ----------------- -------------- ---------- ---------- (DOLLARS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA) CONSOLIDATED STATEMENT OF OPERATIONS DATA Revenue from services............ $ 65,045 $ 59,209 $ 138,560 $ 158,592 Operating expenses: Direct operating expenses...... 52,061 46,617 108,726 121,951 Selling, general and administrative expenses(d)... 7,595 7,378 16,051 19,070 Bad debt expense............... 144 437 624 722 Depreciation................... 126 83 150 264 Amortization................... 536 446 875 859 Non-recurring indirect transaction costs(e)......... -- -- -- -- ---------- ---------- ---------- ---------- Total operating expenses....... 60,462 54,961 126,426 142,866 ---------- ---------- ---------- ---------- Income from operations........... 4,583 4,248 12,134 15,726 Other (income) expenses: Interest expense, net.......... 2,602 1,169 1,647 850 Other (income) expenses........ (1,328) 299 37 183 ---------- ---------- ---------- ---------- Income before income taxes and discontinued operations........ 3,309 2,780 10,450 14,693 Income tax expense(f)............ -- -- -- -- ---------- ---------- ---------- ---------- Income (loss) before discontinued operations..................... 3,309 2,780 10,450 14,693 Discontinued operations: Loss from discontinued operations, net of income taxes(g)..................... -- -- -- -- Loss on disposal(g)............ -- -- -- -- ---------- ---------- ---------- ---------- Net income (loss)................ $ 3,309 $ 2,780 $ 10,450 $ 14,693 ========== ========== ========== ========== Basic and diluted income (loss) per common share(h): Income (loss) before discontinued operations...... Discontinued operations........ Net income (loss)............ Weighted-average number of shares outstanding.................... OTHER OPERATING DATA EBITDA(i)........................ $ 5,245 $ 4,777 $ 13,159 $ 16,849 EBITDA as % of revenue........... 8.1% 8.1% 9.5% 10.6% FTE's(j)......................... 2,100 1,846 2,102 2,264 Weeks worked(k).................. 54,596 47,996 109,313 117,728 Average contract revenue per week(l)........................ $ 1,191 $ 1,234 $ 1,268 $ 1,347 Net cash flow provided by (used in) operating activities....... $ 309 $ 3,875 $ 12,374 $ 14,434 Net cash flow provided by (used in) investing activities....... $ (75) $ (89) $ (309) $ (977) Net cash flow provided by (used in) financing activities....... $ (977) $ (3,854) $ (12,064) $ (13,458) PREDECESSOR(A) ----------------- PERIOD FROM YEAR ENDED DECEMBER 31, PERIOD FROM JULY 30 ------------------------ JANUARY 1 THROUGH THROUGH PRO FORMA JULY 29, DECEMBER 31, AS ADJUSTED 1999 1999(B) 2000 2000(C) ----------------- ------------ ---------- ----------- (DOLLARS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA) CONSOLIDATED STATEMENT OF OPERATIONS DATA Revenue from services............ $ 106,047 $ 87,727 $ 367,690 $ 407,276 Operating expenses: Direct operating expenses...... 80,187 68,036 273,095 297,796 Selling, general and administrative expenses(d)... 12,688 9,257 49,027 57,840 Bad debt expense............... 157 511 433 543 Depreciation................... 212 155 1,324 1,459 Amortization................... 496 4,422 13,701 15,215 Non-recurring indirect transaction costs(e)......... -- -- 1,289 1,289 ---------- ---------- ---------- ---------- Total operating expenses....... 93,740 82,381 338,869 374,142 ---------- ---------- ---------- ---------- Income from operations........... 12,307 5,346 28,821 33,134 Other (income) expenses: Interest expense, net.......... 230 4,821 15,435 4,404 Other (income) expenses........ 190 -- -- -- ---------- ---------- ---------- ---------- Income before income taxes and discontinued operations........ 11,887 525 13,386 28,730 Income tax expense(f)............ -- 672 6,730 12,673 ---------- ---------- ---------- ---------- Income (loss) before discontinued operations..................... 11,887 (147) 6,656 16,057 Discontinued operations: Loss from discontinued operations, net of income taxes(g)..................... -- (195) (1,604) -- Loss on disposal(g)............ -- -- (454) -- ---------- ---------- ---------- ---------- Net income (loss)................ $ 11,887 $ (342) $ 4,598 $ 16,057 ========== Basic and diluted income (loss) per common share(h): Income (loss) before discontinued operations...... $ (.06) $ 1.66 Discontinued operations........ (.07) (.51) ---------- ---------- ---------- Net income (loss)............ $ (.13) $ 1.15 ========== ========== ========== Weighted-average number of shares outstanding.................... 2,635,895 3,999,998 ========== ========== ========== OTHER OPERATING DATA EBITDA(i)........................ $ 13,015 $ 9,923 $ 45,135 $ 51,097 EBITDA as % of revenue........... 12.3% 11.3% 12.3% 12.5% FTE's(j)......................... 2,466 2,789 4,167 4,452 Weeks worked(k).................. 73,980 61,358 216,684 231,504 Average contract revenue per week(l)........................ $ 1,429 $ 1,417 $ 1,616 $ 1,638 Net cash flow provided by (used in) operating activities....... $ 12,178 $ 6,301 $ 10,397 Net cash flow provided by (used in) investing activities....... $ (202) $ 1,380 $ (9,584) Net cash flow provided by (used in) financing activities....... $ (11,977) $ (3,111) $ (5,641)
AS OF DECEMBER 31, AS OF ------------------------------------ AS OF JUNE 30, 1996 1996 1997 1998 JULY 29, 1999 ------------- ---------- ---------- ---------- ------------- CONSOLIDATED BALANCE SHEET DATA Working capital.......................... $ 2,061 $ 12,710 $ 12,372 $ 12,871 $ 9,752 Cash and cash equivalents................ (1,476) -- 1 -- -- Total assets............................. 27,305 34,933 36,080 41,901 44,464 Total debt............................... 45,045 30,280 18,700 13,173 7,874 Stockholders' equity(m).................. (24,738) (2,471) 7,122 13,451 19,466 AS OF DECEMBER 31, ------------------------------- 1999 2000 ---------- ---------- CONSOLIDATED BALANCE SHEET DATA Working capital.......................... $ 33,998 $ 34,375 Cash and cash equivalents................ 4,828 -- Total assets............................. 309,695 317,626 Total debt............................... 159,074 157,272 Stockholders' equity(m).................. 118,742 123,340
19
THREE MONTHS ENDED MARCH 31, ------------------------------------- PRO FORMA AS ADJUSTED 2000 2001 2001(N) ---------- ---------- ----------- (DOLLARS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA) CONSOLIDATED STATEMENT OF OPERATIONS DATA Revenue from services....................................... $ 89,584 $ 103,872 $ 111,565 Operating expenses: Direct operating expenses................................. 67,063 79,002 84,352 Selling, general and administrative expenses.............. 12,054 14,175 15,781 Bad debt expense.......................................... 234 420 420 Depreciation.............................................. 309 518 553 Amortization.............................................. 3,435 3,592 3,853 Non-recurring indirect transaction costs(e)............... 267 -- -- ---------- ---------- ---------- Total operating expenses................................ 83,362 97,707 104,959 ---------- ---------- ---------- Income from operations...................................... 6,222 6,165 6,606 Other expenses: Interest expense, net..................................... 3,833 4,008 1,796 ---------- ---------- ---------- Income before income taxes and discontinued operations...... 2,389 2,157 4,810 Income tax expense(f)....................................... 1,202 1,085 2,106 ---------- ---------- ---------- Income before discontinued operations....................... 1,187 1,072 2,704 Discontinued operations: Loss from discontinued operations, net of income taxes.... (286) (440) -- Loss on disposal.......................................... -- (623) -- ---------- ---------- ---------- Net income.................................................. $ 901 $ 9 $ 2,704 ========== ========== ========== Basic and diluted income (loss) per common share(h): Income before discontinued operations..................... $ .30 $ .27 $ Discontinued operations................................... (.07) (.27) ---------- ---------- ---------- Net income.............................................. $ .23 $ -- $ ========== ========== ========== Weighted-average number of shares outstanding............... 3,999,998 3,999,998 OTHER OPERATING DATA EBITDA(i)................................................... $ 10,233 $ 10,275 $ 11,012 EBITDA as a % of revenue.................................... 11.4% 9.9% 9.9% FTE's(j).................................................... 4,289 4,361 4,631 Weeks worked(k)............................................. 55,757 56,687 60,203 Average contract revenue per week(l)........................ $ 1,544 $ 1,698 $ 1,727 Net cash flow provided by (used in) operating activities.... 3,286 5,009 Net cash flow provided by (used in) investing activities.... (506) (32,605) Net cash flow provided by (used in) financing activities.... $ (7,417) $ 27,596
AS OF MARCH 31, 2001 --------------------------- ACTUAL AS ADJUSTED(O) ---------- -------------- CONSOLIDATED BALANCE SHEET DATA Working capital............................................. $ 37,691 37,691 Cash and cash equivalents................................... -- -- Total assets................................................ 349,926 342,872 Total debt.................................................. 186,883 75,799 Stockholders' equity........................................ $ 122,424 $ 231,937
------------------------------ (a) On July 29, 1999, we acquired the assets of Cross Country Staffing which, for accounting and reporting purposes, is our predecessor. Financial data for periods prior to July 30, 1999 is that of Cross Country Staffing. (b) Includes TravCorps results from December 16, 1999, the date of its acquisition, through December 31, 1999. 20 (c) Reflects the following adjustments as if the offering and the Heritage and ClinForce acquisitions had occurred on January 1, 2000: - additional amortization expense of $0.9 million related to $34.0 million of goodwill and other intangibles acquired in the Heritage and ClinForce acquisitions; - a reduction in interest expense of $11.0 million as a result of the repayment of $35.5 million of senior subordinated debt (12.0% interest rate) and $77.3 million of borrowings outstanding under our credit facility using the weighted average interest rate in effect during the year ended December 31, 2000 (9.74%); and - additional income tax expense of $5.9 million as a result of the above adjustments. (d) Includes expenses related to a discontinued management incentive compensation plan of $2.1 million and $2.7 million for the seven-month period January 1-July 29, 1999 and the year ended December 31, 1998. The management incentive compensation plan was discontinued on July 30, 1999. (e) Non-recurring indirect transaction costs consist of non capitalizable transition bonuses and integration costs related to the TravCorps acquisition. (f) Prior to July 30, 1999, our predecessor, Cross Country Staffing, operated as a partnership under the applicable provisions of the Internal Revenue Code, and, accordingly, income related to the operations of Cross Country Staffing was taxed directly to its partners. (g) Reflects the operating results of HospitalHub, Inc., which began operations in 1999. We completed the divestiture of HospitalHub, Inc. during the second quarter of 2001. (h) The financial data contained herein for periods prior to July 30, 1999, is that of our predecessor, Cross Country Staffing, a partnership, for which share and per share amounts were not applicable. (i) We define EBITDA as income before interest, income taxes, depreciation, amortization and non-recurring indirect transaction costs. EBITDA should not be considered a measure of financial performance under generally accepted accounting principles. Items excluded from EBITDA are significant components in understanding and assessing financial performance. EBITDA is a key measure used by management to evaluate our operations and provide useful information to investors. EBITDA should not be considered in isolation or as an alternative to net income, cash flows generated by operations, investing or financing activities, or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, EBITDA as presented may not be comparable to other similarly titled measures of other companies. (j) FTE's represent the average number of contract staffing personnel on a full-time equivalent basis. (k) Weeks worked is calculated by multiplying the FTE's by the number of weeks during the respective period. (l) Average contract revenue per week is calculated by dividing the revenue received under our staffing contracts by the number of weeks worked during the respective period. (m) Consists of partners' capital for periods prior to July 30, 1999, since our predecessor, Cross Country Staffing, was a partnership. (n) Reflects the following adjustments if the offering and the Heritage and ClinForce acquisitions had occurred on January 1, 2001: - additional amortization expense of $0.2 million related to $34.0 million of goodwill and other intangibles acquired in the Heritage and ClinForce acquisitions; - a reduction in interest expense of $2.2 million as a result of the repayment of $36.6 million of senior subordinated debt (12.0% interest rate) and $75.6 million of borrowings outstanding under our credit facility using the weighted average interest rate in effect during the three months ended March 31, 2001 (9.27%); and - additional income tax expense of $1.0 million as a result of the above adjustments. (o) Reflects the following adjustments as if the offering had occurred on March 31, 2001: - increase in stockholders' equity of $114.8 million of net proceeds from the offering; and - repayment of $36.6 million of senior subordinated debt, plus a $1.5 million redemption premium, and repayment of $75.6 million of borrowings outstanding under our credit facility. 21 UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS We acquired ClinForce on March 16, 2001 and Heritage on December 26, 2000. The pro forma condensed consolidated statement of operations for the year ended December 31, 2000 and the three months ended March 31, 2001 give effect to the acquisitions of Heritage and ClinForce as if the transactions had occurred on January 1, 2000 and January 1, 2001, respectively. The pro forma information is based on the historical statements of the acquired businesses giving effect to the transactions under the purchase method of accounting and the assumptions and adjustments described in the accompanying notes to the Pro Forma Condensed Consolidated Statement of Operations. The pro forma information as adjusted for the offering for the year ended December 31, 2000 and the three months ended March 31, 2000, assumes the repayment of certain of our indebtedness using a portion of the net proceeds received from the offering as if the offering and the repayment had occurred on January 1, 2000 and January 1, 2001, respectively. This pro forma information does not purport to be indicative of the combined results of operations that actually would have taken place if the transactions had occurred at such dates. The pro forma Condensed Consolidated Statement of Operations should be read in conjunction with the Consolidated Financial Statements and related notes thereto included elsewhere in this prospectus.
YEAR ENDED DECEMBER 31, 2000 ------------------------------------------------------------------------------------------------------ PRO FORMA ACQUISITION PRO FORMA ADJUSTMENTS PRO FORMA CROSS COUNTRY CLINFORCE(A) HERITAGE(B) ADJUSTMENTS COMBINED FOR OFFERING AS ADJUSTED ------------- ------------ ----------- ----------- ---------- ------------ ----------- (DOLLARS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA) Revenue from services...... $ 367,690 $ 28,895 $ 10,690 $ 407,276 $ 407,276 Operating expenses: Direct operating expenses............... 273,095 20,128 4,572 297,796 297,796 Selling, general and administrative expenses............... 49,027 4,766 4,047 57,840 57,840 Bad debt expense......... 433 110 -- 543 543 Depreciation............. 1,324 135 -- 1,459 1,459 Amortization............. 13,701 660 -- 854(c) 15,215 15,215 Non-recurring indirect transaction costs...... 1,289 -- -- 1,289 1,289 ---------- ---------- ---------- ---------- ---------- Total operating expenses... 338,869 25,799 8,619 374,142 374,142 Income from operations..... 28,821 3,096 2,071 33,134 33,134 Interest expense, net...... 15,435 -- -- 3,623(d) 19,058 (14,654)(e) 4,404 ---------- ---------- ---------- ---------- ---------- Income before income taxes.................... 13,386 3,096 2,071 14,076 28,730 Income tax expense......... 6,730 1,227 -- (926)(f) 7,031 5,642 (f) 12,673 ---------- ---------- ---------- ---------- ---------- Income from continuing operations............... $ 6,656 $ 1,869 $ 2,071 $ 7,045 $ 16,057 ========== ========== ========== ========== ========== Basic and diluted income from continuing operations per common share.................... $ 1.66 -- -- $ 1.76 ========== ========== ========== ========== Weighted average common shares outstanding....... 3,999,998 -- -- 3,999,998 ========== ========== ========== ==========
22 ------------------------------ (a) Represents the historical consolidated revenue and direct operating expenses of ClinForce for the twelve months ended December 31, 2000. ClinForce was a subsidiary of Edgewater Technology, Inc. prior to being acquired by us in March 2001. The operating results of ClinForce are not necessarily indicative of amounts that would have been incurred had ClinForce operated as a stand-alone business during the period presented. (b) Represents the historical results of Heritage for the period from January 1, 2000 through December 26, 2000. (c) Pro forma adjustment to record the amortization of intangible assets acquired as a result of the ClinForce and Heritage acquisitions. Our intangible assets are amortized on a straight-line basis over periods ranging from 5--25 years. An additional $6.5 million is contingently payable to Heritage based upon future EBITDA results. Such amount is payable through 2003. (d) Pro forma adjustment to record interest costs associated with the financing of the ClinForce and Heritage acquisitions using the weighted average interest rate in effect for the year ended December 31, 2000 (9.74%). (e) Adjustment to record pro forma interest expense reduction as if $114.8 million of estimated offering proceeds were used to reduce outstanding debt through the repayment of $35.5 million of senior subordinated debt and repayment of $77.3 million of borrowings outstanding under our credit facility as of January 1, 2000. (f) Pro forma adjustment for estimated income taxes at combined federal and state statutory rates for the effect of the other adjustments and to record pro forma income tax expense for Heritage which, prior to being acquired by Cross Country, was an LLC for which income tax expense was determined at the individual member level. 23
THREE MONTHS ENDED MARCH 31, 2001 ---------------------------------------------------------------------------------------- PRO FORMA ACQUISITION PRO FORMA ADJUSTMENTS PRO FORMA CROSS COUNTRY CLINFORCE(A) ADJUSTMENTS COMBINED FOR OFFERING AS ADJUSTED ------------- ------------ ----------- ---------- ------------ ----------- (DOLLARS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA) Revenue from services............. $ 103,872 $ 7,693 $ 111,565 $ 111,565 Operating expenses: Direct operating expenses....... 79,002 5,350 84,352 84,352 Selling, general and administrative expenses....... 14,175 1,606 15,781 15,781 Bad debt expense................ 420 420 420 Depreciation.................... 518 35 553 553 Amortization.................... 3,592 92 169(b) 3,853 3,853 Non-recurring indirect transaction costs............. -- -- -- -- ---------- ---------- ---------- ---------- Total operating expenses.......... 97,707 7,083 104,959 104,959 Income from operations............ 6,165 610 6,606 6,606 Interest expense, net............. 4,008 179 421(c) 4,608 (2,812)(d) 1,796 ---------- ---------- ---------- ---------- Income before income taxes........ 2,157 431 1,998 4,810 Income tax expense................ 1,085 166 (228)(e) 1,023 1,083(e) 2,106 ---------- ---------- ---------- ---------- Income from continuing operations...................... $ 1,072 $ 265 $ 975 $ 2,704 ========== ========== ========== ========== Basic and diluted income from continuing operations per common share........................... $ 0.27 -- $ 0.24 $ -- ========== ========== ========== ========== Weighted average common shares outstanding..................... 3,999,998 -- 3,999,998 -- ========== ========== ========== ==========
-------------------------- (a) Represents the historical consolidated revenues and direct operating expenses of ClinForce for the period from January 1, 2001 through March 16, 2001. ClinForce was a subsidiary of Edgewater Technology, Inc. prior to being acquired by us in March 2001. The operating results of ClinForce are not necessarily indicative of amounts that would have been incurred had ClinForce operated as a stand-alone business during the period presented. (b) Pro forma adjustment to record the amortization of intangible assets acquired as a result of the ClinForce acquisition. Our intangible assets are amortized on a straight-line basis over periods ranging from 5--25 years. (c) Pro forma adjustment to record interest costs associated with the financing of the ClinForce acquisition using the weighted average interest rate in effect for the quarter ended March 31, 2001 (9.27%). (d) Adjustment to record pro forma interest expense reduction as if $114.8 million of estimated offering proceeds were used to reduce outstanding debt through the repayment of $36.6 million of senior subordinated debt and repayment of $75.6 million of borrowings outstanding under our credit facility as of January 1, 2001. (e) Pro forma adjustment for estimated income taxes at combined federal and state statutory rates for the effect of the other adjustments. 24 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS THE FOLLOWING DISCUSSION AND ANALYSIS OF OUR FINANCIAL CONDITION AND RESULTS OF OPERATIONS SHOULD BE READ IN CONJUNCTION WITH SELECTED CONSOLIDATED FINANCIAL AND OTHER DATA AND OUR CONSOLIDATED FINANCIAL STATEMENTS AND THE ACCOMPANYING NOTES THAT APPEAR ELSEWHERE IN THIS PROSPECTUS. OVERVIEW We are the largest provider of healthcare staffing services in the United States. Approximately 80% of our revenue is derived from travel nurse staffing. We also provide complementary services, including staffing of clinical trials and allied health professionals, search and recruitment, consulting and education and training. For the year ended December 31, 2000, our revenue and EBITDA, pro forma for the acquisitions of ClinForce and Heritage, were $407.3 million and $51.1 million, respectively. HISTORY In July 1999, an affiliate of Charterhouse Group International, Inc. and certain members of management acquired the assets of Cross Country Staffing, our predecessor, from W. R. Grace & Co. Upon the closing of this transaction, we changed from a partnership to a C corporation form of ownership. In December 1999, we acquired TravCorps, which was owned by investment funds managed by Morgan Stanley Private Equity and certain members of TravCorps' management and subsequently changed our name to Cross Country TravCorps, Inc. In May 2001, we changed our name to Cross Country, Inc. REVENUE Travel nurse staffing revenue is received primarily from acute care hospitals. Our clinical trials staffing revenue is received primarily from pharmaceutical and biotechnology companies, as well as medical device manufacturers. Revenue from allied health staffing services is received from numerous sources, including providers of radiation, rehabilitation and respiratory services at additional venues including nursing homes, sports medicine clinics and schools. Our staffing placements are through contracts with assignments typically lasting 13 weeks or longer. Revenue from our search and recruitment, consulting and education and training services is received from numerous sources, including hospitals, physician group practices, insurance companies and individual healthcare professionals. Our fees are paid directly by our clients rather than by government or other third-party payors. Revenue is recognized when services are rendered. Accordingly, accounts receivable includes an accrual for employees' time worked but not yet invoiced. Our field employees work predominantly under contracts where the individual is our employee. We also offer mobile contracts, under which the individual is an employee of the client facility for the purposes of payroll and we are paid an hourly or weekly administrative fee. Our healthcare staffing revenue and earnings are impacted by the relative supply of and demand for nurses at healthcare facilities. We rely significantly on our ability to recruit and retain nurses and other healthcare personnel who possess the skills, experience and, as required, licensure necessary to meet the specified requirements of our clients. Shortages of qualified nurses and other healthcare personnel could limit our ability to fill open assignments and grow our revenue and EBITDA. Fluctuations in patient occupancy at our clients' facilities may also affect the profitability of our business. As occupancy increases, temporary employees are often added before full-time employees are hired. As occupancy decreases, clients tend to reduce their use of temporary employees before 25 undertaking layoffs of their regular employees. In addition, we may experience more competitive pricing pressure during periods of occupancy downturn. ACQUISITIONS In May 2001, we acquired Gill/Balsano, a healthcare management consulting firm, for $1.8 million in cash and potential earnout payments of $2.0 million. In March 2001, we acquired ClinForce for $31.0 million in cash. ClinForce supplies supplemental staffing services for clinical trials. ClinForce's revenue was $28.9 million for the year ended December 31, 2000. We believe this acquisition will enable us to extend our services into a fragmented and complementary segment of the healthcare staffing market. In December 2000, we completed the acquisition of Heritage, a provider of continuing education programs to the healthcare community, for a purchase price of approximately $6.5 million in cash and potential earnout payments of approximately $6.5 million. In July 2000, we acquired E-Staff, an application service provider that has developed an internet subscription-based communication, scheduling, credentialing and training service business for healthcare providers, for $1.5 million in cash and potential earnout payments of $3.2 million. In December 1999, we acquired all outstanding shares of TravCorps' common stock in exchange for shares of our common stock then valued at approximately $32.1 million and we assumed TravCorps' debt of $45.0 million. TravCorps had revenues of $113.0 million for the period December 27, 1998 to December 15, 1999. DISCONTINUED OPERATIONS In December 2000, we committed to a formal plan to divest HospitalHub, Inc., or HospitalHub, our electronic job board business, which began operations in 1999. The operating results of HospitalHub have been accounted for as discontinued operations in our consolidated financial statements and notes thereto and in the other financial information included herein. We completed the divestiture of HospitalHub in the second quarter of 2001. GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill and other intangible assets from the acquisition of the assets of Cross Country Staffing, our predecessor, and from subsequent acquisitions were $153.4 million and $97.5 million, respectively, at March 31, 2001. Goodwill and other intangible assets are being amortized using the straight-line method over their estimated useful lives ranging from 4.5 to 25 years. Goodwill and other intangible assets represented 205% of our stockholders' equity as of March 31, 2001. The amount of goodwill and other intangible assets amortized equaled 58.3% of our income from operations for the three months ended March 31, 2001. In June 2001, the Financial Accounting Standards Board approved its exposure draft, BUSINESS COMBINATIONS AND INTANGIBLE ASSETS--ACCOUNTING FOR GOODWILL. The statements that will be derived from the exposure draft eliminate the pooling-of-interests method of accounting for business combinations and require that goodwill and certain intangible assets not be amortized. Instead, these assets will be reviewed for impairment annually with any related losses recognized in earnings when incurred. The standards are expected to be issued in July 2001 and will apply to us beginning January 1, 2002 for existing intangible assets and July 1, 2001 for business combinations completed after June 30, 2001. 26 RESULTS OF OPERATIONS The following table summarizes, for the periods indicated, selected statement of operations data expressed as a percentage of revenue:
PREDECESSOR --------------------------- PERIOD FROM PERIOD FROM THREE MONTHS YEAR ENDED JANUARY 1- JULY 30- YEAR ENDED ENDED MARCH 31, DECEMBER 31, JULY 29, DECEMBER 31, DECEMBER 31, ------------------- AS A % OF REVENUE 1998 1999 1999 2000 2000 2001 ----------------- ------------- ----------- ------------ ------------- -------- -------- Revenue........................... 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% Direct operating expenses......... 76.9 75.6 77.6 74.3 74.9 76.1 Selling, general and administrative expenses......... 12.0 12.0 10.5 13.3 13.4 13.6 Bad debt expense.................. 0.5 0.1 0.6 0.1 0.3 0.4 ----- ----- ----- ----- ----- ----- EBITDA(a)......................... 10.6 12.3 11.3 12.3 11.4 9.9 Depreciation and amortization..... 0.7 0.7 5.2 4.1 4.2 4.0 Non-recurring indirect transaction costs........................... -- -- -- 0.4 0.3 -- ----- ----- ----- ----- ----- ----- Income from operations............ 9.9 11.6 6.1 7.8 6.9 5.9 Interest expense, net............. 0.5 0.2 5.5 4.2 4.3 3.9 Other expenses.................... 0.1 0.2 -- -- -- -- ----- ----- ----- ----- ----- ----- Income before income taxes and discontinued operations......... 9.3 11.2 0.6 3.6 2.6 2.0 Income tax expense(b)............. -- -- 0.8 1.8 1.3 1.0 ----- ----- ----- ----- ----- ----- Income (loss) before discontinued operations...................... 9.3 11.2 (0.2) 1.8 1.3 1.0 Loss from discontinued operations, net of income taxes............. -- -- (0.2) (0.4) (0.3) (0.4) Estimated loss on disposal of discontinued operations......... -- -- -- (0.1) -- (0.6) ----- ----- ----- ----- ----- ----- Net income (loss)................. 9.3% 11.2% (0.4)% 1.3% 1.0% 0.0% ===== ===== ===== ===== ===== =====
------------------------ (a) We define EBITDA as income before interest, income taxes, depreciation, amortization and non-recurring indirect transaction costs. EBITDA should not be considered a measure of financial performance under generally accepted accounting principles. Items excluded from EBITDA are significant components in understanding and assessing financial performance. EBITDA is a key measure used by management to evaluate our operations and provide useful information to investors. EBITDA should not be considered in isolation or as an alternative to net income, cash flows generated by operations, investing or financing activities, or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, EBITDA as presented may not be comparable to other similarly titled measures of other companies. (b) Prior to July 30, 1999, we were a partnership for which income tax expense was determined at the partner level. 27 The following sections should be read in conjunction with the History and Acquisitions sections that appear above in this Management's Discussion and Analysis. THREE MONTHS ENDED MARCH 31, 2001 COMPARED TO THREE MONTHS ENDED MARCH 31, 2000 Revenue increased by 16.0% to $103.9 million for the three months ended March 31, 2001 as compared to $89.6 million for the three months ended March 31, 2000. Revenue included from Heritage and ClinForce, which were acquired on December 26, 2000 and March 16, 2001, respectively, totaled $4.9 million for the three months ended March 31, 2001. Excluding the effects of these acquisitions, revenue increased $9.6 million, or 10.7%, as compared with the three months ended March 31, 2000. This increase is primarily due to an increase in the average hourly bill rate offset, in part, by a modest reduction in the average number of hours billed per FTE per week. The average number of field employees remained relatively constant from period to period. The average hourly bill rate increased primarily as a result of bill rate increases and, to a lesser extent, an increase in the percentage of nurses working under staffing rather than mobile contracts. The average number of hours worked per week per FTE decreased primarily as a result of an increase in the number of nurses working three 12 hour shifts rather than five 8 hour shifts. Of the $103.9 million of revenue from the three months ended March 31, 2001, 83.2% of revenue was generated by travel nursing operations, 9.5% from other staffing operations and 7.3% from other services. Of the $89.6 million of revenue from the three months ended March 31, 2000, 87.7% was generated by travel nursing operations, 8.4% from other staffing operations and 3.9% from other services. Direct operating expenses are comprised primarily of field employee compensation expenses, housing expenses, travel expenses and field insurance expenses. Direct operating expenses totaled $79.0 million for the three months ended March 31, 2001 as compared to $67.1 million for the three months ended March 31, 2000. As a percentage of revenue, direct operating expenses represented 76.1% of revenue for the three months ended March 31, 2001 as compared with 74.9% for the three months ended March 31, 2000. The increase in direct operating expenses as a percent of revenue was mostly attributable to an increase in field salaries, housing costs and health insurance. These increases were offset in part by the relatively lower direct operating expenses, as a percent of revenue, for each of Heritage and ClinForce. Selling, general and administrative expenses are comprised primarily of corporate and administrative personnel compensation, advertising, referral bonuses, insurance, communication, rent, utilities and postage and delivery. Selling, general and administrative expenses totaled $14.2 million for the three months ended March 31, 2001 as compared to $12.1 million for the three months ended March 31, 2000. As a percentage of revenue, selling, general and administrative expenses increased to 13.6% of revenue for the three months ended March 31, 2001, as compared with 13.4% for the three months ended March 31, 2000. We expect selling, general and administrative expenses as a percent of revenue to continue to remain higher throughout 2001, as compared to 2000, as a result of the acquisitions of Heritage and ClinForce, which have historically had higher selling, general and administrative expenses than our travel nurse staffing business. Bad debt expense totaled $0.4 million for the three months ended March 31, 2001 as compared to $0.2 million for the three months ended March 31, 2000. As a percentage of revenue, bad debt expense represented 0.4% of revenue for the three months ended March 31, 2001 as compared with 0.3% for the three months ended March 31, 2000. EBITDA, as a result of the above, totaled $10.3 million for the three months ended March 31, 2001 as compared to $10.2 million for the three months ended March 31, 2000. As a percentage of revenue, EBITDA represented 9.9% of revenue for the three months ended March 31, 2001 as compared with 11.4% for the three months ended March 31, 2000. 28 Depreciation and amortization expense totaled $4.1 million for the three months ended March 31, 2001 as compared to $3.7 million for the three months ended March 31, 2000. The increase was primarily due to the increased amortization of goodwill and other intangibles resulting from the Heritage and ClinForce acquisitions. As a percentage of revenue, depreciation and amortization expense declined to 4.0% of revenue for the three months ended March 31, 2001 as compared to 4.2% for the three months ended March 31, 2000. Non-recurring indirect transaction costs for the three months ended March 31, 2000 were $0.3 million, comprised of non capitalizable transition bonuses and integration costs related to the TravCorps acquisition. Income from operations totaled $6.2 million for each of the three months ended March 31, 2001 and for the three months ended March 31, 2000. As a percentage of revenue, income from operations represented 5.9% of revenue for the three months ended March 31, 2001 as compared with 6.9% for the three months ended March 31, 2000. Net interest expense totaled $4.0 million for the three months ended March 31, 2001 as compared to $3.8 million for the three months ended March 31, 2000. This increase was primarily due to borrowings related to the Heritage and ClinForce acquisitions. Income before income taxes and discontinued operations totaled $2.2 million for the three months ended March 31, 2001 as compared to $2.4 million for the three months ended March 31, 2000 due to the factors discussed above. Income tax expense totaled $1.1 million for the three months ended March 31, 2001 as compared to $1.2 million for the three months ended March 31, 2000. Income before discontinued operations totaled $1.1 million for the three months ended March 31, 2001 as compared to $1.2 million for the three months ended March 31, 2000. Losses from discontinued operations, net of income tax benefits, in connection with HospitalHub were $0.4 million for the three months ended March 31, 2001 as compared to $0.3 million for the three months ended March 31, 2000. A $0.6 million loss was recognized on the planned disposal of the HospitalHub operation during the three months ended March 31, 2001. The divestiture of HospitalHub was completed in the second quarter of 2001. Net income for the three months ended March 31, 2001 was $0.0 million as compared to $0.9 million for the three months ended March 31, 2000. YEAR ENDED DECEMBER 31, 2000 COMPARED TO FIVE-MONTH PERIOD JULY 30-DECEMBER 31, 1999 AND THE SEVEN-MONTH PERIOD JANUARY 1-JULY 29, 1999 Revenue for the year ended December 31, 2000 totaled $367.7 million as compared to $193.7 million for the two periods that comprise 1999. Revenue for the two periods that comprise 1999 includes the results of TravCorps from its date of acquisition on December 16, 1999. Had the results of TravCorps' operations for the full year of 1999 been included with the combined revenue for the two periods in 1999, revenue would have increased by 19.9% to $367.7 million in 2000 from $306.6 million in 1999. The increase was attributable to an increase in the average number of traveling nurses, a higher average hourly bill rate and increased allied health staffing revenue. For the year ended December 31, 2000, 87.5% of revenue was generated by travel nursing operations, 7.8% from other staffing operations and 4.7% from other services. Of the $306.6 million of revenue for the two periods that comprise 1999, and including TravCorps for the full year of 1999, 84.9% was generated by travel nursing operations, 8.4% from other staffing operations and 6.7% from other services. Direct operating expenses for the year ended December 31, 2000 totaled $273.1 million as compared to $68.0 million for the five-month period July 30-December 31, 1999 and $80.2 million for 29 the seven-month period January 1-July 29, 1999. As a percentage of revenue, direct operating expenses represented 74.3% of revenue for the year ended December 31, 2000 compared with 77.6% for the five-month period July 30-December 31, 1999 and 75.6% for the seven-month period January 1-July 29, 1999. The relative improvement was largely a result of the inclusion of revenue from our search, recruitment and consulting subsidiaries, for which all salaries and related expenses are classified as selling, general and administrative expenses. We acquired these subsidiaries in December 1999 in connection with our acquisition of the assets of TravCorps. In addition, for 1999, a change was made in the manner by which we compensated travel nurses and allied health professionals which resulted in greater direct operating expenses, as a percentage of revenue for the five-month period July 30-December 31, 1999. Selling, general and administrative expenses for the year ended December 31, 2000 totaled $49.0 million as compared to $9.3 million for the five-month period July 30-December 31, 1999 and $12.7 million for the seven-month period January 1-July 29, 1999. As a percentage of revenue, selling, general and administrative expenses represented 13.3% of revenue for the year ended December 31, 2000 compared with 10.5% for the five-month period July 30-December 31, 1999 and 12.0% for the seven-month period January 1-July 29, 1999. The relative increase in 2000 resulted from inclusion of the TravCorps operations, which historically have had greater selling, general and administrative expenses on a percentage of revenue basis. The decrease in selling, general and administrative expenses during the period July 30-December 31, 1999 as compared with the period January 1-July 30, 1999 was due to the modification of a management incentive program in July 1999. Bad debt expense for the year ended December 31, 2000 totaled $0.4 million as compared to $0.5 million for the five-month period July 30-December 31, 1999 and $0.2 million for the seven-month period January 1-July 29, 1999. As a percentage of revenue, bad debt expense represented 0.1% of revenue for 2000 compared with 0.6% for the five-month period July 30-December 31, 1999 and 0.1% for the seven-month period January 1-July 29, 1999. The increase in bad debt expense during the five-month period July 30-December 31, 1999 was due to the increase in the aging of accounts relating to one provider. EBITDA, as a result of the above, totaled $45.1 million for the year ended December 31, 2000 as compared to $9.9 million for the five-month period July 30-December 31, 1999 and $13.0 million for the seven-month period January 1-July 29, 1999. As a percentage of revenue, EBITDA represented 12.3% of revenue for the year ended December 31, 2000 compared with 11.3% for the five-month period July 30-December 31, 1999 and 12.3% for the seven-month period January 1-July 29, 1999. Depreciation and amortization expense for the year ended December 31, 2000 totaled $15.0 million as compared to $4.6 million for the five-month period July 30-December 31, 1999 and $0.7 million for the seven-month period January 1-July 29, 1999. The increase in depreciation and amortization expense in 2000 was due to amortization of goodwill resulting from the acquisition of the assets of Cross Country Staffing and the TravCorps acquisition. As a percentage of revenue, depreciation and amortization expense represented 4.1% of revenue for 2000 compared with 5.2% for the five-month period July 30-December 31, 1999 and 0.7% for the seven-month period January 1-July 29, 1999. Non-recurring indirect transaction costs totaled $1.3 million for the year ended December 31, 2000, which consisted primarily of transition bonuses related to the TravCorps acquisition. Income from operations for the year ended December 31, 2000 totaled $28.8 million as compared to $5.3 million for the five-month period July 30-December 31, 1999 and $12.3 million for the seven-month period January 1-July 29, 1999. As a percentage of revenue, income from operations represented 7.8% of revenue for the year ended December 31, 2000 compared with 6.1% for the five-month period July 30-December 31, 1999 and 11.6% for the seven-month period January 1-July 29, 1999. 30 Net interest expense for the year ended December 31, 2000 totaled $15.4 million as compared to $4.8 million for the five-month period July 30-December 31, 1999 and $0.2 million for the seven-month period January 1-July 29, 1999. The increase in 2000, and for the five-month period July 30-December 31, 1999, was due to debt incurred in connection with our acquisition of the assets of Cross Country Staffing in July 1999 and a higher weighted average effective borrowing rate. Income before income taxes and discontinued operations for the year ended December 31, 2000 totaled $13.4 million as compared to $0.5 million for the five-month period July 30-December 31, 1999 and $11.9 million for the seven-month period January 1-July 29, 1999. Income tax expense for the year ended December 31, 2000 was $6.7 million as compared to $0.7 million for the five-month period July 30-December 31, 1999. Our effective tax rate was 50.3% for the year ended December 31, 2000 and 128.0% for the period July 30-December 31, 1999 largely as a result of non-deductible expenses. Excluding the effects of non-deductible items and the tax benefit of our discontinued operations, our effective tax rates for the year ended December 31, 2000 and for the period July 30-December 31, 1999 were 41.5% and 34.7%, respectively. Prior to July 30, 1999, we were a partnership for which income tax expense was determined at the partner level. Pro forma adjustments have been made in the Cross Country Staffing financial statements included elsewhere in this prospectus as if we were subject to federal income taxes for the seven-month period January 1-July 29, 1999 using a 49.0% effective tax rate. On a pro forma basis, income tax expense was $5.8 million for the seven-month period January 1-July 29, 1999. Income before discontinued operations totaled $6.7 million for the year ended December 31, 2000 as compared to a loss of $0.1 million for the five-month period July 30-December 31, 1999. Losses from discontinued operations, net of income tax benefits, for the year ended December 31, 2000, and the five-month period July 30-December 31, 1999, were $1.6 million and $0.2 million, respectively, in connection with HospitalHub, which began operations in 1999. Also for the year ended December 31, 2000, a $0.5 million loss was recognized on the planned disposal of HospitalHub. The divestiture of HospitalHub was completed in the second quarter of 2001. Net income for the year ended December 31, 2000 totaled $4.6 million as compared to a net loss of $0.3 million for the five-month period July 30-December 31, 1999. Net income for the seven-month period January 1-July 29, 1999 was $6.0 million, including a pro forma adjustment for income tax expense as discussed above. THE SEVEN-MONTH PERIOD JANUARY 1, 1999-JULY 29, 1999 AND THE FIVE-MONTH PERIOD JULY 30, 1999-DECEMBER 31, 1999 COMPARED TO THE YEAR ENDED DECEMBER 31, 1998 Revenue for the five-month period July 30-December 31, 1999 totaled $87.7 million and for the seven-month period January 1-July 29, 1999 totaled $106.0 million as compared to $158.6 million for 1998. Combined revenue for the two periods that comprise 1999 totaled $193.7 million, representing a 22.1% increase over the year ended December 31, 1998. The increase primarily was due to increases in the number of hours worked by our travel nurses and in the average hourly bill rate, as well as a more favorable staffing mix. Direct operating expenses for the five-month period July 30-December 31, 1999 totaled $68.0 million and for the seven-month period January 1-July 29, 1999 totaled $80.2 million as compared to $122.0 million for the year ended December 31, 1998. As a percentage of revenue, direct operating expenses represented 77.6% of revenue for the five-month period July 30-December 31, 1999 and 75.6% for the seven-month period January 1-July 29, 1999 as compared to 76.9% for the year ended December 31, 1998. In 1999, a change was made in the manner by which we compensated travel nurses and allied health professionals which resulted in greater direct operating expenses, as a percentage of revenue for the five-month period July 30-December 31, 1999. The relative improvement, as a percent 31 of revenue, during the seven-month period January 1-July 29, 1999 as compared to the year ended December 31, 1998 was due to a a greater percentage increase in billing rates than field employee compensation expense. Selling, general and administrative expenses for the five-month period July 30-December 31, 1999 totaled $9.3 million and for the seven-month period January 1-July 29, 1999 totaled $12.7 million as compared to $19.1 million for the year ended December 31, 1998. As a percentage of revenue, selling, general and administrative expenses was 10.5% of revenue for the five-month period July 30-December 31, 1999 and 12.0% for the seven-month period January 1-July 29, 1999 compared with 12.0% for the year ended December 31, 1998. The decrease in selling, general and administrative expenses as percentage of revenue during the July 30-December 31, 1999 period was due to the modification of a management incentive program in July 1999. Bad debt expense for the five-month period July 30-December 31, 1999 totaled $0.5 million and for the seven-month period January 1-July 29, 1999 totaled $0.2 million as compared to $0.7 million for the year ended December 31, 1998. As a percentage of revenue, bad debt expense was 0.6% of revenue for the five-month period July 30-December 31, 1999, 0.1% for the seven-month period January 1-July 29, 1999 and 0.5% for 1998. The relative improvement from 1998 to the seven-month period January 1-July 29, 1999 was attributable to better collections of aged receivables. The increase in bad debt expense during the five-month period July 30-December 31, 1999 was due to the increase in the aging of accounts relating to one provider. EBITDA, as a result of the above, for the five-month period July 30-December 31, 1999 totaled $9.9 million and for the seven-month period January 1-July 29, 1999 totaled $13.0 million as compared to $16.8 million for the year ended December 31, 1998. As a percentage of revenue, EBITDA represented 11.3% of revenue for the five-month period July 30-December 31, 1999 and 12.3% for the seven-month period January 1-July 29, 1999 as compared to 10.6% for the year ended December 31, 1998. Depreciation and amortization expense for the five-month period July 30-December 31, 1999 totaled $4.6 million and for the seven-month period January 1-July 29, 1999 totaled $0.7 million as compared to $1.1 million for the year ended December 31, 1998. As a percentage of revenue, depreciation and amortization expense represented 5.2% of revenue for the five-month period July 30-December 31, 1999 and 0.7% for the seven-month period January 1-July 29, 1999 as compared to 0.7% for the year ended December 31, 1998. The relative increase for the five-month period July 30-December 31, 1999 was due principally to amortization of goodwill and other intangible assets which resulted from the acquisition of the assets of Cross Country Staffing. Income from operations for the five-month period July 30-December 31, 1999 totaled $5.3 million and for the seven-month period January 1-July 29, 1999 totaled $12.3 million as compared to $15.7 million for the year ended December 31, 1998. As a percentage of revenue, income from operations represented 6.1% of revenue for the five-month period July 30-December 31, 1999 and 11.6% for the seven-month period January 1-July 29, 1999 as compared to 9.9% for the year ended December 31, 1998. Net interest expense for the five-month period July 30-December 31, 1999 totaled $4.8 million and for the seven-month period January 1-July 29, 1999 totaled $0.2 million as compared to $0.8 million for the year ended December 31, 1998. The relative increase in net interest expense for the five-month period July 30-December 31, 1999 was due to debt incurred in connection with our acquisition of the assets of Cross Country Staffing, in July 1999, and a higher weighted average effective borrowing rate. Income before income taxes and discontinued operations for the five-month period July 30-December 31, 1999 totaled $0.5 million and for the seven-month period January 1-July 29, 1999 totaled $11.9 million as compared to $14.7 million for the year ended December 31, 1998. As a 32 percentage of revenue, income before income taxes and discontinued operations represented 0.6% of revenue for the five-month period July 30-December 31, 1999 and 11.2% for the seven-month period January 1-July 29, 1999 as compared to 9.3% for the year ended December 31, 1998. Income tax expense for the five-month period July 30-December 31, 1999 totaled $0.7 million. Our effective tax rate was 128% for the five-month period July 30-December 31, 1999 largely as a result of non-deductible expenses. Excluding the effects of non-deductible items and the tax benefit of discontinued operations, our effective tax rate for the five-month period July 30-December 31, 1999 was 34.7%. For the seven-month period January 1-July 29, 1999 and for the year ended December 31, 1998, our predecessor was a partnership for which income tax expense was determined at the partner level. Pro forma adjustments have been made in the Cross Country Staffing financial statements included elsewhere in this prospectus as if we were subject to federal income taxes for the seven-month period January 1-July 29, 1999 using a 49.0% effective tax rate. On a pro forma basis, income tax expense was $5.8 million for the seven-month period January 1-July 29, 1999. Loss before discontinued operations for the five-month period July 30-December 31, 1999 totaled $0.1 million. Loss from discontinued operations, net of taxes, for the five-month period July 30-December 31, 1999 was $0.2 million, in connection with HospitalHub, which began operations in 1999. The divestiture of HospitalHub was completed in the second quarter of 2001. Net loss for the five-month period July 30-December 31, 1999 was $0.3 million. Net income for the seven-month period January 1-July 29, 1999 was $6.1 million, including a pro forma adjustment for income tax expense as discussed above. LIQUIDITY AND CAPITAL RESOURCES As of March 31, 2001, we had a current ratio, the amount of current assets divided by current liabilities, of 1.9 to 1.0. Working capital increased by $3.4 million to $37.7 million as of March 31, 2001, compared to $34.3 million as of December 31, 2000. The increase in working capital is primarily due to a $6.1 million increase in accounts receivable. Although accounts receivable increased, days sales outstanding decreased to 62 days at March 31, 2001 compared with 64 days at December 31, 2000. Our operating cash flows constitute our primary source of liquidity and historically have been sufficient to fund our working capital, capital expenditures, internal business expansion and debt service. We believe that our capital resources are sufficient to meet our working capital needs for the next twelve months. We expect to meet our future working capital, capital expenditures, internal business expansion, debt service and acquisition requirements from a combination of operating cash flow and funds available under our credit facility. CREDIT FACILITY In March 2001, we amended our credit facility. The amended credit facility is comprised of (i) a revolving credit facility of up to $30.0 million, including a swing-line sub-facility of $7.0 million and a letter of credit sub-facility of $6.0 million, and (ii) a $144.9 million term loan facility. The revolving facility matures on July 29, 2005 and the term loan facility has staggered maturities in 2001, 2002, 2003, 2004 and 2005. Borrowings under the amended credit facility bear interest at variable rates based, at our option, on LIBOR or the prime rate plus various applicable margins which are determined by the amended credit facility. As of March 31, 2001, the weighted average effective interest rate under the amended credit facility was 8.99%. We are required to pay a quarterly commitment fee at a rate of 0.50% per annum on unused commitments under the revolving loan facility. As of July 1, 2001, we had availability under our revolving credit facility of $17.7 million and under our letter of credit sub-facility of $1.9 million. 33 The terms of the amended credit facility include customary covenants and events of default. Our investments covenant requires us to obtain the consent of our lenders to complete any acquisition, the costs of which exceeds $10.0 million. In addition, after this offering, if affiliates of Charterhouse and investment funds managed by Morgan Stanley Private Equity, as a group, cease to beneficially own at least 45.0% of our capital stock, a change of control, which constitutes an event of default, will occur under the credit facility. Borrowings under the amended credit facility are collateralized by substantially all our assets and the assets of our subsidiaries. Our credit facility requires us to use the first $40.0 million of proceeds from this offering to reduce amounts outstanding thereunder. If after giving effect to such application of proceeds, we satisfy the requisite debt to EBITDA ratio specified in the credit facility, we are permitted to use remaining net cash proceeds of this offering to redeem the outstanding principal on our senior subordinated pay-in-kind notes, plus accrued interest and any fees and expenses related to prepayment. SENIOR SUBORDINATED PAY-IN-KIND NOTES On July 29, 1999, we issued $30.0 million of senior subordinated pay-in-kind notes to two financial institutions. We used the proceeds of the senior subordinated notes to finance the acquisition of the assets of Cross Country Staffing, our predecessor, and to pay our transaction fees and expenses. Interest on the senior subordinated notes accrues at 12.0% per annum and is compounded quarterly. The senior subordinated notes mature at the earlier of six months after the final maturity of the amended credit facility or upon a change in control. We plan to redeem our senior subordinated pay-in-kind notes out of the proceeds of this offering. In connection with our proposed redemption of the senior subordinated pay-in-kind notes, we will be required to pay a redemption premium equal to 4.0% of outstanding principal plus accrued and unpaid interest on the notes. THREE MONTHS ENDED MARCH 31, 2001 COMPARED TO THREE MONTHS ENDED MARCH 31, 2000 Net cash provided by operating activities for the three months ended March 31, 2001 increased $1.7 million to a provision of $5.0 million as compared to a provision of $3.3 million for the three months ended March 31, 2000. The use of cash from investing activities for the three months ended March 31, 2000 increased $32.1 million to a use of $32.6 million as compared to a use of $0.5 million for the three months ended March 31, 2000. Investing activities during the three months ended March 31, 2001 included $31.3 million for the acquisition of ClinForce. No acquisitions were completed during the three months ended March 31, 2000. Net cash provided by financing activities for the three months ended March 31, 2001 increased by $35.0 million to a provision of $27.6 million as compared to a use of $7.4 million for the three months ended March 31, 2000. YEAR ENDED DECEMBER 31, 2000 COMPARED TO THE FIVE-MONTH PERIOD JULY 30-DECEMBER 31, 1999 AND THE SEVEN-MONTH PERIOD JANUARY 1-JULY 29, 1999 Net cash provided by operating activities for 2000 increased $4.1 million to a provision of $10.4 million as compared to a provision of $6.3 million for the five-month period July 30-December 31, 1999 and a provision of $12.2 million for the seven-month period January 1-July 29, 1999. Excluding income tax expense, our cash flow from operations was $17.1 million in 2000 compared with $7.0 million for the period July 30-December 31, 1999 and $12.2 million for the period January 1-July 29, 1999. The use of cash from investing activities for 2000 increased $11.0 million to a use of $9.6 million as compared to a provision of $1.4 million for the five-month period from July 30-December 31, 19999 and a use of $0.2 million for the seven-month period January 1-July 29, 1999. Investing activities during 2000 included $6.2 million for the acquisition of Heritage and $1.5 million for the acquisition of E-Staff as compared to net cash provided by acquisitions for the five-month period July 30-December 31, 1999 of $1.8 million from the acquisition of TravCorps. No acquisitions were completed during the period from January 1-July 30, 1999. Net cash used by financing activities for 2000 increased $2.5 million to a use of $5.6 million as compared to a use of $3.1 million for the five-month period July 30-December 31, 1999 and a use of $12.0 million for 34 the seven-month period January 1-July 29, 1999. Financing activities for 2000 consisted of borrowings and repayments under debt agreements, including primarily $5.1 million of net repayments under our term loan agreement, borrowing of $3.9 million of subordinated debt and net repayments under our revolver and swing line agreements of $1.0 million. FIVE-MONTH PERIOD JULY 30-DECEMBER 31, 1999 AND THE SEVEN-MONTH PERIOD JANUARY 1-JULY 29, 1999 COMPARED TO THE YEAR ENDED DECEMBER 31, 1998 Net cash provided by operating activities for the five-month period July 30-December 31, 1999 decreased $5.9 million to a provision of $6.3 million as compared to a provision of $12.2 million for the seven-month period January 1-July 29, 1999 and a provision of $14.4 million for 1998. The use of cash from investing activities for the five-month period July 30-December 31, 1999 decreased $1.6 million to a provision of $1.4 million as compared to a use of $0.2 million for the seven-month period from January 1-July 29, 1999 and a use of $1.0 million for 1998. The net cash provided by acquisitions for the five-month period July 30-December 31, 1999 included $1.8 million from the acquisition of TravCorps. Net cash used by financing activities the five-month period July 30-December 31, 1999 decreased $8.9 million to a use of $3.1 million as compared to a use of $12.0 million for the seven-month period January 1-July 29, 1999 and a use of $13.5 million for 1998. INFLATION During the last several years, the rate of inflation in healthcare related services has exceeded that of the economy as a whole. This inflation has increased our direct operating costs. We are also impacted by fluctuations in housing costs. Historically, we have been able to recoup the negative impact of such fluctuations by increasing our billing rates. We may not be able to continue increasing our billing rates and increases in our direct operating costs may adversely affect us in the future. In addition, our clients are impacted by payments of healthcare benefits by federal and state governments as well as private insurers. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK We are exposed to interest rate changes, primarily as a result of our credit facility which bears interest based on floating rates. We are party to an interest rate swap agreement which fixes the interest rate paid on $45.0 million of borrowings under our credit facility at 6.705% effective January 1, 2001, plus the applicable margin. The swap matures in February 2003. Prior to January 2001, we accounted for the swap agreement as a hedge, which means changes in the fair value of the swap were not required to be recognized in earnings. Effective January 1, 2001, we adopted Statement of Financial Accounting Standard No. 133 ACCOUNTING FOR DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES. Upon adopting SFAS No. 133, we recorded a liability for the fair value of the swap, which reduced consolidated stockholders' equity by $910,000. We will recognize changes in the fair value of the swap in earnings to the extent such changes are greater or less than the corresponding change in the fair value of the future variable interest payments on the portion of the debt underlying the swap. We do not contemplate that such changes will be material to our results of operations for the remainder of 2001. However, changes in interest rates which result in a yield curve that is different from those projected may cause changes in the fair value of the swap to have a significant impact on our results of operations. A 1% change in interest rates on variable rate debt would have resulted in interest expense fluctuating approximately $0.4 million for 1999, $1.2 million for 2000, and $0.3 million for the three months ended March 31, 2001. 35 BUSINESS OF CROSS COUNTRY, INC. OVERVIEW OF OUR COMPANY We are the largest provider of healthcare staffing services in the United States. Approximately 80% of our revenue is derived from travel nurse staffing. We also provide complementary services, including staffing of clinical trials and allied health professionals, search and recruitment, consulting, and education and training. Our active client base includes over 2,500 hospitals, pharmaceutical companies and other healthcare providers across all 50 states. Our fees are paid directly by our clients rather than by government or other third-party payors. We are well positioned to take advantage of current industry dynamics, including the growing shortage of nurses in the United States, the growing demand for healthcare services and the trend among healthcare providers toward outsourcing staffing services. For the year ended December 31, 2000, our revenue and EBITDA, pro forma for the acquisitions of ClinForce and Heritage, were $407.3 million and $51.1 million, respectively. OVERVIEW OF OUR INDUSTRY The STAFFING INDUSTRY REPORT, an independent staffing industry publication, estimates that the healthcare segment of the temporary staffing market generated $7.2 billion in revenue in 2000 and that this segment will grow 18% to $8.5 billion in 2001. The most common temporary nurse staffing alternatives available to hospital administrators are travel nurses and per diem nurses. - Travel nurse staffing involves placement of registered nurses on a contracted, fixed-term basis. Travel nurses provide a long-term solution to a nurse shortage, present hospitals and other healthcare facilities with a pool of potential full-time job candidates and enable healthcare facilities to provide their patients with continuity of care. Assignments may run several weeks to one year, but are typically 13 weeks long. The healthcare professional temporarily relocates to the geographic area of the assignment. The staffing company generally is responsible for providing travel nurses with customary employment benefits and for coordinating travel and housing arrangements. - Per diem staffing comprises the majority of all temporary healthcare staffing and involves placement of locally based healthcare professionals on very short-term assignments, often for daily shift work. Per diem staffing often involves little advance notice of assignments by the client. INDUSTRY DYNAMICS SHORTAGE OF NURSES. There is a pronounced shortage of registered nurses, especially experienced, specialty nurses who staff operating rooms, emergency rooms, intensive care units and pediatric wards. A recent study published in the JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, estimates that by 2020, the nationwide registered nurse workforce will be nearly 20% below projected requirements. Several factors have contributed to the decline in the supply of nurses: - The nurse pool is getting older and retiring. The study in the JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION projects that within the next ten years, the average age of registered nurses will increase 3.5 years to over 45. - Enrollment in nursing education programs is decreasing. According to the American Association of Colleges of Nursing, nursing school enrollments have declined at an average rate of 5% for each of the past six years. 36 - Many registered nurses are choosing to pursue careers outside of acute care hospitals or in professions other than nursing. The shortage of nurses drives demand for our services because hospitals turn to temporary nurses to make up for shortfalls in their permanent staff. INCREASING UTILIZATION OF HEALTHCARE SERVICES. There are a number of factors driving an increase in the utilization of healthcare services, including: - Increasing demand for healthcare services as a result of the aging of the baby boomers; and - Technological advances in healthcare delivery. The U.S. Healthcare Financing Administration projects total healthcare expenditures to grow by 8.6% in 2001 and by 7.1% annually from 2001 through 2010. According to these projections, healthcare expenditures will account for approximately $2.6 trillion or 15.9% of U.S. gross domestic product by 2010. INCREASED OUTSOURCING OF STAFFING SERVICES. Healthcare providers are increasingly using temporary staffing to manage seasonal fluctuations in demand for their services. The following factors have created seasonal fluctuations in demand for healthcare personnel: - Seasonal population swings, in areas such as the sunbelt states of Florida, Arizona and California in the winter months and the northeast in the summer months. - Seasonal changes in occupancy rates that tend to increase during the winter months and decrease during the summer months. The use of temporary personnel enables these providers to vary their staffing levels to match these changes in demand and avoid the more costly alternative of hiring permanent medical staff. The healthcare staffing industry also includes the temporary staffing of doctors and dentists, allied health personnel and professionals, and advanced practice professionals, but excludes home healthcare services. Healthcare staffing is also expanding, providing new specialties such as medical billing and receptionists. OUR COMPETITIVE STRENGTHS Our competitive strengths include: - LEADER IN THE RAPIDLY GROWING NURSE STAFFING INDUSTRY. We have operated in the travel nurse staffing industry since the 1970s and have the leading brand name. Our Cross Country TravCorps brand is well recognized among leading healthcare providers and professionals. We believe that through our relationships with existing travel nurse staffing clients, we are positioned to effectively market complementary services, including staffing of clinical trials and allied health professionals, search and recruitment, consulting, and education and training to our existing client base. - STRONG AND DIVERSE CLIENT RELATIONSHIPS. We provide staffing solutions to an active client base of over 2,500 hospitals, pharmaceutical companies and other healthcare providers across all 50 states. We do not rely on any geographic region or client for a significant portion of our revenue. No single client accounted for more than 3% of our revenue in 2000. In 2000, we worked with over 75% of the nation's top hospitals, as identified by U.S. NEWS AND WORLD REPORT. We provide temporary staffing to our clients through assignments that typically have terms of 13 weeks or longer. Our fees are paid directly by our clients rather than by government or other third-party payors. 37 - LEADER IN RECRUITING AND EMPLOYEE RETENTION. We are a leader in the recruitment and the retention of highly qualified healthcare professionals. We recruit healthcare professionals from all 50 states and Canada. In 2000, we received approximately 28,000 requests for applications from potential field employees and approximately 12,500 completed applications were added to our database. Employee referrals generate a majority of our new candidates. We believe we offer appealing assignments, competitive compensation packages, attractive housing options and other valuable benefits. Historically, approximately 70% of our nurses accepted new assignments with us within 35 days of completion of previous assignments. In 1996, we established Cross Country University, the first educational program in the travel nurse industry to be accredited by the American Nurse Credentialing Center. In 2000, we were recognized by WORKING MOTHER MAGAZINE as a top 100 national employer of working mothers. - SCALABLE AND EFFICIENT OPERATING STRUCTURE. We have an efficient centralized operating structure that includes a database of more than 146,000 nurses and other healthcare professionals who have completed job applications with us. Our size and centralized structure provide us with operating efficiencies in key areas such as recruiting, advertising, marketing, training, housing and insurance benefits. Our fully integrated proprietary information system enables us to manage virtually all aspects of our travel staffing operations. This system is designed to accommodate significant future growth of our business. - STRONG MANAGEMENT TEAM WITH EXTENSIVE HEALTHCARE STAFFING AND ACQUISITION EXPERIENCE. Our management team has played a key role in the development of the travel nurse staffing industry. Our management team, which averages 15 years of experience in the healthcare industry, has consistently demonstrated the ability to successfully identify and integrate strategic acquisitions. OUR BUSINESS TRAVEL STAFFING SERVICES OVERVIEW We are a leading provider of travel nurse staffing services. Under the Cross Country TravCorps brand, we provide nurses on a fixed-term contract basis throughout the U.S. We fill the majority of our assignments in acute care hospitals, including teaching institutions, trauma centers and community hospitals. We also fill assignments in non-acute care settings, including nursing homes, skilled nursing facilities and sports medicine clinics, and, to a lesser degree, in non-clinical settings, such as schools. We staff both public and private, for-profit and not-for-profit facilities. In addition to our core nurse staffing business, we provide operating room technicians, therapists and other allied health and advanced practice professionals in a wide range of specialties. We recruit credentialed nurses and other healthcare professionals and place them on assignments away from their homes. While these traveling nurses and other healthcare professionals may be registered with multiple staffing companies, we distinguish ourselves by providing our field employees with high levels of customer service, including access to a large inventory of assignments, free or subsidized housing, competitive benefits, retention programs, professional liability and other insurance, ongoing training and education, and state licensing assistance. CONTRACTS WITH FIELD EMPLOYEES AND CLIENTS Our field employees work predominantly under contracts where the individual is our employee and, as such, we assume all employee costs, including payroll, withholding taxes, benefits and professional liability insurance and Occupational Safety and Health Administration, or OSHA, requirements, as well as any travel and housing arrangements. Clients are billed an hourly rate payable to us, from which the nurse or practitioner is paid a predetermined salary and, in some cases, a bonus. 38 We operate under client contracts that typically have a term of 13 weeks or longer. We also offer mobile contracts, under which the individual is an employee of the client facility for the purposes of payroll and we accept an hourly or weekly administrative fee. Our fees are paid directly by our clients rather than by government or other third-party payors. In 2000, we completed approximately 11,000 individual assignments, typically lasting 13 weeks. RECRUITING AND RETENTION In 2000, we received approximately 28,000 requests for applications from potential field employees and approximately 12,500 completed applications were added to our database. More than half of our field employees have been referred by current or former employees, with the remainder attracted by advertisements in trade publications and our internet website. Our internet site allows potential applicants to review our business profile, apply on-line, view our company-provided housing and participate in on-line forums. We offer appealing assignments, attractive compensation packages, housing and other benefits, as well as substantial training opportunities through Cross Country University. Our recruiters are responsible for recruiting applicants, handling placements, maintaining a regular dialogue with nurses on assignment, making themselves available to address nurses' concerns regarding current assignments and future opportunities, and other significant job support and guidance. Recognizing that a nurse's relationship with the recruiter is the key to retaining qualified applicants, our recruiters establish lasting partnerships with the nurses. As part of the screening process, we conduct in-depth telephone interviews with our applicants and verify references to determine qualifications. Along with our hospital clients, we typically review our travel nurses' performance after each assignment and use this information to maintain the high quality of our staffing. Our recruiters utilize our sophisticated database of positions, which is kept up-to-date by our account managers, to match assignment opportunities with the experience, skills and geographic preferences of their candidates. Once an assignment is selected, the account manager reviews the candidate's resume package before submitting it to the client for review. Our educational and training services give us a competitive advantage by enhancing both the quality of our nurses and the effectiveness of our recruitment efforts. We typically monitor the quality of our workforce in the field through performance reviews after each assignment and further develop the capabilities of our recruits through Cross Country University and our Cross Country Seminars brand. These services offer substantial benefits, such as: - improving the quality of our nurses by offering them substantial training opportunities; - enabling our nurses to easily complete state licensing requirements; - providing professional development opportunities to our nurses; and - enhancing our image within the industry. We recently initiated Assignment America, a recruitment program for foreign-trained nurses. Assignment America is designed to address the current shortage of nurses in the United States. Through Assignment America, we plan to recruit registered nurses from foreign English-speaking countries, assist them in obtaining U.S. nursing licenses, sponsor them for U.S. permanent residency visas and then place them in domestic acute care hospitals. We believe Assignment America will help us meet a greater portion of the demand for our services. Because the recruitment process for foreign nurses is more onerous than for domestic nurses, Assignment America nurses commit to long-term contracts which typically range from 18 to 24 months. We plan to initially recruit nurses from the United Kingdom, South Africa, New Zealand and Australia. 39 OPERATIONS We service all of the assignment needs of our field employees and client facilities through two operations centers located in Boca Raton, FL and Malden, MA. These centers perform key support activities such as coordinating assignment accommodations, payroll processing, benefits administration, billing and collections, contract processing, client care, and risk management. Hours worked by field employees are recorded by our operations system which then transmits the data directly to Automated Data Processing for payroll processing. As a result, client billings can be generated automatically once the payroll information is complete, enabling real time management reporting capabilities as to hours worked, billings and payroll costs. Our payroll department also provides customer support services for field employees who have questions. We have approximately 2,900 apartments on lease throughout the U.S. Our client accommodations department secures leases, and arranges for furniture rental and utilities for field employees at their assignment locations. Typically, we provide for shared accommodations with lease terms which correspond to the length of the assignment. We believe that our economies of scale help us secure preferred pricing and favorable lease terms. We have also developed expertise in insurance, benefits administration and risk management. For workers compensation coverage, we provide an attractive program that is partially self-insured. For medical coverage, we use a partially self-insured preferred provider organization plan. SALES AND MARKETING Our sales and marketing activities are comprised of the following: NEW ACCOUNT DEVELOPMENT. Our new account development efforts are driven principally through inbound telemarketing activities managed by a two-person team of new business executives. In addition to negotiating new contracts with prospective clients, these account executives also actively seek out specific job opportunities for candidates who are not able to match our existing database of opportunities. These activities generate approximately 350 new clients each year. MANAGEMENT OF EXISTING ACCOUNTS. We have a sales force composed of account executives and managers of business development assigned to geographic markets who manage approximately 75 to 90 client accounts each. This sales force determines the appropriate billing rate and nurse pay rate for a given facility utilizing a proprietary pricing model. Day-to-day management of client accounts is handled by a team of approximately 20 professionals. The account managers, who often have a nursing background, are responsible for contacting active client facilities to obtain open orders for staff. Once a candidate is submitted to the account manager for submission to the facility, the account manager reviews the candidate's credentials and confirms the appropriateness of the match. The account manager then electronically submits appropriate materials to the facility. BRAND MARKETING. Our brand marketing initiatives help develop Cross Country's image in the markets we serve. Our brand is reinforced by our professionally designed website, brochures and pamphlets, direct mail and advertising materials. We believe that our branding initiatives coupled with our high-quality client service differentiate us from our competitors and establish us as a leader in temporary nurse staffing. TRADE AND ASSOCIATION RELATIONSHIP MANAGEMENT. We actively manage trade and association relationships through attendance at numerous national, regional and local conferences and meetings, including National Association of Health Care Recruiters, Association of Critical Care Nurses, American Organization of Nurse Executives, American Society for Healthcare Human Resource 40 Administration, American College of Healthcare Executives and Medical Group Management Association. CLINICAL RESEARCH AND TRIALS STAFFING Through our ClinForce brand, we provide clinical research professionals for both contract assignments and permanent placement to many of the world's leading companies in the pharmaceutical, biotechnology, medical device and related industries. We provide an array of professionals in such areas as clinical research and clinical data sciences, medical review and writing, and pharmaeconomics and regulatory affairs. Our understanding of the clinical research process enables us to provide responsive service to our clients and to offer greater opportunities to our research professionals. PER DIEM STAFFING Cross Country Local provides per diem nurse staffing services to healthcare facilities in select markets. Per diem staffing is short-term, shift-by-shift staffing to augment, or replace, longer term, temporary assignments. While per diem services accounted for less than 1% of our revenue in 2000, we believe this market presents a significant growth opportunity. OTHER HUMAN CAPITAL MANAGEMENT SERVICES We provide an array of healthcare-oriented human capital management services, which complement our core travel nurse staffing business. These services include: - SEARCH AND RECRUITMENT. We provide both retained and contingency search and recruitment services to healthcare organizations throughout the United States, including hospitals, pharmaceutical companies, insurance companies and physician groups. Our search services include the placement of physicians, healthcare executives and nurses. - HEALTHCARE CONSULTING SERVICES. We provide healthcare-oriented consulting services, including consulting related to physician compensation, strategy, operations, facilities planning, workforce management and merger integration. - EDUCATION AND TRAINING SERVICES. Cross Country University is a national leader in providing continuing education programs to the healthcare industry. Cross Country University holds national conferences, as well as one-day seminars, on topics relevant to nurses and healthcare professionals and provides conference management services. To enhance Cross Country University, in December 2000 we acquired Heritage, which produced over 2,600 seminars and conferences that were attended by over 65,000 registrants in more than 200 cities across the U.S. in 2000. In addition, we extend these educational services to our field employees on favorable terms as a recruitment and retention tool. - RESOURCE MANAGEMENT SERVICES. We provide software tools and services designed to enhance clients' capabilities to manage their nursing staff and their relationships with external staffing vendors. Our E-Staff tool is a subscription-based, online communication, scheduling and training service for the nursing industry. SYSTEMS Our placement and support operations are supported by sophisticated information systems that facilitate smooth interaction between our recruitment and support functions. Our fully integrated proprietary information system enables us to manage virtually all aspects of our travel staffing operations. The system is designed to accommodate significant future growth of our business. In addition, its parallel process design allows for the addition of further capacity to its existing hardware platform. We have proprietary software that handles most facets of our business, including contract 41 pricing and profitability, contract processing, job posting, housing management, billing/payroll and insurance. Our systems provide reliable support to our facility clients and field employees and enable us to efficiently fulfill and renew job assignments. Our systems also provide detailed information on the status and skill set of each registered field employee. Our financial and management reporting is managed on the PeopleSoft Financial Suite. PeopleSoft is an industry leading enterprise resource planning software suite that provides modules used to manage our accounts receivable, accounts payable, general ledger and billing. This system is designed to accommodate significant future growth of our business. GROWTH STRATEGY We intend to continue to grow our businesses by: - ENHANCING OUR ABILITY TO FILL UNMET DEMAND FOR OUR TRAVEL STAFFING SERVICES. There is substantial unmet demand for our travel staffing services. We are striving to meet a greater portion of this demand by recruiting additional healthcare personnel. Our recruitment strategy for nurses and other healthcare professionals is focused on: - increasing referrals from existing field employees by providing them with superior service; - expanding our advertising presence to reach more nursing professionals; - using the internet to accelerate the recruitment-to-placement cycle; - increasing the number of staff dedicated to the recruitment of new nurses; and - developing Assignment America, our recruitment program for foreign-trained acute care nurses residing abroad. - INCREASING OUR MARKET PRESENCE IN THE PER DIEM STAFFING MARKET. We intend to use our existing brand recognition, client relationships and database of nurses who have expressed an interest in temporary assignments to expand our per diem services to the acute care hospital market. While we have not historically had a significant presence in per diem staffing services, we believe that this market presents a substantial growth opportunity. - EXPANDING THE RANGE OF SERVICES WE OFFER OUR CLIENTS. We plan to utilize our relationships with existing travel staffing clients to more effectively market complementary services, including staffing of clinical trials and allied health professionals, search and recruitment, consulting, and education and training. - ACQUIRING COMPLEMENTARY BUSINESSES. We intend to continue to evaluate opportunities to acquire complementary businesses to strengthen and broaden our market presence. - INCREASING OPERATING EFFICIENCIES. We seek to increase our operating margins by increasing the productivity of our administrative personnel, using our purchasing power to achieve greater savings in key areas such as housing and benefits and continuing to invest in our information systems. COMPETITIVE ENVIRONMENT The travel nurse staffing industry is highly competitive, with limited barriers to entry. Our principal competitor in the travel nurse staffing industry is American Mobile Healthcare. We also compete with a number of nationally and regionally focused temporary nurse staffing companies that have the capabilities to relocate nurses geographically and, to a lesser extent, with local temporary nurse agencies. 42 In addition, the markets for our clinical staffing, allied staffing and per diem nurse staffing and for our healthcare-oriented human capital management services are highly competitive and highly fragmented, with limited barriers to entry. The principal competitive factors in attracting qualified candidates for temporary employment are salaries and benefits, quality of accommodations, quality and breadth of assignments, speed of placements, quality of recruitment teams and reputation. We believe that persons seeking temporary employment through us are also pursuing employment through other means, including other temporary staffing firms, and that multiple staffing companies have the opportunity to place employees with many of our clients. Therefore, the ability to respond to candidate inquiries and submit candidates to clients more quickly than our competitors is an important factor in our ability to fill assignments. In addition, because of the large overlap of assignments, we focus on retaining field employees by providing long-term benefits such as 401(k) plans and cash bonuses. Although we believe that the relative size of our database and economies of scale derived from the size of our operations make us an attractive employer for nurses seeking travel opportunities, we expect competition for candidates to continue to increase. The principal competitive factors in attracting and retaining temporary healthcare staffing clients include the ability to fill client needs, size of available pool of qualified candidates, quality assurance and screening capabilities, compliance with regulatory requirements, an understanding of the client's work environment, risk management policies and coverages, general industry reputation, and, to a lesser extent, price. FACILITIES We do not own any real property. Our principal leases are listed below.
LOCATION FUNCTION SQUARE FEET LEASE EXPIRATION -------- -------- ----------- ---------------- Boca Raton, Florida Headquarters 43,000 April 30, 2008 Malden, Massachusetts Staffing administration, general office use and 27,812 June 30, 2005 storage space Clayton, Missouri Search and recruitment headquarters 26,411 November 30, 2003 Durham, North Clinical research and trials staffing 12,744 December 31, 2004 Carolina headquarters
REGULATORY ISSUES In order to service our client facilities and to comply with OSHA and Joint Commission or Accreditation of Healthcare Organizations standards, we have developed a risk management program. The program is designed to protect against the risk of negligent hiring by requiring a detailed skills assessment from each healthcare professional. We conduct extensive reference checks and credential verifications for each of the nurses and other healthcare professionals that we might staff. In addition, we have a claims-based professional liability insurance policy with a limit of $1.0 million per claim and an aggregate limit of $3.0 million. We also have a fully insured umbrella liability insurance policy with a limit of $10.0 million. PROFESSIONAL LICENSURE AND CORPORATE PRACTICE. Nurses and other healthcare professionals employed by us are required to be individually licensed or certified under applicable state law. In addition, the healthcare professionals that we staff frequently are required to have been certified to provide certain medical care, such as CPR and anesthesiology, depending on the positions in which they are placed. Our comprehensive compliance program is designed to ensure that our employees possess all necessary 43 licenses and certifications, and we believe that our employees, including nurses and therapists, comply with all applicable state laws. BUSINESS LICENSES. A number of states require state licensure for businesses that, for a fee, employ and assign personnel, including healthcare personnel, to provide services on-site at hospitals and other healthcare facilities to support or supplement the hospitals' or healthcare facilities' work force. A number of states also require state licensure for businesses that operate placement services for individuals attempting to secure employment. Failure to obtain the necessary licenses can result in injunctions against operating, cease and desist orders, and/or fines. We endeavor to maintain in effect all required state licenses. REGULATIONS AFFECTING OUR CLIENTS. Many of our clients are reimbursed under the federal Medicare program and state Medicaid programs for the services they provide. In recent years, federal and state governments have made significant changes in these programs that have reduced reimbursement rates. In addition, insurance companies and managed care organizations seek to control costs by requiring that healthcare providers, such as hospitals, discount their services in exchange for exclusive or preferred participation in their benefit plans. Future federal and state legislation or evolving commercial reimbursement trends may further reduce, or change conditions for, our clients' reimbursement. Such limitations on reimbursement could reduce our clients' cash flows, hampering their ability to pay us. EMPLOYEES As of March 31, 2001, we had approximately 650 corporate employees and approximately 5,000 field employees. None of our employees are subject to a collective bargaining agreement. We consider our relationship with our employees to be good. LEGAL PROCEEDINGS We are not presently a party to any material legal proceedings. 44 MANAGEMENT DIRECTORS AND EXECUTIVE OFFICERS The table below provides information regarding our directors and executive officers. In connection with our application to list our common stock on the Nasdaq National Market, we intend to appoint three additional directors prior to the offering who will not be our employees or affiliated with management.
NAME AGE POSITION ---- -------------------- ---------------------------------------------------- Joseph A. Boshart...................... 45 President and Chief Executive Officer and Director Emil Hensel............................ 50 Chief Financial Officer and Chief Operating Officer and Director Vickie Anenberg........................ 36 President, Travel Staffing Division Kevin Conlin........................... 43 President, Consulting Division Dr. Franklin A. Shaffer, RN............ 58 President, Education and Training Division Tony Sims.............................. 41 President, Clinical Trials Staffing Division Carol D. Westfall...................... 51 President, Search and Recruitment Division Karen H. Bechtel....................... 52 Director Bruce A. Cerullo....................... 42 Director Thomas C. Dircks....................... 43 Director A. Lawrence Fagan...................... 71 Director Alan Fitzpatrick....................... 31 Director Fazle Husain........................... 37 Director Lori Livers............................ 35 Director
JOSEPH A. BOSHART has served as President and Chief Executive Officer since July 1999, and formerly served in such capacity at our predecessor since 1993. He has served as a director since July 1999. Mr. Boshart holds a B.S. degree in economics from the University of Michigan. EMIL HENSEL has served as Chief Financial Officer and Chief Operating Officer since July 1999 and formerly served in such capacity at our predecessor since 1991. He has served as a director since July 1999. Mr. Hensel holds a B.S. degree in electrical engineering from Columbia University and a Masters degree in Business Administration from New York University. VICKIE ANENBERG has served as President of the Travel Staffing Division since February 2000, and formerly served as Vice President of the Nursing Division for our predecessor, since 1995. Prior to joining Cross Country Staffing in 1990, she worked for Proctor & Gamble since 1986. KEVIN CONLIN has served as President of the Consulting Division since April 2001. Before joining Cross Country, he served from 1996 to March 2001 as the President and Chief Executive Officer of Partners First, a consulting firm focused on physician-hospital partnering and managed care. He also served as a senior executive at Ascension Health, one of the largest not-for-profit hospital systems in the U.S. He holds a B.A. in Biological Sciences from Rutgers University and a Masters of Health Administration from Duke University. DR. FRANKLIN A. SHAFFER, RN has served as President, Education and Training Division since March 2001. He also served as Vice President in our Education Division since February 1996. Dr. Shaffer has also served as adjunct faculty in graduate nursing programs at Teachers College, Columbia University, Adelphi University and Hunter College. Dr. Shaffer holds a Doctorate of Education in Nursing Administration and a Masters of Education and a Masters of Arts from Teachers College, Columbia University. TONY SIMS has served as President, Clinical Trials Staffing Division since January 2001, as Executive Vice President of Operations for ClinForce from March 1998 to December 2000 and as Managing 45 Director of ClinForce from August 1997 to March 1998. Before joining ClinForce, Mr. Sims served in various roles, including National Account Executive and Business Development Manager, with the healthcare staffing and support groups at Kelly Scientific Resources from August 1996 to August 1997. Mr. Sims holds a B.S. in Chemistry from Piedmont College. CAROL D. WESTFALL has served as President, Search and Recruitment Division since October 2000. Ms. Westfall served as Senior Vice President of Cejka & Company's Physician Search and Outsourced Executive Search Divisions from August 1999 to October 2000 and Vice President of the Outsourced Executive and Physician Search Division from 1994 to July 1999. Ms. Westfall holds a B.S. degree in Education from Michigan State University and has completed graduate work in Secondary Administration with Purdue University. KAREN H. BECHTEL has been a director since December 1999. Ms. Bechtel has been a Managing Director of MSDW Capital Partners IV, Inc. since 1998 and of Morgan Stanley & Co. Incorporated since 1986. She received a B.A. in mathematics from the University of Texas and an M.B.A. from the Harvard Graduate School of Business Administration. She is also a director of a number of privately held companies. BRUCE A. CERULLO has been a director since December 1999 and served as Chairman of the Board from December 1999 until December 2000. Mr. Cerullo served as President of TravCorps from 1994 to December 1999 and Chief Executive Officer of TravCorps from 1995 to December 1999. Mr. Cerullo holds a B.S. degree from the University of New Hampshire and a master's degree from Pennsylvania State University. THOMAS C. DIRCKS has been a director since December 1999, and has been President of Charterhouse Group International, a private equity firm, since June 2001. Mr. Dircks served as Executive Vice President of Charterhouse from July 2000 until June 2001 and has been employed as an executive officer of Charterhouse since 1983. He was previously employed as a Certified Public Accountant at a predecessor of PricewaterhouseCoopers, LLP. He holds a B.S. in Accounting and an M.B.A. from Fordham University. Mr. Dircks also is a director of Interliant, Inc., an application service provider, and a number of privately held companies. A. LAWRENCE FAGAN has been a director since December 1999. Mr. Fagan has been Vice Chairman of Charterhouse since June 2001 and served as President and Chief Operating Officer of Charterhouse from December 1996 until June 2001 and formerly served as Executive Vice President of Charterhouse since 1984. Mr. Fagan received a B.A. from Yale University and an M.B.A. from Columbia University. He also is a director of Top Image Systems, Ltd. and a number of privately held companies. ALAN FITZPATRICK has been a director since March 2001. Mr. Fitzpatrick has been a Vice President of Morgan Stanley & Co. Incorporated and MSDW Capital Partners IV, Inc. since 2000. He joined Morgan Stanley Private Equity in June 1999. Mr. Fitzpatrick was previously employed as an Associate at J.P. Morgan & Co. from August 1997 to May 1999 and attended The Wharton School from 1995 to May 1997. He received a B.A. in Economics from Carleton College and an M.B.A. from the University of Pennsylvania. FAZLE HUSAIN has been a director since December 1999. He has been an Executive Director of Morgan Stanley Private Equity and Morgan Stanley & Co., Inc. since February 1997. Mr. Husain has been at Morgan Stanley Private Equity since 1987, and since 1991 has focused on investing in medical technology and enterprise software industries. Mr. Husain received a B.S. in Chemical Engineering from Brown University and an M.B.A. from Harvard Graduate School of Business Administration. He also is a director of Allscripts, Inc., The Medicines Company, HealthStream, Cardiac Pathways and several privately held companies. LORI LIVERS has been a director since December 1999. Ms. Livers has been a Senior Vice President of Charterhouse since June 2001 and was a Vice President of Charterhouse from January 1997 until 46 June 2001. Ms. Livers has been employed at Charterhouse since April 1994. She holds a B.A. from the University of Pennsylvania and an M.B.A. from Columbia University. THE BOARD OF DIRECTORS Currently, we have nine members on our board of directors. We intend to add three independent directors before the date of the offering. Each of our directors was elected by Charterhouse and investment funds managed by Morgan Stanley Private Equity in accordance with the provisions of our by-laws and our stockholders' agreement. Each of our directors holds office until his or her successor is duly elected and qualified or until his or her resignation or removal, if earlier, as provided in our by-laws. No family relationship exists among any of the directors or executive officers. COMMITTEES OF THE BOARD OF DIRECTORS We have established an audit committee and a compensation committee. The audit committee reviews our internal accounting procedures and considers and reports to the board of directors with respect to other auditing and accounting matters, including the selection of our independent auditors, the scope of annual audits, fees to be paid to our independent auditors and the performance of our independent auditors. Our audit committee currently consists of Thomas Dircks, Lori Livers and Fazle Husain. In connection with our application to list our common stock on the Nasdaq National Market, we intend to change the membership of our audit committee to consist of three directors who are not our employees or otherwise affiliated with us. The compensation committee reviews and recommends to the board of directors the salaries, benefits and stock option grants for all employees, consultants, directors and other individuals compensated by us. The compensation committee also administers our stock option and other employee benefit plans. The compensation committee consists of Thomas Dircks, Lori Livers and Karen Bechtel. EXECUTIVE COMPENSATION The following table sets forth certain summary information with respect to compensation we paid in 2000 to our Chief Executive Officer and our four other most highly compensated executive officers as of December 31, 2000 whose salary and bonus earned in 2000 exceeded $100,000.
ALL OTHER SALARY BONUS COMPENSATION NAME AND POSITION ($) ($) ($)(A) ----------------- -------- -------- ------------ Joseph A. Boshart........................................... 263,465 193,883 5,250 President and Chief Executive Officer Emil Hensel................................................. 218,976 159,794 5,250 Chief Financial Officer and Chief Operating Officer Vickie Anenberg............................................. 112,769 70,318 3,938 President, Travel Staffing Division Dr. Franklin A. Shaffer, RN................................. 114,000 12,000 3,201 President, Education and Training Division Carol D. Westfall........................................... 140,000 280,740 8,603 President, Search and Recruitment Division
------------------------ (a) Amounts consist of employer matching contributions to our 401(k) plan, except that Ms. Westfall's amount also includes a $3,503 matching contribution to a non-qualified savings program. 47 AGGREGATED OPTION VALUES AS OF DECEMBER 31, 2000 The executive officers named in the summary compensation table did not exercise any stock options during the year ended December 31, 2000. The following table sets forth information concerning the year-end number and value of unexercised options with respect to our named executive officers. There was no public trading market for our common stock as of December 31, 2000. Accordingly, the values set forth below have been calculated on the basis of the assumed initial public offering price of $ per share, less the applicable exercise price per share, multiplied by the number of shares underlying the options.
NUMBER OF SECURITIES UNDERLYING UNEXERCISED VALUE OF UNEXERCISED OPTIONS AT FISCAL IN-THE-MONEY OPTIONS YEAR-END (#) AT FISCAL YEAR-END ($) --------------------------- --------------------------- EXERCISABLE UNEXERCISABLE EXERCISABLE UNEXERCISABLE ----------- ------------- ----------- ------------- Joseph A. Boshart.............................. 22,094 66,281 Emil Hensel.................................... 17,675 53,025 Vickie Anenberg................................ 8,838 26,512 Dr. Franklin A. Shaffer, RN.................... 2,488 7,462 Carol D. Westfall.............................. 1,450 4,350
OPTION GRANTS No stock options were granted for the year ended 2000 to any of Mr. Boshart, Mr. Hensel, Ms. Anenberg, Dr. Shaffer or Ms. Westfall. EMPLOYMENT AGREEMENTS We are party to employment agreements with each of Joseph Boshart and Emil Hensel, pursuant to which Mr. Boshart serves as our president and chief executive officer and Mr. Hensel serves as our chief operating officer and chief financial officer. The initial term of each agreement expires on July 29, 2002. Upon expiration of such initial term, each agreement will be automatically renewed for successive one-year terms unless prior to the end of such renewal term either party has given at least 90 days' prior written notice of its intention not to renew the agreement. Messrs. Boshart and Hensel currently receive annual base salaries of $273,000 and $225,000, respectively. These salaries are subject to increase upon annual review by the board of directors, and each of Messrs. Boshart and Hensel is eligible to receive an annual bonus under our bonus plan. Messrs. Boshart and Hensel are eligible to participate in all benefit plans and fringe benefit arrangements available to our senior executives. If either executive's employment is terminated without cause, the executive will be entitled to the greater of (x) base salary, for the balance of the initial or renewal term, certain other benefits provided in the agreement and bonus for the fiscal year in which termination occurs and (y) one year's worth of his base salary in effect as of the date of termination. Each of Messrs. Boshart and Hensel is subject to a two-year post-termination noncompetition covenant. However, if either executive's employment is terminated without cause, then the non-competition agreement will be effective only if we continue to pay the executive's base salary, bonus and other benefits provided in the agreement for the term of the noncompetition covenant. We are permitted to terminate the noncompetition covenant, and related payments, upon 30 days' prior written notice. OUR STOCK PLANS 1999 STOCK OPTION PLAN. We have reserved for issuance 209,302 shares of common stock under our 1999 Stock Option Plan, subject to adjustment for stock splits or similar corporate events. Our 1999 Stock Option Plan provides for the granting of options to purchase shares of our common stock to any of our employees or consultants. Each stock option granted under our 1999 Stock Option Plan is either 48 intended to qualify as an incentive stock option or is a non-qualified stock option. The plan is currently administered by the compensation committee of our board of directors. The exercise price of options granted under our 1999 Stock Option Plan is determined by the committee, except that in the case of substitute options, the exercise price cannot be less than 100% of the fair market value of the common stock on the date of the grant. In the case of incentive stock options granted to ten percent stockholders, the exercise price cannot be less than 110% of the fair market value of the common stock. In the event of a change of control of our company, stock options granted and not previously exercisable, will become exercisable unless the committee determines in good faith that an alternative option will be substituted. As of March 31, 2001, under our 1999 Stock Option Plan, options to purchase shares of common stock were outstanding. EQUITY PARTICIPATION PLAN. We have reserved for issuance 441,860 shares of common stock under our Equity Participation Plan, subject to adjustment for stock splits or similar corporate events. Our Equity Participation Plan provides for the granting of options to purchase shares of our common stock to key management employees of our company and our affiliates. Each stock option granted under our Equity Participation Plan is either intended to qualify as an incentive stock option or is a non-qualified stock option. The exercise price of options granted under our Equity Participation Plan is divided into five tranches ranging from 100 percent to 300 percent of the fair market value of the common stock on the date of grant. However, for incentive stock options granted to ten percent stockholders, the exercise price in the first tranche cannot be less than 110 percent of the fair market value of the common stock on the date of grant. The plan is currently administered by the compensation committee of our board of directors. In the event of a change in control of our company, stock options granted and not previously exercisable, will become exercisable unless the committee determines in good faith that an alternative option will be substituted. As of March 31, 2001, under our Equity Participation Plan, options to purchase shares of common stock were outstanding. 401(K) PLAN. We maintain a 401(k) Plan. The plan permits eligible employees to make voluntary, pre-tax contributions to the plan up to a specified percentage of compensation, subject to applicable tax limitations. We may make a discretionary matching contribution to the plan equal to a pre-determined percentage of an employee's voluntary, pre-tax contributions and may make an additional discretionary profit sharing contribution to the plan, subject to applicable tax limitations. Eligible employees who elect to participate in the plan are generally vested in any matching contribution after three years of service with the company. The plan is intended to be tax-qualified under Section 401(a) of the Internal Revenue Code so that contributions to the plan, and income earned on plan contributions, are not taxable to employees until withdrawn from the plan, and so that our contributions, if any, will be deductible by us when made. 49 RELATED PARTY TRANSACTIONS In connection with our acquisition of the assets of Cross Country Staffing in July 1999 from W. R. Grace, CEP III purchased 2,039,228 shares of our common stock for an aggregate of $71.8 million, and we paid a transaction fee to Charterhouse in the amount of $2.8 million. In addition, in July 1999, in connection with the acquisition, Messrs. Boshart and Hensel and Ms. Anenberg purchased 29,829, 14,204 and 2,842 shares of our common stock for an aggregate of $1.7 million. In December 1999, Messrs. Boshart, Hensel and Shaffer and Ms. Anenberg received stock bonuses of 1,525, 1,500, 375 and 725 shares of our common stock for a purchase price of $0.01 per share. In connection with our acquisition of TravCorps in December 1999, investment funds managed by Morgan Stanley Private Equity acquired 1,233,345 shares of our common stock in exchange for their shares of TravCorps common stock. In addition, in connection with the our acquisition of TravCorps, we paid a transaction fee to Charterhouse in the amount of $0.3 million. We are party to an agreement with Bruce Cerullo, pursuant to which Mr. Cerullo has agreed to continue as a Director and provide certain consulting services to us. He is subject to a four-year noncompetition covenant which expires four years from the date he ceases to serve as a director. Under the agreement, we will pay him an hourly sum for such consulting services. Additionally, he retained all options that were vested and exercisable as of December 31, 2000 in consideration of his continued service as a director. 50 PRINCIPAL STOCKHOLDERS The following table sets forth certain information regarding the beneficial ownership of our common stock as of July 1, 2001 and as adjusted to reflect the sale of the shares of common stock pursuant to this offering for: - each person who is known by us to be the beneficial owner of more than 5% of our common stock; - each executive officer named in the summary compensation table; - each of our directors; and - all directors and executive officers as a group. In connection with our application to list our common stock on the Nasdaq National Market, we intend to appoint three additional directors prior to this offering who will not be our employees or affiliated with management. Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission and includes voting or investment power with respect to the securities. Except as otherwise indicated, the persons or entities listed below have sole voting and investment power with respect to all shares of common stock beneficially owned by them, except to the extent such power may be shared with a spouse.
PERCENT BENEFICIALLY OWNED(A) SHARES BENEFICIALLY --------------------- OWNED PRIOR TO BEFORE AFTER NAME AND ADDRESS OFFERING OFFERING OFFERING ---------------- ------------------- --------- --------- 5% STOCKHOLDERS: Charterhouse Equity Partners III, L.P.(b)................... 2,167,681 51.8% % c/o Charterhouse Group International, Inc. 535 Madison Avenue New York, NY 10022 Morgan Stanley Private Equity(c)............................ 1,357,926 32.4 1221 Avenue of the Americas, 33rd Floor New York, NY 10020 DIRECTORS: Karen H. Bechtel(d)......................................... -- Joseph A. Boshart(e)........................................ 68,600 1.6 Bruce A. Cerullo(f)......................................... 75,636 1.8 Thomas C. Dircks(g)......................................... -- -- A. Lawrence Fagan(g)........................................ -- -- Alan Fitzpatrick(d)......................................... -- -- Emil Hensel(h).............................................. 45,262 1.1 Fazle Husain(d)............................................. -- -- Lori Livers(g).............................................. -- -- OTHER NAMED EXECUTIVE OFFICERS: Vickie Anenberg(i).......................................... 17,737 * * Dr. Franklin A. Shaffer, RN(j).............................. 6,001 * * Carol D. Westfall(k)........................................ 3,066 * * All directors and executive officers as a group (14 216,302 5.2% % persons)(l)...............................................
------------------------ * Less than 1%. (a) For purposes of this table, information as to the shares of common stock assumes, in the case of the column "After Offering," that the underwriters' over-allotment option is not exercised. In addition, a person or group of persons is deemed to have "beneficial ownership" of any shares of common stock when such person or persons has the right to acquire them within 60 days after the date of this prospectus. For purposes of computing the percentage of outstanding shares of 51 common stock held by each person or group of persons named above, any shares which such person or persons have the right to acquire within 60 days after the date of this prospectus is deemed to be outstanding but is not deemed to be outstanding for the purpose of computing the percentage ownership of any other person. (b) The general partner of CEP III is CHUSA Equity Investors III, L.P., whose general partner is CEP III, Inc., a wholly owned subsidiary of Charterhouse. As a result of the foregoing, all of the shares held by CEP III would, for purposes of the Securities Exchange Act of 1934, be considered to be beneficially owned by Charterhouse. (c) Consists of 1,223,320 shares owned by Morgan Stanley Dean Witter Capital Partners IV, L.P. and its related investment funds (collectively, "MSDWCP") and 134,606 shares owned by Morgan Stanley Venture Partners III, L.P. and its related investment funds (collectively, "MSVP"). The general partner of MSDWCP is MSDW Capital Partners IV, LLC, the institutional managing member of which is MSDW Capital Partners IV, Inc. ("MSDWCP Inc."), a wholly owned subsidiary of Morgan Stanley Dean Witter & Co. ("MSDW"). The general partner of MSVP is Morgan Stanley Venture Partners III, L.L.C., the institutional managing member of which is Morgan Stanley Venture Partners III, Inc. ("MSVP Inc."), a wholly owned subsidiary of MSDW. (d) Karen H. Bechtel is a Managing Director of MSDWCP Inc. and Morgan Stanley & Co. Incorporated, ("MS & Co."), a wholly owned subsidiary of MSDW. Alan Fitzpatrick is a Vice President of MSDWCP Inc. and MS & Co. Fazle Husain is an Executive Director of MSVP Inc. and MS & Co. Ms. Bechtel and Messrs. Fitzpatrick and Husain each disclaim beneficial ownership of the shares of common stock beneficially owned by Morgan Stanley Private Equity and its affiliates, except to the extent of any direct pecuniary interest therein. (e) Includes 33,141 shares subject to options that are currently exercisable or exercisable within 60 days of the date of this prospectus. (f) Includes 22,094 shares subject to options that are currently exercisable or exercisable within 60 days of the date of this prospectus. (g) Thomas C. Dircks, A. Lawrence Fagan and Lori Livers are executive officers of Charterhouse. Mr. Fagan is also a director and stockholder of Charterhouse. Messrs. Dircks and Fagan and Ms. Livers each disclaim beneficial ownership of the shares of common stock beneficially owned by Charterhouse. (h) Includes 26,513 shares subject to options that are currently exercisable or exercisable within 60 days of the date of this prospectus. (i) Includes 13,256 shares subject to options that are currently exercisable or exercisable within 60 days of the date of this prospectus. (j) Includes 3,731 shares subject to options that are currently exercisable or exercisable within 60 days of the date of this prospectus. (k) Includes 1,863 shares subject to options that are currently exercisable or exercisable within 60 days of the date of this prospectus. (l) Includes an aggregate of 100,598 shares subject to options that are currently exercisable or exercisable within 60 days of the date of this prospectus. 52 DESCRIPTION OF CAPITAL STOCK Our amended and restated certificate of incorporation, which will become effective prior to the consummation of the offering, authorizes the issuance of up to shares of common stock and shares of preferred stock, the rights and preferences of which may be established from time to time by our board of directors. As of , 2001, we had shares of common stock outstanding and no shares of preferred stock outstanding. The following description of our capital stock and provisions of our amended and restated certificate of incorporation and amended and restated by-laws are summaries and are qualified by reference to the certificate of incorporation and the by-laws that will become effective prior to the effective date of the registration statement registering shares included in this offering. Copies of these documents have been filed with the Securities and Exchange Commission as exhibits to our registration statement, of which this prospectus forms a part. COMMON STOCK Holders of common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders and do not have cumulative voting rights. Accordingly, a plurality of the votes cast in any election of directors may elect all of the directors standing for election. Morgan Stanley and Charterhouse have certain rights with respect to the board of directors and other related matters. Holders of common stock are entitled to receive ratably such dividends, if any, as may be declared by the board of directors out of legally available funds. Upon our liquidation, dissolution or winding-up, holders of common stock are entitled to receive ratably our net assets available for distribution after the payment of all of our liabilities. The outstanding shares of common stock are, and the shares sold in the offering will be, when issued and paid for, validly issued, fully paid and nonassessable. PREFERRED STOCK The board of directors has the authority, without action by the stockholders, to designate and issue preferred stock and to designate the rights, preferences and privileges of each series of preferred stock, which may be greater than the rights attached to the common stock. It will not be possible to state the actual effect of the issuance of any shares of preferred stock on the rights of holders of common stock until the board of directors determines the specific rights attached to that preferred stock. The effects of issuing preferred stock could include one or more of the following: - restricting dividends on the common stock; - diluting the voting power of the common stock; - impairing the liquidation rights of the common stock; or - delaying or preventing a change of control of our Company. LIMITATION ON LIABILITY AND INDEMNIFICATION MATTERS Our amended and restated certificate of incorporation limits the liability of our directors to us and our stockholders to the fullest extent permitted by Delaware law. Specifically, our directors will not be personally liable for money damages for breach of fiduciary duty as a director, except for liability. - for any breach of the director's duty of loyalty to us or our stockholders; - for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law; - under Section 174 of the Delaware General Corporation Law, which concerns unlawful payments of dividends, stock purchases or redemptions; and - for any transaction from which the director derived an improper personal benefit. Our amended and restated certificate of incorporation and amended and restated by-laws also contain provisions indemnifying our directors and officers to the fullest extent permitted by Delaware 53 law. The indemnification permitted under Delaware law is not exclusive of any other rights to which these persons may be entitled. In addition, we maintain directors' and officers' liability insurance to provide our directors and officers with insurance coverage for losses arising from claims based on breaches of duty, negligence, errors and other wrongful acts. ANTI-TAKEOVER EFFECTS OF PROVISIONS OF DELAWARE LAW AND OUR CERTIFICATE OF INCORPORATION AND BY-LAWS A number of provisions under Delaware law and in our amended and restated certificate of incorporation and amended and restated by-laws may make it more difficult to acquire control of us. These provisions could deprive the stockholders of opportunities to realize a premium on the shares of common stock owned by them. In addition, these provisions may adversely affect the prevailing market price of the common stock. These provisions are intended to: - enhance the likelihood of continuity and stability in the composition of the board and in the policies formulated by the board; - discourage certain types of transactions which may involve an actual or threatened change in control of our company; - discourage certain tactics that may be used in proxy fights; and - encourage persons seeking to acquire control of our company to consult first with the board of directors to negotiate the terms of any proposed business combination or offer. SECTION 203 OF THE DELAWARE GENERAL CORPORATION LAW. We are subject to the provisions of Section 203 of the Delaware General Corporation Law. Subject to certain exceptions, Section 203 of Delaware law prohibits a publicly held Delaware corporation from engaging in a "business combination" with an "interested stockholder" for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the interested stockholder attained such status with the approval of the board of directors or unless the "business combination" is approved in a prescribed manner. A "business combination" is defined as a merger, asset sale or other transaction resulting in a financial benefit to the interested stockholder. Subject to various exceptions, an "interested stockholder" is a person who, together with affiliates and associates, owns, or within the past three years did own 15% or more of a corporation's voting stock. This statute could prohibit or delay the accomplishment of mergers or other takeover or change in control attempts with respect to us and, accordingly, may discourage attempts to acquire us. STOCKHOLDER ACTION BY WRITTEN CONSENT. Our amended and restated by-laws provide that stockholders may take action by written consent. AUTHORIZED BUT UNISSUED SHARES OF COMMON STOCK. The authorized but unissued shares of common stock and preferred stock are available for future issuance without stockholder approval. These additional shares may be utilized for a variety of corporate purposes, including future public offerings to raise additional capital, corporate acquisitions and employee benefit plans. The existence of authorized but unissued shares of common stock and preferred stock could render more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise. TRANSFER AGENT AND REGISTRAR The transfer agent and registrar for our common stock is . Its address is . LISTING We expect our common stock to be approved for quotation on the Nasdaq National Market under the symbol CCRN. 54 SHARES ELIGIBLE FOR FUTURE SALE RULE 144 SECURITIES Upon the consummation of this offering, we will have shares of common stock outstanding, assuming no exercise of the underwriters' over-allotment option and no exercise of outstanding options. All of the shares of common stock sold in this offering will be freely tradable without restriction or further registration under the Securities Act, except for any of the shares that are acquired by "affiliates" as that term is defined in Rule 144 under the Securities Act. The shares of common stock held by our affiliates and our directors and executive officers and other existing shareholders after the offering will be "restricted" securities under the meaning of Rule 144 under the Securities Act and may not be sold in the absence of registration under the Securities Act, unless an exemption from registration is available, including exemptions pursuant to Rule 144 or Rule 144A under the Securities Act. In general, under Rule 144 as currently in effect, beginning 90 days after the date of this prospectus, a person who has beneficially owned shares of our common stock for at least one year would be entitled to sell within any three-month period a number of shares that does not exceed the greater of either of the following: - 1% of the number of shares of common stock then outstanding, which will equal approximately shares outstanding immediately after this offering, or - the average weekly trading volume of the common stock on the Nasdaq National Market during the four calendar weeks preceding the filing of a notice on Form 144 with respect to such sale. Sales under Rule 144 are also subject to certain manner of sale provisions and notice requirements and to the availability of current public information about us. Under Rule 144(k), a person who is not deemed to have been one of our "affiliates" at any time during the 90 days preceding a sale, and who has beneficially owned the shares proposed to be sold for at least two years, including the holding period of any prior owner other than an "affiliate," is entitled to sell its shares without complying with the manner of sale, public information, volume limitation or notice provisions of Rule 144. Therefore, unless otherwise restricted, "144(k) shares" may be sold immediately upon the completion of this offering. The sale of these shares, or the perception that sales will be made, could adversely affect the price of our common stock after the offering because a greater supply of shares would be, or would be perceived to be, available for sale in the public market. We and our executive officers and directors and substantially all existing stockholders have agreed that, without the prior written consent of Merrill Lynch & Co. on behalf of the underwriters, we will not, during the period ended 180 days after the date of this prospectus, sell shares of common stock or take certain related actions, subject to limited exceptions, all as described under "Underwriting." RULE 701 In general, under Rule 701, any of our employees, directors, officers, consultants or advisors who purchases common stock from us in connection with a compensatory stock or option plan or other written agreement before the effective date of this prospectus is entitled to resell those shares 90 days after the effective date of this prospectus in reliance on Rule 144, without having to comply with certain restrictions (including the holding period) contained in Rule 144. Rule 701 permits affiliates to sell their Rule 701 shares under Rule 144 without complying with the holding period requirements of Rule 144. It permits non-affiliates to sell their Rule 701 shares in reliance on Rule 144 without having to comply with the holding period, public information, volume limitation or notice provisions of Rule 144. All holders of Rule 701 shares are required to wait until 90 days after the date of this prospectus before selling those shares. 55 STOCK OPTIONS Following the completion of this offering, we intend to file a registration statement on Form S-8 under the Securities Act covering shares of common stock issued or reserved for issuance under our various stock option plans. The registration statement will become effective automatically upon filing. As of March 31, 2001, options to purchase shares of common stock were issued and outstanding, of which shares have vested. Accordingly, shares registered will, subject to vesting provisions and Rule 144 volume limitations applicable to our affiliates, be available for sale in the open market immediately after the 180-day lock-up agreements expire. REGISTRATION RIGHTS Each of CEP III and investment funds managed by Morgan Stanley Private Equity may require us on up to two occasions to use our best efforts to file registration statements on Form S-1 or Form S-2 covering public sale of shares of common stock held by them. We have the right, under specified circumstances, to delay any registration required by up to 90 days. In addition, the holders are entitled to require us to register their shares on registrations that we initiate and we have granted the holders unlimited demand rights to cause us to file a registration statement on Form S-3. DB Capital Investors, L.P. and The Northwestern Mutual Life Insurance Company may require us on one occasion to use our best efforts to file a registration statement covering the public sale of shares of common stock held by them. We have the right, under specified circumstances, to delay any registration required by up to 90 days. In addition, the holders are entitled to require us to register their shares on registrations that we initiate. The registration rights expire at such time as the shares are eligible for resale under Rule 144 of the Securities Act. 56 UNITED STATES FEDERAL TAX CONSIDERATIONS FOR NON-UNITED STATES HOLDERS The following is a general discussion of the principal United States Federal income and estate tax consequences of the ownership and disposition of our common stock by a non-U.S. holder. As used in this discussion, the term "non-U.S. holder" means a beneficial owner of our common stock that is not, for U.S. Federal income tax purposes: - an individual who is a citizen or resident of the United States; - a corporation created or organized in or under the laws of the United States or of any political subdivision of the United States or a partnership not engaged in trade or business within the United States; - an estate whose income is includible in gross income for U.S. Federal income tax purposes regardless of its source; or - a trust, in general, if a U.S. court is able to exercise primary supervision over the administration of the trust and one or more U.S. persons have authority to control all substantial decisions of the trust. An individual may be treated as a resident of the United States in any calendar year for U.S. Federal income tax purposes, instead of a nonresident, by, among other ways, being present in the United States on at least 31 days in that calendar year and for an aggregate of at least 183 days during a three-year period ending in the current calendar year. For purposes of this calculation, you would count all of the days present in the current year, one-third of the days present in the immediately preceding year and one-sixth of the days present in the second preceding year. Residents are taxed for U.S. Federal income purposes as if they were U.S. citizens. This discussion does not consider: - U.S. state and local or non-U.S. tax consequences; - specific facts and circumstances that may be relevant to a particular non-U.S. holder's tax position, including, if the non-U.S. holder is a partnership that the U.S. tax consequences of holding and disposing of our common stock may be affected by certain determinations made at the partner level; - the tax consequences for the shareholders, partners or beneficiaries of a non-U.S. holder; - special tax rules that may apply to particular non-U.S. holders, such as financial institutions, insurance companies, tax-exempt organizations, U.S. expatriates, broker-dealers, and traders in securities; or - special tax rules that may apply to a non-U.S. holder that holds our common stock as part of a "straddle," "hedge," "conversion transaction," "synthetic security" or other integrated investment. The following discussion is based on provisions of the U.S. Internal Revenue Code of 1986, as amended, applicable U.S. Treasury regulations and administrative and judicial interpretations, all as in effect on the date of this prospectus, and all of which are subject to change, retroactively or prospectively. The following summary assumes that a non-U.S. holder holds our common stock as a capital asset. EACH NON-U.S. HOLDER SHOULD CONSULT A TAX ADVISOR REGARDING THE U.S. FEDERAL, STATE, LOCAL, AND NON-U.S. INCOME AND OTHER TAX CONSEQUENCES OF ACQUIRING, HOLDING, AND DISPOSING OF SHARES OF OUR COMMON STOCK. DIVIDENDS We do not anticipate paying cash dividends on our common stock in the foreseeable future. See "Dividend Policy." In the event, however, that we pay dividends on our common stock, we will have to withhold a U.S. Federal withholding tax at a rate of 30%, or a lower rate under an applicable income 57 tax treaty, from the gross amount of the dividends paid to a non-U.S. holder. Non-U.S. holders should consult their tax advisors regarding their entitlement to benefits under a relevant income tax treaty. With respect to any such dividends: - a non-U.S. holder who claims the benefit of an applicable income tax treaty rate generally will be required to satisfy applicable certification and other requirements; - in the case of common stock held by a foreign partnership, the certification requirement will generally be applied to the partners of the partnership and the partnership will be required to provide certain information, including a U.S. taxpayer identification number; and - look-through rules will apply for tiered partnerships. A non-U.S. holder that is eligible for a reduced rate of U.S. Federal withholding tax under an income tax treaty may obtain a refund or credit of any excess amounts withheld by filing an appropriate claim for refund with the U.S. Internal Revenue Service. Dividends that are effectively connected with a non-U.S. holder's conduct of a trade or business in the United States or, alternatively, if an income tax treaty applies, are attributable to a permanent establishment maintained by the non-U.S. holder in the United States, are taxed on a net income basis at the regular graduated rates and in the manner applicable to U.S. persons. In that case, we will not have to withhold U.S. Federal withholding tax if the non-U.S. holder complies with applicable certification and disclosure requirements. In addition, a "branch profits tax" may be imposed at a 30% rate, or a lower rate under an applicable income tax treaty, on dividends received by a foreign corporation that are effectively connected with the conduct of a trade or business in the United States. GAIN ON DISPOSITION OF COMMON STOCK A non-U.S. holder generally will not be taxed on gain recognized on a disposition of our common stock unless: - the gain is effectively connected with the non-U.S. holder's conduct of a trade or business in the United States or, alternatively, if an income tax treaty applies, is attributable to a permanent establishment maintained by the non-U.S. holder in the United States; in these cases, the gain will be taxed on a net income basis at the regular graduated rates and in the manner applicable to U.S. persons and, if the non-U.S. holder is a foreign corporation, the "branch profits tax" described above may also apply; - the non-U.S. holder is an individual who holds our common stock as a capital asset, is present in the United States for more than 182 days in the taxable year of the disposition and meets other requirements; or - we are or have been a "U.S. real property holding corporation" for U.S. Federal income tax purposes at any time during the shorter of the five year period ending on the date of disposition or the period that the non-U.S. holder held our common stock. In general, we will be treated as a "U.S. real property holding corporation" if the fair market value of our "U.S. real property interests" equals or exceeds 50% of the sum of the fair market value of our worldwide real property interests and our other assets used or held for use in a trade or business. Currently, it is our best estimate that the fair market value of our U.S. real property interests is, and has been for at least the previous five years, less than 50% of the sum of the fair market value of our worldwide real property interests and our other assets, including goodwill, used or held for use in a trade or business. Therefore, we believe that we are not currently a U.S. real property holding corporation. Nor do we anticipate becoming a U.S. real property holding corporation in the future. However, even if we are or have been a U.S. real property holding corporation, a non-U.S. holder that did not beneficially own, directly or indirectly, more than 5% of the total fair market value of our common stock at any time during the shorter of the five-year period ending on the date of disposition 58 or the period that our common stock was held by the non-U.S. holder (a "non-5% holder") and which is not otherwise taxed under any other circumstances described above, generally will not be taxed on any gain realized on the disposition of our common stock if, at any time during the calendar year of the disposition, our common stock was regularly traded on an established securities market within the meaning of the applicable U.S. Treasury regulations. We have applied to have our common stock listed on the Nasdaq National Market. Although not free from doubt, our common stock should be considered to be regularly traded on an established securities market for any calendar quarter during which it is regularly quoted on the Nasdaq National Market by brokers or dealers which hold themselves out to buy or sell our common stock at the quoted price. If our common stock were not considered to be regularly traded on the Nasdaq National Market at any time during the applicable calendar quarter and we are or have been a U.S. real property holding corporation, then a non-5% holder would be taxed for U.S. Federal income tax purposes on any gain realized on the disposition of our common stock on a net income basis as if the gain were effectively connected with the conduct of a U.S. trade or business by the non-5% holder during the taxable year and, in such case, the person acquiring our common stock from a non-5% holder generally would have to withhold 10% of the amount of the proceeds of the disposition. Such withholding may be reduced or eliminated pursuant to a withholding certificate issued by the U.S. Internal Revenue Service in accordance with applicable U.S. Treasury regulations. We urge all non-U.S. holders to consult their own tax advisors regarding the application of these rules to them. FEDERAL ESTATE TAX Common stock owned or treated as owned by an individual who is a non-U.S. holder at the time of death will be included in the individual's gross estate for U.S. Federal estate tax purposes, unless an applicable estate tax or other treaty provides otherwise and, therefore, may be subject to U.S. Federal estate tax. INFORMATION REPORTING AND BACKUP WITHHOLDING TAX We must report annually to the U.S. Internal Revenue Service and to each non-U.S. holder the amount of dividends paid to that holder and the tax withheld from those dividends. Copies of the information returns reporting those dividends and withholding may also be made available to the tax authorities in the country in which the non-U.S. holder is a resident under the provisions of an applicable income tax treaty or agreement. The gross amount of dividends paid to a non-U.S. holder that fails to certify its non-U.S. holder status in accordance with applicable U.S. Treasury regulations generally will be reduced by backup withholding at a rate of 31%. The payment of the proceeds of the disposition of common stock by a non-U.S. holder to or through the U.S. office of a broker generally will be reported to the U.S. Internal Revenue Service and reduced by backup withholding at a rate of 31% unless the non-U.S. holder either certifies its status as a non-U.S. holder under penalties of perjury or otherwise establishes an exemption and the broker has no actual knowledge to the contrary. The payment of the proceeds on the disposition of common stock by a non-U.S. holder to or through a non-U.S. office of a broker generally will not be reduced by backup withholding or reported to the U.S. Internal Revenue Service. If however, the broker is a U.S. person or has certain enumerated connections with the United States, the proceeds from such disposition generally will be reported to the U.S. Internal Revenue Service (but not reduced by backup withholding) unless certain conditions are met. Non-U.S. holders should consult their own tax advisors regarding the application of the information reporting and backup withholding rules to them. Any amounts withheld under the backup withholding rules from a payment to a non-U.S. holder will be refunded, or credited against the holder's U.S. Federal income tax liability, if any, provided that the required information is furnished to the U.S. Internal Revenue Service. 59 UNDERWRITING We intend to offer the shares in the U.S. and Canada through the U.S. underwriters and elsewhere through the international managers. Merrill Lynch, Pierce, Fenner & Smith Incorporated, Salomon Smith Barney Inc., Banc of America Securities LLC, The Robinson-Humphrey Company, LLC and CIBC World Markets Corp. are acting as U.S. representatives of the U.S. underwriters named below. Subject to the terms and conditions described in a U.S. purchase agreement between us and the U.S. underwriters, and concurrently with the sale of shares to the international managers, we have agreed to sell to the U.S. underwriters, and the U.S. underwriters severally have agreed to purchase from us, the number of shares listed opposite their names below.
NUMBER OF SHARES U.S. UNDERWRITER --------- Merrill Lynch, Pierce, Fenner & Smith Incorporated...................................... Salomon Smith Barney Inc.................................... Banc of America Securities LLC.............................. The Robinson-Humphrey Company, LLC.......................... CIBC World Markets Corp..................................... ------ Total............................................. ======
We have also entered into an international purchase agreement with the international managers for sale of the shares outside the U.S. and Canada for whom Merrill Lynch International, Salomon Brothers International Limited, Banc of America Securities Limited, The Robinson-Humphrey Company, LLC and CIBC World Markets plc are acting as lead managers. Subject to the terms and conditions in the international purchase agreement, and concurrently with the sale of shares to the U.S. underwriters pursuant to the U.S. purchase agreement, we have agreed to sell to the international managers, and the international managers severally have agreed to purchase shares from us. The initial public offering price per share and the total underwriting discount per share are identical under the U.S. purchase agreement and the international purchase agreement. The U.S. underwriters and the international managers have agreed to purchase all of the shares sold under the U.S. and international purchase agreements if any of these shares are purchased. If an underwriter defaults, the U.S. and international purchase agreements provide that the purchase commitments of the nondefaulting underwriters may be increased or the purchase agreements may be terminated. The closings for the sale of shares to be purchased by the U.S. underwriters and the international managers are conditioned on one another. We have agreed to indemnify the U.S. underwriters and the international managers against certain liabilities, including liabilities under the Securities Act, or to contribute to payments the U.S. underwriters and international managers may be required to make in respect of those liabilities. The U.S. underwriters are offering the shares, subject to prior sale, when, as and if issued to and accepted by them, subject to approval of legal matters by their counsel, including the validity of the shares, and other conditions contained in the purchase agreements, such as the receipt by the underwriters of officer's certificates and legal opinions. The U.S. underwriters reserve the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part. COMMISSIONS AND DISCOUNTS The U.S. representatives have advised us that the U.S. underwriters propose initially to offer the shares to the public at the initial public offering price on the cover page of this prospectus and to dealers at that price less a concession not in excess of $ per share. The U.S. underwriters may 60 allow, and the dealers may reallow, a discount not in excess of $ per share to other dealers. After the initial public offering, the public offering price, concession and discount may be changed. The following table shows the public offering price, underwriting discount and proceeds before expenses to Cross Country. The information assumes either no exercise or full exercise by the U.S. underwriters and the international managers of their over-allotment options.
PER SHARE WITHOUT OPTION WITH OPTION --------- -------------- ----------- Public offering price..................... $ $ $ Underwriting discount..................... $ $ $ Proceeds, before expenses, to Cross Country................................. $ $ $
The expenses of the offering, not including the underwriting discount, are estimated at $ and are payable by Cross Country. OVERALLOTMENT OPTIONS We have granted an option to the U.S. underwriters to purchase up to additional shares at the public offering price less the underwriting discount. The U.S. underwriters may exercise this option for 30 days from the date of this prospectus solely to cover any overallotments. If the U.S. underwriters exercise this option, each will be obligated, subject to conditions contained in the purchase agreements, to purchase a number of additional shares proportionate to that U.S. underwriter's initial amount reflected in the above table. We have also granted an option to the international managers, exercisable for 30 days from the date of this prospectus, to purchase up to additional shares to cover any overallotments on terms similar to those granted to the U.S. underwriters. INTERSYNDICATE AGREEMENT The U.S. underwriters and the international managers have entered into an intersyndicate agreement that provides for the coordination of their activities. Under the intersyndicate agreement, the U.S. underwriters and the international managers may sell shares to each other for purposes of resale at the initial public offering price, less an amount not greater than the selling concession. Under the intersyndicate agreement, the U.S. underwriters and any dealer to whom they sell shares will not offer to sell or sell shares to persons who are non-U.S. or non-Canadian persons or to persons they believe intend to resell to persons who are non-U.S. or non-Canadian persons, except in the case of transactions under the intersyndicate agreement. Similarly, the international managers and any dealer to whom they sell shares will not offer to sell or sell shares to U.S. persons or Canadian persons or to persons they believe intend to resell to U.S. or Canadian persons, except in the case of transactions under the intersyndicate agreement. RESERVED SHARES At our request, the underwriters have reserved for sale, at the initial public offering price, up to shares offered by this prospectus for sale to some of our directors, officers, employees, distributors, dealers, business associates and related persons. If these persons purchase reserved shares, this will reduce the number of shares available for sale to the general public. Any reserved shares that are not orally confirmed for purchase within one day of the pricing of this offering will be offered by the underwriters to the general public on the same terms as the other shares offered by this prospectus. 61 NO SALES OF SIMILAR SECURITIES We and our executive officers and directors and substantially all existing stockholders have agreed, with exceptions, not to sell or transfer any common stock for 180 days after the date of this prospectus without first obtaining the written consent of Merrill Lynch. Specifically, we and these other individuals have agreed not to directly or indirectly: - offer, pledge, sell or contract to sell any common stock; - sell any option or contract to purchase any common stock; - purchase any option or contract to sell any common stock; - grant any option, right or warrant for the sale of any common stock; - lend or otherwise dispose of or transfer any common stock; - request or demand that we file a registration statement related to the common stock; or - enter into any swap or other agreement that transfers, in whole or in part, the economic consequence of ownership of any common stock whether any such swap or transaction is to be settled by delivery of shares or other securities, in cash or otherwise. This lockup provision applies to common stock and to securities convertible into or exchangeable or exercisable for or repayable with common stock. It also applies to common stock owned now or acquired later by the person executing the agreement or for which the person executing the agreement later acquires the power of disposition. QUOTATION ON THE NASDAQ NATIONAL MARKET We expect the shares to be approved for quotation on the Nasdaq National Market, subject to notice of issuance, under the symbol "CCRN." Before this offering, there has been no public market for our common stock. The initial public offering price will be determined through negotiations among us and the U.S. representatives and lead managers. In addition to prevailing market conditions, the factors to be considered in determining the initial public offering price are: - the valuation multiples of publicly traded companies that the U.S. representatives and the lead managers believe to be comparable to us; - our financial information; - the history of, and the prospects for, our company and the industry in which we compete; - an assessment of our management, its past and present operations, and the prospects for, and timing of, our future revenue; - the present state of our development; and - the above factors in relation to market values and various valuation measures of other companies engaged in activities similar to ours. An active trading market for the shares may not develop. It is also possible that after the offering the shares will not trade in the public market at or above the initial public offering price. The U.S. underwriters do not expect to sell more than 5% of the shares in the aggregate to accounts over which they exercise discretionary authority. 62 NASD REGULATIONS More than ten percent of the proceeds of the offering will be applied to pay down debt obligations owed to affiliates of Merrill Lynch, Salomon Smith Barney Inc., Banc of America Securities LLC and The Robinson-Humphrey Company, LLC. Because more than ten percent of the net proceeds of the offering will be paid to members or affiliates of members of the National Association of Securities Dealers, Inc. participating in the offering, the offering will be conducted in accordance with NASD Conduct Rule 2710(c)(8). This rule requires that the public offering price of an equity security be no higher than the price recommended by a qualified independent underwriter which has participated in the preparation of the registration statement and performed its usual standard of due diligence with respect to that registration statement. CIBC World Markets Corp. has agreed to act as qualified independent underwriter for the offering. The price of the shares will be no higher than that recommended by CIBC World Markets Corp. The underwriters will not confirm sales of shares to any account over which they exercise discretionary authority without the prior written specific approval of the customer. PRICE STABILIZATION, SHORT POSITIONS AND PENALTY BIDS Until the distribution of the shares is completed, SEC rules may limit underwriters and selling group members from bidding for and purchasing our common stock. However, the U.S. representatives may engage in transactions that stabilize the price of the common stock, such as bids or purchases to peg, fix or maintain that price. The underwriters may purchase and sell our common stock in the open market. These transactions may include short sales, stabilizing transactions and purchases to cover positions created by short sales. Short sales involve the sale by the underwriters of a greater number of shares than they are required to purchase in the offering. "Covered" short sales are sales made in an amount not greater than the underwriters' option to purchase additional shares from the issuer in the offering. The underwriters may close out any covered short position by either exercising their option to purchase additional shares or purchasing shares in the open market. In determining the source of shares to close out the covered short position, the underwriters will consider, among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase shares through the over-allotment option. "Naked" short sales are any sales in excess of such option. The underwriters must close out any naked short position by purchasing shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the common shares in the open market after pricing that could adversely affect investors who purchase in the offering. Stabilizing transactions consist of various bids for or purchases of common shares made by the underwriters in the open market prior to the completion of the offering. The underwriters may also impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discount received by it because the representatives have repurchased shares sold by or for the account of such underwriter in stabilizing or short covering transactions. Similar to other purchase transactions, the underwriters' purchases to cover the syndicate short sales may have the effect of raising or maintaining the market price of our common stock or preventing or retarding a decline in the market price of the common shares. As a result, the price of our common stock may be higher than the price that might otherwise exist in the open market. Neither we nor any of the underwriters makes any representation or prediction as to the direction or magnitude of any effect that the transactions described above may have on the price of the common stock. In addition, neither we nor any of the underwriters makes any representation that the U.S. 63 representatives or the lead managers will engage in these transactions or that these transactions, once commenced, will not be discontinued without notice. OTHER RELATIONSHIPS Some of the underwriters and their affiliates have engaged in, and may in the future engage in, investment banking and other commercial dealings in the ordinary course of business with us. They have received customary fees and commissions for these transactions. Salomon Smith Barney Inc. acted as the arranger, and affiliates of Salomon Smith Barney Inc. and The Robinson-Humphrey Company, LLC acted as administrative agent, collateral agent, issuing bank and swingline lender under our credit facility. In addition, affiliates of Merrill Lynch, Salomon Smith Barney Inc., Banc of America Securities LLC and The Robinson-Humphrey Company, LLC are lenders under our credit facility. INTERNET DISTRIBUTION Merrill Lynch will be facilitating internet distribution for the offering to some of its internet subscription customers. Merrill Lynch intends to allocate a limited number of shares for sale to its online brokerage customers. An electronic prospectus is available on the website maintained by Merrill Lynch. Other than the prospectus in electronic format, the information on the Merrill Lynch website relating to the offering is not a part of this prospectus. 64 LEGAL MATTERS The validity of the shares of common stock offered by this prospectus will be passed upon for us by Proskauer Rose LLP, New York, New York. Certain legal matters related to the offering will be passed upon for the Underwriters by Debevoise & Plimpton, New York, New York. EXPERTS The consolidated financial statements of Cross Country, Inc. at December 31, 2000 and 1999, and for the year ended December 31, 2000 and for the period from July, 30, 1999 to December 31, 1999, appearing in this Prospectus and Registration Statement have been audited by Ernst & Young LLP, independent auditors, as set forth in their report thereon appearing elsewhere herein, and are included in reliance upon such report given on the authority of such firm as experts in accounting and auditing. The financial statements of Cross Country Staffing (a Partnership) as of July 29, 1999 and December 31, 1998, and for the period from January 1, 1999 through July 29, 1999 and for the year ended December 31, 1998, included in this Prospectus have been so included in reliance on the report of PricewaterhouseCoopers LLP, independent accountants, given on the authority of said firm as experts in auditing and accounting. The consolidated financial statements of TravCorps Corporation and Subsidiary at December 15, 1999, and for the period from December 27, 1998 to December 15, 1999, appearing in this Prospectus and Registration Statement have been audited by Ernst & Young LLP, independent auditors, and at December 26, 1998, and for the year ended December 26, 1998, by Deloitte & Touche LLP, independent auditors, as set forth in their respective reports thereon appearing elsewhere herein, and are included in reliance upon such reports given on the authority of such firms as experts in accounting and auditing. The consolidated financial statements of ClinForce, Inc. at December 31, 2000 and 1999, and for each of the two years in the period ended December 31, 2000, appearing in this Prospectus and Registration Statement have been audited by Ernst & Young LLP, independent auditors, as set forth in their report thereon appearing elsewhere herein, and are included in reliance upon such report given on the authority of such firm as experts in accounting and auditing. WHERE YOU CAN FIND MORE INFORMATION We have filed with the Commission a registration statement on Form S-1, which includes amendments, exhibits, schedules and supplements, under the Securities Act and the rules and regulations under the Securities Act, for the registration of the common stock offered by this prospectus. Although this prospectus, which forms a part of the registration statement, contains all material information included in the registration statement, parts of the registration statement have been omitted from this prospectus as permitted by the rules and regulations of the Commission. For further information with respect to us and the common stock offered by this prospectus, please refer to the registration statement. Statements contained in this prospectus as to the contents of any contracts or other document referred to in this prospectus are not necessarily complete and, where such contract or other document is an exhibit to the registration statement, each such statement is qualified in all respects by the provisions of such exhibit, to which reference is now made. The registration statement can be inspected and copied at prescribed rates at the public reference facilities maintained by the Commission at Room 1024, 450 Fifth Street, N.W., Washington, D.C. 20549, and at the Commission's regional offices at Seven World Trade Center, 13th Floor, New York, New York 10048 and Northwestern Atrium Center, 500 West Madison Street, Suite 1400, Chicago, Illinois 60661. The public may obtain information regarding the Washington, D.C. Public Reference Room by calling the Commission at 1-800-SEC-0330. In addition, the registration statement is publicly available through the Commission's site on the Internet's World Wide Web, located at: http://www.sec.gov. After the offering, we will be subject to the full informational requirements of the Securities Exchange Act. To comply with these requirements, we will file periodic reports, proxy statements and other information with the Commission. 65 INDEX TO FINANCIAL STATEMENTS
PAGE -------- HISTORICAL FINANCIAL STATEMENTS CROSS COUNTRY, INC. Report of Independent Certified Public Accountants........ F-2 Consolidated Balance Sheets as of December 31, 1999 and 2000 and March 31, 2001 (Unaudited)..................... F-3 Consolidated Statements of Operations for the Period from July 30, 1999 to December 31, 1999, for the Year Ended December 31, 2000 and for the Three Months Ended March 31, 2000 and 2001 (Unaudited)........................... F-4 Consolidated Statements of Stockholders' Equity for the Period from July 30, 1999 to December 31, 1999, for the Year Ended December 31, 2000, and for the Three Months Ended March 31, 2001 (Unaudited)........................ F-5 Consolidated Statements of Cash Flows for the Period from July 30, 1999 to December 31, 1999, for the Year Ended December 31, 2000, and for the Three Months Ended March 31, 2000 and 2001 (Unaudited)........................... F-6 Notes to the Consolidated Financial Statements............ F-8 CROSS COUNTRY STAFFING ("PREDECESSOR COMPANY") Report of Independent Certified Public Accountants........ F-24 Balance Sheets as of July 29, 1999 and December 31, 1998.................................................... F-25 Statements of Income and Partners' Capital for the Period from January 1, 1999 to July 29, 1999 and for the Year Ended December 31, 1998................................. F-26 Statements of Cash Flows for the Period from January 1, 1999 to July 29, 1999 and for the Year Ended December 31, 1998................................................ F-27 Notes to Financial Statements............................. F-28 TRAVCORPS CORPORATION AND SUBSIDIARY Independent Auditors' Report.............................. F-34 Consolidated Balance Sheets as of December 15, 1999 and December 26, 1998....................................... F-36 Consolidated Statements of Income for the Year Ended December 26, 1998 and for the Period from December 27, 1998 to December 15, 1999............................... F-38 Consolidated Statements of Stockholders' (Deficit) Equity for the Period from December 27, 1998 to December 15, 1999 and the Year Ended December 26, 1998............... F-39 Consolidated Statements of Cash Flows for the Period from December 27, 1998 to December 15, 1999 and the Year Ended December 26, 1998................................. F-40 Notes to the Consolidated Financial Statements............ F-41 CLINFORCE, INC. Report of Independent Auditors............................ F-49 Consolidated Statements of Assets Acquired and Liabilities Assumed as of December 31, 2000 and 1999................ F-50 Consolidated Statements of Operating Revenues and Expenses for the Years Ended December 31, 2000 and 1999.......... F-51 Notes to the Financial Statements........................... F-52
F-1 Report of Independent Certified Public Accountants The Board of Directors and Stockholders Cross Country, Inc. We have audited the accompanying consolidated balance sheets of Cross Country, Inc. as of December 31, 1999 and 2000 and the related consolidated statements of operations, stockholders' equity and cash flows for the period from July 30, 1999 to December 31, 1999 and the year ended December 31, 2000. Our audit also included the financial statement schedule listed in the Index at Item 14(a). These financial statements and schedule are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements and schedule based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Cross Country, Inc. at December 31, 1999 and 2000, and the results of their operations and their cash flows for the period from July 30, 1999 to December 31, 1999 and the year ended December 31, 2000, in conformity with accounting principles generally accepted in the United States. Also, in our opinion, the related financial statement schedule, when considered in relation to the basic financial statements taken as a whole, present fairly, in all material respects, the information set forth therein. /S/ ERNST & YOUNG LLP West Palm Beach, Florida May 7, 2001 F-2 CROSS COUNTRY, INC. CONSOLIDATED BALANCE SHEETS
DECEMBER 31 --------------------------- MARCH 31, 1999 2000 2001 ------------ ------------ ------------ (UNAUDITED) ASSETS Current assets: Cash...................................................... $ 4,827,877 $ -- $ -- Accounts receivable, less allowance for doubtful accounts of $2,144,110 in 1999, $2,087,747 in 2000 and $2,410,068 in 2001................................................. 50,243,772 65,087,380 71,148,856 Deferred income taxes..................................... 1,779,592 3,140,522 3,140,522 Income taxes receivable................................... 2,936,436 2,076,471 814,445 Prepaid rent on employees' apartments..................... 2,922,723 3,309,673 3,402,909 Deposits on employees' apartments, net of allowance of $300,445 in 1999, $418,775 in 2000 and $332,485 in 2001.................................................... 1,518,071 1,055,106 1,063,268 Other current assets...................................... 449,595 2,032,437 2,993,494 ------------ ------------ ------------ Total current assets........................................ 64,678,066 76,701,589 82,563,494 Property and equipment, net of accumulated depreciation and amortization of $3,470,984 in 1999, $5,024,756 in 2000 and $6,420,976 in 2001........................................ 3,975,129 6,168,505 7,294,542 Trademark, net of accumulated amortization of $158,644 in 1999, $746,669 in 2000 and $897,144 in 2001............... 14,541,356 13,953,331 15,902,856 Goodwill, net of accumulated amortization of $2,417,217 in 1999, $10,767,664 in 2000 and $13,001,554 in 2001......... 200,315,122 199,373,353 221,659,546 Other identifiable intangible assets, net of accumulated amortization of $949,236 in 1999, $3,746,200 in 2000 and $4,453,961 in 2001........................................ 15,480,764 12,683,800 13,276,039 Debt issuance costs, net of accumulated amortization of $746,341 in 1999, $2,616,598 in 2000 and $3,100,039 in 2001...................................................... 10,475,198 8,604,941 9,103,333 Other assets................................................ 229,634 140,148 125,820 ------------ ------------ ------------ Total assets................................................ $309,695,269 $317,625,667 $349,925,630 ============ ============ ============ LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable.......................................... $ 4,677,411 $ 6,445,501 $ 3,674,072 Accrued employee compensation and benefits................ 13,818,840 17,430,804 20,026,057 Accrued expenses.......................................... 5,963,985 3,801,172 4,309,393 Current portion of long-term debt......................... 5,120,000 12,400,000 12,400,000 Note payable.............................................. 54,972 484,108 461,810 Net liabilities from discontinued operations.............. 309,670 534,999 2,033,103 Other current liabilities................................. 735,219 1,229,840 1,967,221 ------------ ------------ ------------ Total current liabilities................................... 30,680,097 42,326,424 44,871,656 Interest rate swap.......................................... -- -- 987,423 Deferred income taxes....................................... 6,374,436 7,571,311 7,621,997 Long-term debt.............................................. 153,899,000 144,388,000 174,021,000 ------------ ------------ ------------ Total liabilities........................................... 190,953,533 194,285,735 227,502,076 Commitments and contingencies Stockholders' equity: Common stock, Class A--$.01 par value; 7,850,000 shares authorized; 3,868,945 shares issued and outstanding at December 31, 1999, 2000 and March 31, 2001.............. 38,689 38,689 38,689 Common stock, Class B--$.01 par value; 150,000 shares authorized; 131,053 shares issued and outstanding at December 31, 1999, 2000 and March 31, 2001.............. 1,311 1,311 1,311 Additional paid-in capital................................ 119,043,201 119,043,201 119,043,201 Accumulated other comprehensive income.................... -- -- (924,929) (Accumulated deficit) retained earnings................... (341,465) 4,256,731 4,265,282 ------------ ------------ ------------ Total stockholders' equity.................................. 118,741,736 123,339,932 122,423,554 ------------ ------------ ------------ Total liabilities and stockholders' equity.................. $309,695,269 $317,625,667 $349,925,630 ============ ============ ============
See accompanying notes. F-3 CROSS COUNTRY, INC. CONSOLIDATED STATEMENTS OF OPERATIONS
THREE MONTHS ENDED PERIOD FROM JULY 30, YEAR ENDED MARCH 31 1999 TO DECEMBER 31, DECEMBER 31, -------------------------- 1999 2000 2000 2001 -------------------- ------------ ----------- ------------ (UNAUDITED) Revenue from services..................... $87,727,219 $367,689,902 $89,583,837 $103,871,739 Operating expenses: Direct operating expenses............... 68,036,524 273,094,434 67,062,402 79,001,406 Selling, general and administrative expenses.............................. 9,256,719 49,027,376 12,053,999 14,175,411 Bad debt expense........................ 511,341 432,973 234,300 419,926 Depreciation............................ 154,590 1,323,397 309,424 518,213 Amortization............................ 4,421,577 13,701,384 3,434,811 3,592,093 Non-recurring indirect transaction costs................................. -- 1,289,217 266,921 -- ----------- ------------ ----------- ------------ Total operating expenses.................. 82,380,751 338,868,781 83,361,857 97,707,049 ----------- ------------ ----------- ------------ Income from operations.................... 5,346,468 28,821,121 6,221,980 6,164,690 Other expenses: Interest expense, net................... 4,821,302 15,435,236 3,833,261 4,008,034 ----------- ------------ ----------- ------------ Income before income taxes and discontinued operations................. 525,166 13,385,885 2,388,719 2,156,656 Income tax expense........................ (671,917) (6,730,024) (1,201,526) (1,084,396) ----------- ------------ ----------- ------------ (Loss) income before discontinued operations.............................. (146,751) 6,655,861 1,187,193 1,072,260 Discontinued operations: Loss from discontinued operations of HospitalHub, less income tax benefit of $140,710 in 1999, $1,159,013 in 2000, and $200,564 and $450,976 for the three months ended March 31, 2000 and 2001, respectively, (194,714) (1,603,833) (286,423) (440,281) Estimated loss on disposal of HospitalHub, less income tax benefit of $0 in 1999, $327,963 in 2000 and $0 and $638,572 for the three months ended March 31, 2000 and 2001, respectively.......................... -- (453,832) -- (623,428) ----------- ------------ ----------- ------------ Net (loss) income......................... $ (341,465) $ 4,598,196 $ 900,770 $ 8,551 =========== ============ =========== ============ Net (loss) income per common share--basic and diluted: (Loss) income before discontinued operations............................ $ (.06) $ 1.66 $ .30 $ .27 Discontinued operations................. (.07) (.51) (.07) (.27) ----------- ------------ ----------- ------------ Net (loss) income......................... $ (.13) $ 1.15 $ .23 $ -- =========== ============ =========== ============ Weighted average common shares outstanding............................. 2,635,895 3,999,998 3,999,998 3,999,998 =========== ============ =========== ============
See accompanying notes. F-4 CROSS COUNTRY, INC. CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
CLASS A CLASS B ACCUMULATED (ACCUMULATED COMMON STOCK COMMON STOCK ADDITIONAL OTHER DEFICIT) ---------------------- --------------------- PAID-IN COMPREHENSIVE RETAINED SHARES DOLLARS SHARES DOLLARS CAPITAL INCOME EARNINGS --------- ---------- -------- ---------- ------------ ------------- ------------ Balance at July 29, 1999 (date of incorporation)......... 2,260,660 $ 22,607 -- $ -- $ 79,567,516 $ -- $ -- Issuance of common stock in conjunction with issuance of long-term debt....... 65,530 655 131,053 1,311 6,918,072 -- -- Issuance of common stock in exchange for employee services.... 22,755 227 -- -- 470,413 -- -- Issuance of common stock in conjunction with acquisition of TravCorps Corporation.......... 1,520,000 15,200 -- -- 32,087,200 -- -- Net loss............... -- -- -- -- -- -- (341,465) --------- ---------- ------- ---------- ------------ ---------- ---------- Balance at December 31, 1999................... 3,868,945 38,689 131,053 1,311 119,043,201 -- (341,465) Net income............. -- -- -- -- -- -- 4,598,196 --------- ---------- ------- ---------- ------------ ---------- ---------- Balance at December 31, 2000................... 3,868,945 38,689 131,053 1,311 119,043,201 -- 4,256,731 Interest rate swap (unaudited)............ -- -- -- -- -- (924,929) -- Net income (unaudited)... -- -- -- -- -- -- 8,551 --------- ---------- ------- ---------- ------------ ---------- ---------- Balance at March 31, 2001 (unaudited)............ 3,868,945 $ 38,689 131,053 $ 1,311 $119,043,201 $ (924,929) $4,265,282 ========= ========== ======= ========== ============ ========== ========== TOTAL STOCKHOLDERS' EQUITY ------------- Balance at July 29, 1999 (date of incorporation)......... $ 79,590,123 Issuance of common stock in conjunction with issuance of long-term debt....... 6,920,038 Issuance of common stock in exchange for employee services.... 470,640 Issuance of common stock in conjunction with acquisition of TravCorps Corporation.......... 32,102,400 Net loss............... (341,465) ------------ Balance at December 31, 1999................... 118,741,736 Net income............. 4,598,196 ------------ Balance at December 31, 2000................... 123,339,932 Interest rate swap (unaudited)............ (924,929) Net income (unaudited)... 8,551 ------------ Balance at March 31, 2001 (unaudited)............ $122,423,554 ============
See accompanying notes. F-5 CROSS COUNTRY, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS
PERIOD FROM THREE MONTHS ENDED JULY 30, 1999 TO YEAR ENDED MARCH 31 DECEMBER 31, DECEMBER 31, --------------------------- 1999 2000 2000 2001 ---------------- ------------ ----------- ------------- (UNAUDITED) OPERATING ACTIVITIES Net (loss) income.............................. $ (341,465) $ 4,598,196 $ 900,770 $ 8,551 Adjustments to reconcile net (loss) income to net cash provided by operating activities: Amortization............................... 4,421,577 13,701,384 3,434,811 3,592,093 Depreciation............................... 154,590 1,323,397 309,424 518,213 Bad debt expense........................... 511,341 432,973 234,300 419,926 Cumulative interest due at maturity........ 1,537,000 3,839,000 918,000 1,033,000 Estimated loss on disposal of discontinued operations............................... -- 453,832 -- 623,428 Loss on derivative instrument.............. -- -- -- 62,494 Changes in operating assets and liabilities: Accounts receivable........................ (1,874,246) (15,096,581) 356,172 (697,405) Prepaid rent, deposits, and other current assets................................... (3,381,084) (1,385,374) 514,853 (923,069) Accounts payable and accrued expenses...... 1,793,712 2,679,076 (5,109,986) (1,240,494) Net liabilities from discontinued operations............................... 309,670 (228,503) 378,734 874,676 Other current liabilities.................. 3,170,112 79,621 1,348,681 737,381 ------------ ----------- ----------- ------------- Net cash provided by operating activities...... 6,301,207 10,397,021 3,285,759 5,008,794 INVESTING ACTIVITIES Acquisition of TravCorps, net cash acquired.... 1,787,434 -- -- -- Acquisition of covenant not to compete......... (250,000) -- -- -- Issuance of common stock....................... 10,000 -- -- -- Acquisition of E-Staff, Inc.................... -- (1,500,000) -- -- Acquisition of Heritage Professional Education, LLC.......................................... -- (6,200,000) -- (46,680) Acquisition of Clinforce, Inc.................. -- -- -- (31,347,239) (Increase) decrease in other assets............ -- (6,205) (241,014) 32,090 Increase in other liabilities.................. -- 1,196,875 -- -- Purchase of property and equipment............. (167,170) (1,992,109) (264,905) (948,559) Increase in software development costs......... -- (1,082,595) -- (294,275) ------------ ----------- ----------- ------------- Net cash provided by (used in) investing activities................................... 1,380,264 (9,584,034) (505,919) (32,604,663) FINANCING ACTIVITIES Debt issuance costs............................ 494,535 -- -- (981,833) Repayment of debt.............................. (148,305,305) (65,258,097) (27,450,198) (14,922,298) Proceeds from issuance of debt................. 144,700,000 59,617,233 20,033,126 43,500,000 ------------ ----------- ----------- ------------- Net cash (used in) provided by financing activities................................... (3,110,770) (5,640,864) (7,417,072) 27,595,869 Change in cash................................. 4,570,701 (4,827,877) (4,637,232) Cash at beginning of period.................... 257,176 4,827,877 4,827,877 -- ------------ ----------- ----------- ------------- Cash at end of period.......................... $ 4,827,877 $ -- $ 190,645 $ -- ============ =========== =========== =============
See accompanying notes. F-6 CROSS COUNTRY, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
PERIOD FROM THREE MONTHS ENDED JULY 30, 1999 TO YEAR ENDED MARCH 31 DECEMBER 31, DECEMBER 31, ----------------------- 1999 2000 2000 2001 ---------------- ------------ ---------- ---------- (UNAUDITED) SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES Issuance of common stock in connection with issuance of debt......................... $ 6,920,038 $ -- $ -- $ -- =========== =========== ========== ========== Issuance of common stock with TravCorps acquisition.............................. $32,102,400 $ -- $ -- $ -- =========== =========== ========== ========== Issuance of common stock in exchange for employee services........................ $ 470,640 $ -- $ -- $ -- =========== =========== ========== ========== SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Interest paid.............................. $ 3,005,467 $10,711,873 $2,643,446 $3,013,259 =========== =========== ========== ========== Income taxes paid.......................... $ 437,873 $ 221,467 $ 62,750 $ -- =========== =========== ========== ==========
See accompanying notes. F-7 CROSS COUNTRY, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 1999 AND 2000 (INFORMATION PERTAINING TO MARCH 31, 2001 AND TO THE THREE MONTH PERIODS ENDED MARCH 31, 2001 AND 2000 IS UNAUDITED) 1. ORGANIZATION AND BASIS OF PRESENTATION On July 29, 1999, Cross Country Staffing, Inc. (CCS), a Delaware corporation, was established through an acquisition of certain assets of Cross Country Staffing (the Partnership), a Delaware general partnership. The Partnership was engaged in the business of providing nurses and other allied health personnel to health care providers primarily on a contract basis. CCS recorded the assets and certain assumed liabilities, as defined in the asset purchase agreement, at fair market value. In addition to the recorded assets and liabilities, the Partnership contributed the value of the business, which included certain intangible assets primarily related to proprietary databases and contracts. The purchase price of approximately $189,000,000 exceeded the fair market value of the assets less the assumed liabilities by approximately $167,537,000, of which $20,890,000 was allocated to certain identifiable intangible assets ($8,900,000--trademark, $8,440,000--databases, $1,040,000--workforce, and $2,510,000--hospital relations), and $250,000 relating to a covenant not to compete. The remaining $146,397,000 was allocated to goodwill. On December 16, 1999, CCS entered into a Plan of Merger with TravCorps Corporation (TravCorps). TravCorps and its wholly-owned subsidiary, Cejka & Company (Cejka) provide flexible staffing, search, consulting and related outsourced services to health care providers throughout the United States. Pursuant to the Plan of Merger, all outstanding shares of TravCorps' common stock were exchanged for common stock in CCS and TravCorps became a wholly-owned subsidiary of CCS. The fair value of the shares of common stock issued to the stockholders of TravCorps, as determined by a valuation of the common stock in January 2000, was $32,102,000. The purchase price exceeded the fair value of the net tangible assets acquired by approximately $66,575,000, of which $10,240,000 was allocated to certain identifiable intangible assets ($5,800,000--trademark, $2,910,000--databases, $630,000--workforce, and $900,000--hospital relations). The remaining $56,335,000 was allocated to goodwill. The acquisition was accounted for as a purchase and, accordingly, the accompanying consolidated financial statements include the results of TravCorps from the acquisition date. Effective October 1, 2000, TravCorps changed its name to TVCM, Inc. (TVCM). Effective October 10, 2000, CCS changed its name to Cross Country TravCorps, Inc. (CCT). Subsequent to December 31, 2000, CCT changed its name to Cross Country, Inc. (the Company). The Company is primarily engaged in the business of providing temporary health care staffing services to acute and subacute care facilities nationwide. The consolidated financial statements include the accounts of the Company and its wholly-owned direct and indirect subsidiaries, TVCM (f/k/a TravCorps), Cejka, CC Staffing, Inc., E-Staff, Inc. (E-Staff), HospitalHub, Inc. (f/k/a Ashley One, Inc.)(HospitalHub), and Cross Country Seminars, Inc. (f/k/a CCS/Heritage Acquisition Corp.) (Cross Country Seminars). All material intercompany transactions and balances have been eliminated in consolidation. The accompanying unaudited condensed consolidated financial statements as of March 31, 2001 and for the three months ended March 31, 2000 and 2001 have been prepared in accordance with generally accepted accounting principles for interim financial information. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to present fairly the financial position, results of operations and cash flows have been included. The results of F-8 CROSS COUNTRY, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999 AND 2000 (INFORMATION PERTAINING TO MARCH 31, 2001 AND TO THE THREE MONTH PERIODS ENDED MARCH 31, 2001 AND 2000 IS UNAUDITED) 1. ORGANIZATION AND BASIS OF PRESENTATION (CONTINUED) operations for the three months ended March 31, 2001 are not necessarily indicative of the results that may be expected for the year ended December 31, 2001. 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES USE OF ESTIMATES The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. CONCENTRATION OF CREDIT RISK Financial instruments that potentially subject the Company to concentrations of credit risk as defined by Financial Accounting Standards Board (FASB) Statement No. 105, DISCLOSURE OF INFORMATION ABOUT FINANCIAL INSTRUMENTS WITH OFF-BALANCE-SHEET RISK AND FINANCIAL INSTRUMENTS WITH CONCENTRATIONS OF CREDIT RISK, consist principally of accounts receivable. The Company's customers are health care providers and accounts receivable represent amounts due from these providers. The Company performs ongoing credit evaluations of its customers' financial conditions and, generally, does not require collateral. Overall, based on the large number of customers in differing geographic areas throughout the United States and its territories, the Company believes the concentration of credit risk is limited. As of December 31, 1999, approximately 8% of the outstanding accounts receivable were due from one customer and as of December 31, 2000, approximately 9% of the outstanding accounts receivable were due from four customers. As of March 31, 2001, approximately 10% of the outstanding accounts receivable were due from five customers. PREPAID RENT AND DEPOSITS The Company leases a number of apartments for its employees under short-term agreements (typically three to six months), which generally coincide with each employee's staffing contract. As a condition of these agreements, the Company places security deposits on the leased apartments. Prepaid rent and deposits relate to these short-term agreements. PROPERTY AND EQUIPMENT Property and equipment are stated at cost, less accumulated depreciation. Depreciation is determined on a straight-line basis over the estimated useful lives of the assets, which generally range from three to seven years. Leasehold improvements are depreciated over the lives of the related leases or the useful life of an individual lease, whichever is shorter. Certain software development costs are capitalized in accordance with the provisions of Statement of Position 98-1, ACCOUNTING FOR THE COSTS OF COMPUTER SOFTWARE DEVELOPED OR OBTAINED FOR INTERNAL USE and FASB Statement No. 86, ACCOUNTING FOR COSTS OF COMPUTER SOFTWARE TO BE SOLD, LEASED, OR OTHERWISE MARKETED. Such costs include charges for consulting services and costs for personnel associated with F-9 CROSS COUNTRY, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999 AND 2000 (INFORMATION PERTAINING TO MARCH 31, 2001 AND TO THE THREE MONTH PERIODS ENDED MARCH 31, 2001 AND 2000 IS UNAUDITED) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) programming, coding, and testing such software. Amortization of capitalized software costs begins when the software is placed into service and is included in depreciation expense in the accompanying consolidated statements of operations. Software development costs are being amortized using the straight-line method over five years or revenue to projected revenue, if greater. RESERVES FOR CLAIMS Workers' compensation and health care benefits are provided under partially self-insured plans. The Company records its estimate of the ultimate cost of, and reserves for, workers' compensation and health care benefits based on actuarial computations using the loss history as well as industry statistics. Furthermore, in determining its reserves, the Company includes reserves for estimated claims incurred but not reported. The ultimate cost of workers' compensation and health care benefits will depend on actual costs incurred to settle the claims and may differ from the amounts reserved by the Company for those claims. Accruals for workers' compensation claims and health care benefits are included in accrued employee compensation and benefits in the consolidated balance sheets. GOODWILL AND INTANGIBLE ASSETS Goodwill represents the excess of purchase price over the fair value of net assets acquired. Goodwill is being amortized using the straight-line method over its estimated useful life ranging from 5 to 25 years. Other identifiable intangible assets, net, consist of database (approximately $10,550,000, $8,259,000, and $7,686,000), workforce (approximately $1,593,000, $1,315,000, and $2,128,000) and hospital relations (approximately $3,338,000, $3,110,000, and $3,462,000) at December 31, 1999, December 31, 2000, and March 31, 2001, respectively. Identifiable intangible assets are being amortized using the straight-line method over their estimated useful lives ranging from 4.5 to 25 years. In accordance with FASB Statement No. 121, ACCOUNTING FOR THE IMPAIRMENT OF LONG-LIVED ASSETS AND FOR LONG-LIVED ASSETS TO BE DISPOSED OF, long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The Company periodically reviews goodwill to determine if any impairment exists based upon projected, undiscounted net cash flows of the Company. Recoverability of intangible assets is measured by comparison of the carrying amount of the asset to net future cash flows expected to be generated from the asset. Identifiable intangible assets not covered by FASB Statement No. 121 and goodwill not identified with assets that are subject to an impairment loss are evaluated in accordance with Accounting Principles Board (APB) Opinion No. 17, INTANGIBLE ASSETS. At December 31, 1999, December 31, 2000 and March 31, 2001, the Company believes that no impairment of goodwill or identifiable intangible assets exists. DEBT ISSUANCE COSTS Deferred costs related to the issuance of debt are being amortized on a straight-line basis, which approximates the effective interest method, over the six-year term of the debt. Debt issuance costs of approximately $11,222,000, less accumulated amortization of approximately $746,000 and $2,617,000 at F-10 CROSS COUNTRY, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999 AND 2000 (INFORMATION PERTAINING TO MARCH 31, 2001 AND TO THE THREE MONTH PERIODS ENDED MARCH 31, 2001 AND 2000 IS UNAUDITED) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) December 31, 1999 and December 31, 2000, respectively, are recorded in the consolidated balance sheets. Debt issuance costs of approximately $12,203,000, less accumulated amortization of approximately $3,100,000 are recorded in the consolidated balance sheet at March 31, 2001. REVENUE RECOGNITION Revenue from services consists primarily of temporary staffing revenues. Revenue is recognized when services are rendered. Accordingly, accounts receivable includes an accrual for employees' time worked but not yet invoiced. At December 31, 1999, December 31, 2000, and March 31, 2001, the amounts accrued are approximately $5,526,000, $14,970,000, and $12,536,000, respectively. STOCK-BASED COMPENSATION The Company, from time to time, grants stock options for a fixed number of common shares to employees. The Company accounts for employee stock option grants in accordance with Accounting Principles Board Opinion No. 25, ACCOUNTING FOR STOCK ISSUED TO EMPLOYEES, and accordingly, recognizes no compensation expense for the stock option grants when the exercise price of the options equals, or is greater than, the market value of the underlying stock on the date of grant. Accordingly, the Company did not recognize any compensation cost during the period from July 30, 1999 to December 31, 1999, the year ended December 31, 2000, or the three months ended March 31, 2000 and 2001 for stock-based employee compensation awards. ADVERTISING The Company's advertising expense consists primarily of print media, online advertising and promotional material. Advertising costs are expensed as incurred and were approximately $404,000 for the period from July 30, 1999 to December 31, 1999, $2,450,000 for the year ended December 31, 2000, and $556,000 and $521,000 for the three months ended March 31, 2000 and 2001, respectively. DERIVATIVE FINANCIAL INSTRUMENTS The Company is exposed to market risks arising from changes in interest rates. To protect against such risks, the Company has one derivative financial instrument, an interest rate swap agreement, which is more fully disclosed in Note 13, INTEREST RATE SWAP. COMPREHENSIVE INCOME The Company has adopted FASB Statement No. 130, COMPREHENSIVE INCOME, which requires that an enterprise: (a) classify items of other comprehensive income by their nature in the financial statements; and (b) display the accumulated balance of other comprehensive income separately from retained earnings and additional paid-in capital in the equity section of the balance sheet. The items of other comprehensive income that are typically required to be displayed are foreign currency items, minimum pension liability adjustments and unrealized gains and losses on certain investments in debt and equity securities. There are no other components of comprehensive income or loss other than the F-11 CROSS COUNTRY, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999 AND 2000 (INFORMATION PERTAINING TO MARCH 31, 2001 AND TO THE THREE MONTH PERIODS ENDED MARCH 31, 2001 AND 2000 IS UNAUDITED) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) Company's consolidated net (loss) income for the period from July 30, 1999 to December 31, 1999, the year ended December 31, 2000, and the three months ended March 31, 2000. During the three months ended March 31, 2001, the Company recorded the fair value of the interest rate swap transaction which resulted in a reduction in consolidated stockholders' equity of approximately $925,000. INCOME TAXES The Company accounts for income taxes under FASB Statement No. 109, ACCOUNTING FOR INCOME TAXES. Deferred income tax assets and liabilities are determined based upon differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. RECENT ACCOUNTING PRONOUNCEMENTS During 1998, the FASB issued Statement No. 133, ACCOUNTING FOR DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES, which was effective beginning January 1, 2001. The Company implemented the provisions of FASB Statement No. 133 on January 1, 2001. FASB Statement No. 133 resulted in a reduction in consolidated stockholders' equity of approximately $910,000 as of January 1, 2001. In December 1999, the Securities and Exchange Commission staff released Staff Accounting Bulletin (SAB) No. 101, REVENUE RECOGNITION. SAB No. 101 provides interpretive guidance on the recognition, presentation, and disclosure of revenue in financial statements. The Company believes that its current revenue recognition policies comply with SAB No. 101. RECLASSIFICATIONS Certain amounts in the 1999 consolidated financial statements have been reclassified to conform to the 2000 presentation. 3. ACQUISITIONS Effective July 31, 2000, the Company acquired substantially all of the assets of E-Staff, a Pennsylvania corporation, for $1,500,000. E-Staff is a development-stage company creating an Internet, subscription-based communication, scheduling, credentialing and training service business. The acquisition met the accounting criteria of a purchase and, accordingly, the accompanying consolidated financial statements include the results of E-Staff from the acquisition date. The consideration for this acquisition included $1,500,000 in cash. In addition, the asset purchase agreement provides for potential earnout payments of up to $3,250,000 to the seller based on the profits of E-Staff over a three-year period ending July 31, 2003. This contingent consideration is not related to the seller's employment. Upon payment, the earnouts will be allocated to goodwill as additional purchase price and amortized over the remaining life of the asset. The excess of the aggregate purchase price over the fair market value of the assets acquired of approximately $927,000 was allocated to goodwill and is being amortized over five years. F-12 CROSS COUNTRY, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999 AND 2000 (INFORMATION PERTAINING TO MARCH 31, 2001 AND TO THE THREE MONTH PERIODS ENDED MARCH 31, 2001 AND 2000 IS UNAUDITED) 3. ACQUISITIONS (CONTINUED) Effective December 26, 2000, Cross Country Seminars acquired substantially all of the assets of Heritage Professional Education, LLC (Heritage), a Tennessee limited liability company. Heritage provides continuing professional education courses to medical and healthcare personnel through seminars and study programs servicing the healthcare industry. The acquisition met the accounting criteria of a purchase and, accordingly, the accompanying consolidated financial statements include the results of Heritage from the acquisition date. The consideration for this acquisition included $6,200,000 in cash and a post-closing adjustment of approximately $300,000, to be paid 90 days from the closing date. In addition, the asset purchase agreement provides for potential earnout payments of approximately $6,500,000 based on adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) (as defined in the asset purchase agreement) of Heritage over a three-year period ending December 31, 2003. This contingent consideration is not related to the seller's employment. Upon payment, the earnouts will be allocated to goodwill as additional purchase price and amortized over the remaining life of the asset. The excess of the aggregate purchase price over the fair market value of the assets acquired of approximately $6,482,000 was allocated to goodwill and is being amortized over 25 years. On December 15, 2000, the Company entered into a stock purchase agreement to acquire substantially all of the outstanding stock of two subsidiaries that comprise ClinForce Inc., a Delaware corporation that provides temporary staffing and permanent placement of clinical trials support services personnel, for approximately $31,000,000. The acquisition was consummated on March 16, 2001 and met the accounting criteria of a purchase. The transaction was primarily funded through the issuance of additional debt. The purchase price is subject to a post-closing adjustment based on changes in the net working capital of the acquired companies between October 31, 2000 and March 16, 2001. The following unaudited pro forma summary presents the consolidated results of operations as if the Company's acquisitions had occurred as of the beginning of each period presented, after giving effect to certain adjustments, including amortization of goodwill and other specifically identifiable intangibles, interest expense incurred on additional borrowings and related income tax effects. The pro forma financial information does not purport to be indicative of the results of operations that would have occurred had the transactions taken place at the beginning of the periods presented or of future results of operations.
PERIOD FROM THREE MONTHS JULY 30, 1999 YEAR ENDED ENDED TO DECEMBER 31, DECEMBER 31, MARCH 31, 1999 2000 2001 --------------- ------------ ------------ Revenue from services.............. $151,849,680 $407,275,744 $111,564,489 ============ ============ ============ Net (loss) income.................. $ (4,702,050) $ 3,976,004 $ (212,212) ============ ============ ============ Net (loss) income per common share--basic and diluted......... $ (1.78) $ .99 $ .05 ============ ============ ============
F-13 CROSS COUNTRY, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999 AND 2000 (INFORMATION PERTAINING TO MARCH 31, 2001 AND TO THE THREE MONTH PERIODS ENDED MARCH 31, 2001 AND 2000 IS UNAUDITED) 4. PROPERTY AND EQUIPMENT At December 31, 1999, December 31, 2000 and March 31, 2001, property and equipment consist of the following:
DECEMBER 31, ------------------------- MARCH 31, 1999 2000 2001 ----------- ----------- ------------ Computer equipment................... $ 4,601,677 $ 4,830,242 $ 5,443,015 Computer software.................... 875,672 3,900,076 4,751,537 Office equipment..................... 548,190 760,527 1,051,824 Furniture and fixtures............... 736,551 833,786 1,409,950 Leasehold improvements............... 684,023 868,630 1,059,192 ----------- ----------- ------------ 7,446,113 11,193,261 13,715,518 Less accumulated depreciation and amortization....................... (3,470,984) (5,024,756) (6,420,976) ----------- ----------- ------------ $ 3,975,129 $ 6,168,505 $ 7,294,542 =========== =========== ============
At December 31, 2000 and March 31, 2001, computer software includes approximately $1,481,000 and $1,775,000, respectively, of software development costs capitalized in accordance with the provisions of FASB Statement No. 86. 5. ACCRUED COMPENSATION AND BENEFITS At December 31, 1999, December 31, 2000 and March 31, 2001, accrued employee compensation and benefits consist of the following:
DECEMBER 31, ------------------------- MARCH 31, 1999 2000 2001 ----------- ----------- ----------- Salaries.............................. $ 5,660,772 $ 6,903,347 $ 8,077,661 Bonuses............................... 5,686,305 6,858,620 7,884,852 Accrual for workers' compensation claims.............................. 1,896,543 2,095,720 2,217,594 Accrual for health care benefits...... 372,000 1,295,632 1,438,502 Accrual for vacation.................. 203,220 277,485 407,448 ----------- ----------- ----------- $13,818,840 $17,430,804 $20,026,057 =========== =========== ===========
F-14 CROSS COUNTRY, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999 AND 2000 (INFORMATION PERTAINING TO MARCH 31, 2001 AND TO THE THREE MONTH PERIODS ENDED MARCH 31, 2001 AND 2000 IS UNAUDITED) 6. LONG-TERM DEBT AND NOTE PAYABLE At December 31, 1999, December 31, 2000 and March 31, 2001, long-term debt consists of the following:
DECEMBER 31, --------------------------- MARCH 31, 1999 2000 2001 ------------ ------------ ------------ Term Loan, interest at 9.46% at December 31, 1999, 9.52%, 9.50%, and 9.41% for $65,000,000, $45,000,000 and $4,880,000, respectively at December 31, 2000 and 8.35% and 7.98% for $111,780,000 and $30,000,000, at March 31, 2001................... $120,000,000 $114,880,000 $141,780,000 Revolving Loan Facility, interest at 9.46% and 10.50% for $5,400,000 and $3,000,000, respectively, at December 31, 1999, 11.25% and 9.40% for $1,250,000 and $6,200,000, respectively at December 31, 2000 and 8.06% and 10.00% for $6,200,000 and $2,250,000, respectively, at March 31, 2001............................. 8,400,000 7,450,000 8,450,000 Swingline Loan, interest at 10.00% at March 31, 2001................ -- -- 700,000 Subordinated Pay-In-Kind Notes, interest at 12%.................. 30,619,000 34,458,000 35,491,000 ------------ ------------ ------------ 159,019,000 156,788,000 186,421,000 Less current portion............... (5,120,000) (12,400,000) (12,400,000) ------------ ------------ ------------ $153,899,000 $144,388,000 $174,021,000 ============ ============ ============
On July 29, 1999, the Company entered into a $105 million senior secured credit facility consisting of a $75,000,000 term loan and a $30,000,000 revolving loan facility. The term loan and the revolving loan facility bear interest based on either an alternate base rate plus a margin of 2.00%, 1.75%, and 2.00% at December 31, 1999, December 31, 2000, and March 31, 2001 respectively, or LIBOR plus a margin of 3.00%, 2.75%, and 3.00% at December 31, 1999, December 31, 2000, and March 31, 2001, respectively, (each as defined in the senior secured credit facility). During fiscal year 2000, the Company met certain covenants which provided for the above reduction in interest rates. On December 16, 1999, the senior credit facility was increased to $120 million. The Company has pledged all of the assets of the Company as collateral for the senior credit facility. F-15 CROSS COUNTRY, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999 AND 2000 (INFORMATION PERTAINING TO MARCH 31, 2001 AND TO THE THREE MONTH PERIODS ENDED MARCH 31, 2001 AND 2000 IS UNAUDITED) 6. LONG-TERM DEBT AND NOTE PAYABLE (CONTINUED) The senior credit facility allows for the issuance of letters of credit in an aggregate face amount at any time outstanding not in excess of $4,000,000, $5,000,000, and $6,000,000 at December 31, 1999, December 31, 2000, and March 31, 2001, respectively. Additionally, swingline loans, as defined in the senior credit facility, not to exceed an aggregate principal amount at any time outstanding of $7,000,000 are available under the senior credit facility. The senior credit facility requires that the Company meet certain covenants, including the maintenance of certain debt and interest expense ratios, capital expenditure limits, and the maintenance of a minimum level of EBITDA (as defined in the senior credit facility). The senior credit facility also limits the Company's ability to declare and pay cash dividends on its common stock. On July 29, 1999, the Company issued $30,000,000 in senior subordinated pay-in-kind notes to two financial institutions. The proceeds of the loan were used by the Company solely to finance the CCS acquisition and to pay fees and expenses incurred in connection therewith. The interest rate on the subordinated notes is 12% per annum, compounded quarterly. The pay-in-kind notes represent additional debt issued by the Company in lieu of cash payments for accrued interest. The maturity date is the earlier of six months after the final maturity of the term and revolving debt issuances (January 29, 2006) or change in control of the Company. In connection with the issuance of the subordinated debt, the Company issued 86,957 shares of its common stock to the financial institutions. Debt issuance costs of $6,920,000 relating to this transaction were recorded, which represented the fair market value of the shares at the time of issuance. The revolving loan facility matures on July 29, 2005. The aggregate scheduled maturities of the term notes, the subordinated notes and the revolving loan facility are as follows:
YEAR ENDING DECEMBER 31: ------------------------ 2001........................................................ $ 12,400,000 2002........................................................ 20,160,000 2003........................................................ 29,600,000 2004........................................................ 34,720,000 2005........................................................ 25,450,000 Thereafter.................................................. 34,458,000 ------------ $156,788,000 ============
On July 16, 2000, the Company entered into a note payable with a third party. The proceeds from the note payable were used to pay the Company's insurance premiums. Principal and interest are payable over an 11-month period at an interest rate of 7.10%. At December 31, 2000 and March 31, 2001, respectively, the outstanding balance was $484,108 and $461,810. 7. EMPLOYEE BENEFIT PLANS The Company maintains a voluntary defined contribution 401(k) profit-sharing plan covering all eligible employees as defined in the plan documents. The plan provides for a discretionary matching F-16 CROSS COUNTRY, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999 AND 2000 (INFORMATION PERTAINING TO MARCH 31, 2001 AND TO THE THREE MONTH PERIODS ENDED MARCH 31, 2001 AND 2000 IS UNAUDITED) 7. EMPLOYEE BENEFIT PLANS (CONTINUED) contribution, which is equal to a percentage of each contributing participant's elective deferral, which the Company, at its sole discretion, determines from year to year. Contributions by the Company, net of forfeitures, under this plan amounted to approximately $487,000 for the period from July 30, 1999 to December 31, 1999, and $885,000 for the year ended December 31, 2000. Contributions by the Company, net of forfeitures, under this plan amounted to approximately $319,000 and $384,000 for the three months ended March 31, 2000 and 2001, respectively. TVCM employees were covered under a separate benefit plan for both 2000 and 1999. TVCM has a 401(k) defined contribution plan for eligible employees. Eligible employees may make pretax savings contributions to the 401(k) Plan of up to 20% of their earnings to a certain statutory limit. TVCM matches employee contributions from 1% to 3% of compensation based on years of service. Contributions to the 401(k) Plan were approximately $630,000 for the year ended December 31, 2000 and $135,000 and $109,000 for the three months ended March 31, 2000 and 2001, respectively. Effective fiscal 2001, TVCM employees will participate in the Company's defined contribution 401(k) profit-sharing plan. 8. COMMITMENTS AND CONTINGENCIES The Company has entered into noncancelable operating lease agreements for the rental of space. Future minimum lease payments associated with these agreements are as follows:
YEAR ENDING DECEMBER 31: ------------------------ 2001........................................................ $ 894,000 2002........................................................ 944,000 2003........................................................ 965,000 2004........................................................ 905,000 2005........................................................ 919,000 Thereafter.................................................. 1,557,000 ---------- $6,184,000 ==========
Rent expense related to office facilities was approximately $308,000 for the period July 30, 1999 to December 31, 1999, $1,527,000 for the year ended December 31, 2000, and $380,000 and $470,000 for the three months ended March 31, 2000 and 2001, respectively. The Company is subject to legal proceedings and claims that arise in the ordinary course of its business. In the opinion of management, the outcome of these matters will not have a significant effect on the Company's consolidated financial position or results of operations. 9. ESTIMATED FAIR VALUE OF FINANCIAL INSTRUMENTS The carrying amounts reported in the consolidated balance sheets for cash, accounts receivable, accounts payable and accrued expenses approximate fair value because of their short maturity. The F-17 CROSS COUNTRY, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999 AND 2000 (INFORMATION PERTAINING TO MARCH 31, 2001 AND TO THE THREE MONTH PERIODS ENDED MARCH 31, 2001 AND 2000 IS UNAUDITED) 9. ESTIMATED FAIR VALUE OF FINANCIAL INSTRUMENTS (CONTINUED) carrying amount of the revolving credit note and term loan approximates fair value because the interest rate is tied to a quoted variable index. 10. INCOME TAXES The components of the income tax expense are as follows:
DECEMBER 31, ----------------------- 1999 2000 ---------- ---------- Current.............................................. $ 15,000 $5,407,103 Deferred............................................. 516,207 (164,055) ---------- ---------- $ 531,207 $5,243,048 ========== ==========
Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred tax assets and liabilities are as follows:
DECEMBER 31, ------------------------- 1999 2000 ----------- ----------- Deferred tax assets: Accrued and prepaid expenses..................... $ 1,038,863 $ 2,376,762 Allowance for doubtful accounts.................. 347,492 841,844 Net operating loss carryforward.................. 85,324 -- Other............................................ 307,913 (78,084) ----------- ----------- 1,779,592 3,140,522 Deferred tax liabilities: Depreciation and amortization.................... (2,190,845) (3,720,933) Identifiable intangibles......................... (4,183,591) (3,850,378) ----------- ----------- (6,374,436) (7,571,311) ----------- ----------- Net deferred taxes................................. $(4,594,844) $(4,430,789) =========== ===========
FASB Statement No. 109 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of the evidence, it is more likely than not that some of or all of the deferred tax assets will not be realized. After consideration of all the evidence, both positive and negative, management has determined that a valuation allowance at December 31, 1999 and 2000 is not F-18 CROSS COUNTRY, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999 AND 2000 (INFORMATION PERTAINING TO MARCH 31, 2001 AND TO THE THREE MONTH PERIODS ENDED MARCH 31, 2001 AND 2000 IS UNAUDITED) 10. INCOME TAXES (CONTINUED) necessary. The reconciliation of income tax computed at the U. S. federal statutory rate to income tax expense is as follows:
DECEMBER 31, ------------------------ 1999 2000 ---------- ----------- Tax at U. S. statutory rate......................... $ 183,808 $ 4,685,061 State taxes, net of federal benefit................. 18,706 468,908 Non-deductible goodwill............................. 50,686 1,136,323 Non-deductible meals and entertainment.............. 438,895 38,862 Benefit from discontinued operations................ (140,710) (1,486,976) Other............................................... (20,178) 400,870 ---------- ----------- $ 531,207 $ 5,243,048 ========== ===========
At December 31, 1999, the Company had available net operating loss carryforwards of approximately $207,000. There were no available net operating loss carryforwards at December 31, 2000 and March 31, 2001. 11. STOCKHOLDERS' EQUITY Effective on December 10, 1999, the Company approved a 2.26066 for 1 stock split of its common stock. All common stock data in these consolidated financial statements have been adjusted to give retroactive effect to the stock split. Effective April 27, 2001, the 131,053 issued and outstanding shares of the Company's Class B common stock were converted to an equal number of shares of Class A common stock of the Company. STOCK OPTIONS On December 16, 1999, the Company's Board of Directors approved the 1999 Stock Option Plan and Equity Participation Plan (collectively, the Plans), which provide for the issuance of incentive stock options (ISOs) and non-qualified stock options to eligible employees for the purchase of up to 651,162 shares of Class A common stock. Non-qualified stock options may also be issued to consultants. Under the Plans, the exercise price of options granted must equal or exceed the fair market value of the Company's common stock on the date of grant, and the exercise price of ISOs granted may not be less than 110% of such fair market value with respect to any options granted to a participant who owns 10% or more of the Company's outstanding common stock. Options granted during 1999 and 2000 under the 1999 Stock Option Plan generally vest ratably over 4 years. Options granted during 1999 and 2000 under the Equity Participation Plan vest 25% on the first anniversary of the date of grant and then vest 12.5% every 6 months thereafter. All options expire on the tenth (or, in the case of a 10% shareholder, the fifth) anniversary of the date of grant. F-19 CROSS COUNTRY, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999 AND 2000 (INFORMATION PERTAINING TO MARCH 31, 2001 AND TO THE THREE MONTH PERIODS ENDED MARCH 31, 2001 AND 2000 IS UNAUDITED) 11. STOCKHOLDERS' EQUITY (CONTINUED) Information regarding the Company's stock option activity is summarized below:
WEIGHTED AVERAGE STOCK OPTION EXERCISE PRICE ACTIVITY OPTION PRICE PER SHARE ------------ -------------- ---------------- Options outstanding at July 29, 1999............... -- $ -- $ -- Granted.......................................... 593,275 44.96-134.88 69.05 ------- Options outstanding at December 31, 1999........... 593,275 44.96-134.88 69.05 Granted.......................................... 35,813 58.76-176.28 69.13 Canceled......................................... (91,856) 44.96-134.88 69.05 ------- Options outstanding at December 31, 2000........... 537,232 44.96-176.28 68.49 GRANTED.......................................... CANCELED......................................... (2,513) 44.96-62.55 45.69 ------- OPTIONS OUTSTANDING AT MARCH 31, 2001.............. 534,719 $ 44.96-176.28 $68.30 =======
There were no exercisable options at December 31, 1999. The number of options exercisable at December 31, 2000 was 125,354 and at March 31, 2001 was 124,776. The weighted-average grant-date fair value of options granted during 1999 and 2000 was $23.50 per share and $35.07 per share, respectively. The weighted-average grant-date fair value of options granted during the three months ended March 31, 2001 was $37.92 per share.
EXERCISE OPTIONS REMAINING OPTIONS PRICE OUTSTANDING CONTRACTUAL LIFE EXERCISABLE --------------------- ----------- ---------------- ----------- $ 44.96 218,739 8.75 years 54,932 58.76 9,974 9.25 years -- 62.55 21,700 9.75 years -- 67.44 114,617 8.75 years 28,654 88.14 2,021 9.25 years -- 89.92 114,617 8.75 years 28,654 117.52 2,021 9.25 years -- 112.40 25,073 8.75 years 6,268 146.90 442 9.25 years -- 134.88 25,073 8.75 years 6,268 176.28 442 9.25 years --
Had compensation cost for stock options granted during 1999, 2000, and 2001 been measured under the fair value based method prescribed by FASB Statement No. 123, ACCOUNTING FOR STOCK-BASED F-20 CROSS COUNTRY, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999 AND 2000 (INFORMATION PERTAINING TO MARCH 31, 2001 AND TO THE THREE MONTH PERIODS ENDED MARCH 31, 2001 AND 2000 IS UNAUDITED) 11. STOCKHOLDERS' EQUITY (CONTINUED) COMPENSATION, the Company's consolidated net income (loss) would have changed to the pro forma amounts set forth below.
DECEMBER 31, ----------------------- MARCH 31, 1999 2000 2001 ---------- ---------- ---------- Pro forma net (loss) income.............. $ (444,569) $2,481,763 $ (529,858) ========== ========== ========== Pro forma (loss) income per common share--basic and diluted: (Loss) income from continuing operations........................... $ (.10) $ 1.13 $ .13 Discontinued operations................ (.07) (.51) (.26) ---------- ---------- ---------- Net (loss) income...................... $ (.17) $ .62 $ (.13) ========== ========== ==========
The fair value of options granted used to compute pro forma net income (loss) disclosures were estimated on the date of grant using the Black-Scholes option-pricing model based on the following assumptions:
DECEMBER 31, ------------------- MARCH 31, 1999 2000 2001 -------- -------- --------- Dividend yield................................... 0.00% 0.00% 0.00% Expected volatility.............................. 60.00 60.00 60.00 Risk-free interest rate.......................... 5.19 5.19 5.19 Expected life.................................... 6 years 6 years 6 YEARS
The effect of applying FASB Statement No. 123 for providing pro forma disclosures is not likely to be representative of the effect on reported net income in future years. 12. EARNINGS PER SHARE In accordance with the requirements of FASB Statement No. 128, EARNINGS PER SHARE, basic earnings per share is computed by dividing net income or loss by the weighted average number of shares outstanding and diluted earnings per share reflects the dilutive effects of stock options (as calculated utilizing the treasury stock method). Shares of common stock that are issuable upon the exercise of options have been excluded from the 1999, 2000, and 2001 per share calculations because their effect would have been anti-dilutive. 13. INTEREST RATE SWAP The Company's senior credit facility requires that the Company maintain an interest rate protection agreement to manage the impact of interest rate changes on the Company's variable rate obligations. Effective February 7, 2000, the Company entered into an interest rate swap agreement (the Agreement) with a financial institution. Interest rate swap agreements involve the exchange of floating interest rate payments for fixed interest rate payments over the life of the agreement without an F-21 CROSS COUNTRY, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999 AND 2000 (INFORMATION PERTAINING TO MARCH 31, 2001 AND TO THE THREE MONTH PERIODS ENDED MARCH 31, 2001 AND 2000 IS UNAUDITED) 13. INTEREST RATE SWAP (CONTINUED) exchange of the underlying notional amount. The Company entered into the Agreement to reduce the exposure to adverse fluctuations in floating interest rates on the underlying debt obligation as required by the senior credit facility and not for trading purposes. The interest rate swap matures on February 7, 2003 and has an underlying notional amount of $45,000,000. The floating interest rate to be paid to the Company is based on the three-month U.S. dollar London Interbank Offered Rate (LIBOR), which is reset quarterly, while the fixed interest rate to be paid by the Company is 6.625% if the three-month US dollar LIBOR is less than 7.25%, the three-month U.S. dollar LIBOR if LIBOR is greater than or equal to 7.25% but less than 8.5%, and 8.5% if the three-month U.S. dollar LIBOR is greater than or equal to 8.5% over the term of the Agreement. Any differences paid or received under the terms of the Agreement are recognized as adjustments to interest expense over the life of the swap, thereby adjusting the effective interest rate on the underlying debt obligation. For the period from February 7, 2000 through December 31, 2000, the Company paid a fixed interest rate of 6.625% based on an underlying notional amount of $45,000,000. The floating interest rate paid by the financial institution to the Company approximated 6.7503%. The carrying value of the interest rate swap at December 31, 2000 and March 31, 2001 was immaterial as to the net amount due from the financial institution. The fair value of the interest rate swap approximated a $910,000 and $987,000 net payable based on quoted market prices for similar instruments at December 31, 2000 and March 31, 2001, respectively. The estimated fair value of the swap will fluctuate over time based on changes in floating interest rates; however, these fair value amounts should not be viewed in isolation but rather in relation to the overall reduction in the Company's exposure to adverse fluctuations in floating interest rates. The fair value of the interest rate swap transaction is not reflected in the consolidated financial statements at December 31, 2000 as it properly qualified for hedge accounting treatment under applicable accounting guidance. The Company recorded the fair value of the interest rate swap transaction at March 31, 2001 which resulted in a reduction in consolidated stockholders' equity of approximately $925,000. The Company has no plans to terminate the Agreement earlier than the maturity date. The Company is exposed to credit loss in the event of nonperformance by the counterparty to the Agreement. The amount of such exposure is limited to the unpaid portion of amounts due to the Company, if any, pursuant to the Agreement. However, management believes that this exposure is mitigated by provisions in the Agreement that allow for the legal right of offset of any amounts due to the Company from the counter party with any amounts payable to the counterparty by the Company. As a result, management considers the risk of counter party default to be minimal. Effective January 1, 2001, the Agreement was amended to change the fixed rate to be paid by the Company to 6.705%. In addition, the maturity date of the Agreement was extended to February 28, 2003. F-22 CROSS COUNTRY, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) DECEMBER 31, 1999 AND 2000 (INFORMATION PERTAINING TO MARCH 31, 2001 AND TO THE THREE MONTH PERIODS ENDED MARCH 31, 2001 AND 2000 IS UNAUDITED) 14. RELATED PARTY TRANSACTIONS In connection with the July 29, 1999 CCS acquisition, Charterhouse Equity Partners III, L.P. (Charterhouse), a majority shareholder of the Company, received approximately $2,835,000 in transaction fees. In connection with the TravCorps merger on December 16, 1999, Charterhouse received approximately $300,000 in transaction fees. These transaction fees were capitalized in accordance with the purchase method of accounting. 15. DISCONTINUED OPERATIONS On December 20, 2000, the Company committed itself to a formal plan to dispose of its wholly-owned subsidiary, HospitalHub, through a sale or liquidation of the business segment. Pursuant to APB Opinion No. 30, REPORTING THE RESULTS OF OPERATIONS-REPORTING THE EFFECTS OF DISPOSAL OF A SEGMENT OF A BUSINESS, AND EXTRAORDINARY, UNUSUAL AND INFREQUENTLY OCCURRING EVENTS AND TRANSACTIONS, the consolidated financial statements of the Company have been reclassified to reflect the discontinuance of HospitalHub. Accordingly, the revenue, costs and expenses, assets and liabilities of HospitalHub have been segregated and reported as discontinued operations in the accompanying consolidated balance sheets and statements of operations. The divestiture was completed in the second quarter of, 2001. F-23 REPORT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS To the Partners of Cross Country Staffing (a Partnership): In our opinion, the accompanying balance sheets and the related statements of income and partners' capital and of cash flows present fairly, in all material respects, the financial position of Cross Country Staffing (a Partnership) at July 29, 1999 and December 31, 1998, and the results of its operations and its cash flows for the periods then ended in conformity with accounting principles generally accepted in the United States. These financial statements are the responsibility of the Partnership's management; our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits of these statements in accordance with auditing standards generally accepted in the United States, which require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for the opinion expressed above. As discussed in Note 1 to the financial statments, Cross Country Staffing's assets were sold on July 29, 1999. The amounts included in the financial statements pursuant to the Management Incentive Compensation Plan give no effect to the additional amount payable as determined by the change in control transaction as further discussed in Note 5 to the financial statements. /s/ PricewaterhouseCoopers LLP Fort Lauderdale, Florida November 5, 1999, except for Note 8 as to which the date is December 16, 1999 F-24 CROSS COUNTRY STAFFING BALANCE SHEETS
JULY 29, DECEMBER 31, 1999 1998 ----------- -------------- ASSETS Current assets: Cash.................................................... $ -- $ 110 Accounts receivable, less allowance for doubtful accounts (1999-$1,158,039; 1998-$1,327,983)........... 31,494,858 28,794,335 Other current assets.................................... 3,255,994 2,886,333 ----------- ----------- Total current assets.................................. 34,750,852 31,680,778 Fixed assets, net of accumulated depreciation (1999-$842,971; 1998-$630,848)............................ 1,208,713 1,219,319 Goodwill, net of accumulated amortization (1999-$7,261,467; 1998-$6,809,880).......................................... 8,365,716 8,817,303 Other assets................................................ 138,852 183,817 ----------- ----------- Total assets................................................ $44,464,133 $41,901,217 =========== =========== LIABILITIES AND PARTNERS' CAPITAL Current liabilities: Short-term debt......................................... $ 7,874,004 $ 3,533,039 Accounts payable........................................ 2,329,396 3,446,433 Accrued employee compensation and benefits.............. 7,256,162 5,515,526 Accrued distribution payable............................ -- 5,645,354 Accrued interest payable................................ 19,443 23,926 Accrued management incentive compensation............... 6,940,000 -- Other current liabilities............................... 579,473 645,612 ----------- ----------- Total current liabilities............................. 24,998,478 18,809,890 Debt........................................................ -- 4,800,000 Accrued management incentive compensation plan.............. -- 4,840,000 ----------- ----------- Total liabilities........................................... 24,998,478 28,449,890 Commitments and contingencies (Note 7) Partners' capital........................................... 19,465,655 13,451,327 ----------- ----------- Total liabilities and partners' capital..................... $44,464,133 $41,901,217 =========== ===========
The accompaying notes are an integral part of these financial statements. F-25 CROSS COUNTRY STAFFING STATEMENTS OF INCOME AND PARTNERS' CAPITAL
PERIOD ENDED PERIOD ENDED JULY 29, DECEMBER 31, 1999 1998 ---------------- ----------------- Revenue................................................ $106,046,826 $158,591,804 ------------ ------------ Operating expenses: Compensation and benefits............................ 80,186,753 121,950,872 Selling, general and administrative expenses......... 10,587,604 16,377,419 Management incentive compensation plan............... 2,100,000 2,693,001 Bad debt expense..................................... 156,772 721,510 Depreciation......................................... 212,123 264,026 Amortization......................................... 496,551 859,159 ------------ ------------ Total operating expenses......................... 93,739,803 142,865,987 ------------ ------------ Operating income....................................... 12,307,023 15,725,817 Other income (expense): Interest income...................................... 62,026 48,423 Interest expense..................................... (292,642) (897,606) Other................................................ (189,858) (183,435) ------------ ------------ Net income............................................. 11,886,549 14,693,199 Partners' capital at beginning of year................. 13,451,327 7,122,155 Distributions to partners.............................. (5,872,221) (8,364,027) ------------ ------------ Partners' capital at end of period..................... $ 19,465,655 $ 13,451,327 ============ ============ Pro Forma net income data Net income as reported............................... $ 11,886,549 $ 14,693,199 Pro Forma adjustment for income taxes................ (5,824,409) (7,199,668) ------------ ------------ Pro Forma net income................................. $ 6,062,140 $ 7,493,531 ============ ============
The accompanying notes are an integral part of these financial statements. F-26 CROSS COUNTRY STAFFING STATEMENTS OF CASH FLOWS
JULY 29, 1999 DECEMBER 31, 1998 ------------- ----------------- Cash flows from operating activities: Net income................................................ $ 11,886,549 $ 14,693,199 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization........................... 708,674 1,123,185 Provision for management incentive compensation plan.... 2,100,000 2,693,001 Changes in operating assets and liabilities: Increase in net accounts receivable..................... (2,700,523) (5,690,790) Increase in other current assets........................ (369,661) (507,668) Decrease in other assets................................ -- 230,000 (Decrease) increase in accounts payable................. (1,117,037) 1,202,369 Increase in accrued employee compensation and benefits.............................................. 1,740,636 792,962 Decrease in accrued interest payable.................... (4,483) (57,534) Decrease in other current liabilities................... (66,139) (44,409) ------------ ------------ Net cash provided by operating activities............. 12,178,016 14,434,315 ------------ ------------ Cash flows from investing activities: Net purchases of equipment............................ (201,516) (976,672) ------------ ------------ Net cash used in investing activities................. (201,516) (976,672) ------------ ------------ Cash flows from financing activities: Net repayment of debt................................. (459,035) (10,366,961) Distributions to partners............................. (11,517,575) (3,091,365) ------------ ------------ Net cash used in financing activities................. (11,976,610) (13,458,326) ------------ ------------ Net decrease in cash.................................. (110) (683) Cash at beginning of year................................... 110 793 ------------ ------------ Cash at end of year......................................... $ -- $ 110 ============ ============ Supplemental disclosure of cash flow information: Amounts paid during the period for interest............... $ 293,857 $ 955,140 ============ ============
The accompanying notes are an integral part of these financial statements. F-27 CROSS COUNTRY STAFFING (A PARTNERSHIP) NOTES TO FINANCIAL STATEMENTS FOR THE PERIODS ENDED JULY 29, 1999 AND DECEMBER 31, 1998 1. ORGANIZATION AND BASIS OF PRESENTATION On July 1, 1996, Cross Country Staffing (CCS or the Partnership), a Delaware general partnership, was established through a Joint Venture Agreement (Agreement) between CCHP, Inc. (CCHP) and MRA Staffing Systems, Inc. (MRA), with ownership percentages of 64% and 36%, respectively. CCHP is a 94% owned subsidiary of W. R. Grace & Co.-Conn., a Connecticut corporation (Grace). Prior to the transaction on July 28, 1999 described below, MRA was a wholly owned subsidiary of Nestor Healthcare Group plc (Nestor), a public company registered in the U.K. CCHP and MRA (the Partners) were each engaged in the business of providing nurses and other allied health personnel primarily on a contract basis. The Partnership recorded the assets and assumed the liabilities, as defined in the Agreement, of its Partners. Assets and liabilities contributed by the Partners to the joint venture were recorded at predecessor basis. In addition to the recorded assets and liabilities, the Partners contributed the value of their businesses, which included certain unrecorded intangible assets primarily related to proprietary databases and contracts. On July 28, 1999, Grace purchased Nestor's ownership interest in MRA. On July 29, 1999, the assets of CCS were sold (the "Sale") to Cross Country Staffing, Inc. (the "Buyer"), an unrelated entity and affiliate of Charterhouse Group International, Inc. The amounts included in these Financial Statements give no effect to the Sale, including the repayment of outstanding bank debt and liquidation of the Management Incentive Compensation Plan liability. See Notes 4 and 5 for further detail. CCS is engaged in the business of providing staffing and placement of healthcare and other professionals throughout the United States and its territories. 2. ACCOUNTING POLICIES USE OF ESTIMATES The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. FIXED ASSETS Fixed assets include office furniture, business machines and leasehold improvements which are stated at cost, less accumulated depreciation. Depreciation is determined on a straight-line basis over the estimated useful lives of the assets of five years. RESERVES FOR CLAIMS Workers' compensation and health care benefits are provided under partially self-insured plans. CCS records its estimate of the ultimate cost of, and reserves for, workers' compensation and health care benefits based on actuarial computations using its loss history as well as industry statistics. Furthermore, in determining its reserves, CCS includes reserves for estimated claims incurred but not reported. F-28 CROSS COUNTRY STAFFING (A PARTNERSHIP) NOTES TO FINANCIAL STATEMENTS (CONTINUED) FOR THE PERIODS ENDED JULY 29, 1999 AND DECEMBER 31, 1998 2. ACCOUNTING POLICIES (CONTINUED) The ultimate cost of workers' compensation and health care benefits will depend on actual costs incurred in settling the claims and may differ from the amounts reserved by CCS for those claims. Accruals for workers' compensation claims and health care benefits are included in accrued employee compensation and benefits in the Balance Sheet. GOODWILL Goodwill contributed by one of the Partners at inception is amortized using the straight-line method over its estimated useful life of 14 years (approximately 11 years remaining at July 29, 1999). CCS assesses the recoverability of goodwill whenever adverse events or changes in circumstance or business climate indicate that expected future undiscounted cash flows are not sufficient to support the carrying value. At July 29, 1999 and December 31, 1998 the Partnership believes that no impairment of goodwill exists. DEFERRED DEBT ISSUE COSTS Deferred costs related to the issuance of debt are amortized on a straight-line basis over the five year term of the debt. At July 29, 1999 and December 31, 1998 costs of $389,000 less accumulated amortization of $250,148 and $205,183, respectively, are recorded as other assets in the Balance Sheet. FAIR VALUE OF FINANCIAL INSTRUMENTS At July 29, 1999 and December 31, 1998 the recorded value of cash, trade receivables and debt approximated their fair value, based on the maturities of these instruments and the terms of the individual debt agreements. REVENUE RECOGNITION Revenue is recognized when the service is performed. Accordingly, accounts receivable includes an accrual for employees' time worked but not yet invoiced. At July 29, 1999 and December 31, 1998 the amounts accrued are $7,176,798 and $4,835,971. CONCENTRATIONS OF CREDIT RISK CCS's clients are principally health care providers and accounts receivable represent amounts due from these providers. CCS performs ongoing credit evaluations of its clients' financial condition and does not require collateral. Overall, based on the large number of clients in differing geographic areas throughout the United States and its territories, CCS believes the concentration of credit risk is limited. INCOME TAXES CCS is not subject to federal taxation at the Partnership level as income is taxed directly to the Partners. Accordingly, a provision for income taxes has not been included in the financial statements. The General Partnership Agreement (Partnership Agreement) provides for quarterly distributions to the Partners based on the Partnership's estimated taxable income for the year. Generally, it has been the practice of the Partnership to make such distributions based on actual tax liabilities of the F-29 CROSS COUNTRY STAFFING (A PARTNERSHIP) NOTES TO FINANCIAL STATEMENTS (CONTINUED) FOR THE PERIODS ENDED JULY 29, 1999 AND DECEMBER 31, 1998 2. ACCOUNTING POLICIES (CONTINUED) individual Partners. Currently, distributions are made at the request of the Partners up to the quarterly distribution amount provided for in the Partnership Agreement. A distribution payable was recorded to equalize the distributions based on the respective Partners' ownership percentages. RECLASSIFICATIONS Certain amounts in prior year financial statements and related notes have been reclassified to conform to current year's presentation. 3. OTHER BALANCE SHEET ITEMS At July 29 and December 31, other current assets are composed of the following:
JULY 29, DECEMBER 31, 1999 1998 ---------- ------------ Prepaid rent on employees' apartments............... $1,907,276 $1,538,636 Deposits on employees' apartments, net of allowance (1999-$299,246; 1998-$236,756).................... 1,025,308 866,354 Other............................................... 323,410 481,343 ---------- ---------- $3,255,994 $2,886,333 ========== ==========
CCS leases a number of apartments for its employees under short-term agreements (typically three to six months) which generally coincide with each employee's staffing contract. As a condition of those agreements, CCS places security deposits on the leased apartments. Prepaid rent and deposits relate to these short-term agreements. At July 29 and December 31, accrued employee compensation and benefits is composed of the following:
JULY 29, DECEMBER 31, 1999 1998 ---------- ------------ Salaries............................................ $2,984,990 $1,947,117 Bonus............................................... 2,152,918 2,070,759 Accrual for workers' compensation claims............ 1,596,170 1,148,849 Accrual for health care benefits.................... 345,500 206,033 Accrual for vacation................................ 176,584 142,768 ---------- ---------- $7,256,162 $5,515,526 ========== ==========
F-30 CROSS COUNTRY STAFFING (A PARTNERSHIP) NOTES TO FINANCIAL STATEMENTS (CONTINUED) FOR THE PERIODS ENDED JULY 29, 1999 AND DECEMBER 31, 1998 4. DEBT On July 30, 1999, CCS repaid all of its long-term debt, which consists of the Term Note and Revolving Loan Facility. Accordingly, they have been classified as short-term at July 29, 1999. At July 29 and December 31, short-term debt is composed of the following:
JULY 29, DECEMBER 31, 1999 1998 ---------- ------------ Current maturities of long-term debt................ $7,850,000 $3,500,000 Note payable........................................ 24,004 33,039 ---------- ---------- $7,874,004 $3,533,039 ========== ==========
At July 29 and December 31, long-term debt is composed of the following:
JULY 29, DECEMBER 31, 1999 1998 ----------- ------------ Term Loan, interest at the Eurodollar rate plus 0.325%, or the greater of the prime or Federal Funds effective rate plus 0.5% (5.535% and 5.955%, at July 29, 1999 and December 31, 1998, respectively).................................... $ 3,800,000 $ 3,500,000 Revolving Loan Facility, interest at the Eurodollar rate plus 0.325%, or the greater of the prime or Federal Funds effective rate plus 0.5% (8.0% and 5.955%, at July 29, 1999 and December 31,1998, respectively).................................... 4,050,000 4,800,000 ----------- ----------- 7,850,000 8,300,000 (7,850,000) (3,500,000) ----------- ----------- $ -- $ 4,800,000 =========== ===========
Grace acts as guarantor of the Term Note and Revolving Loan Facility and, as such, is paid a monthly fee based on the average outstanding balance. For the periods ended July 29, 1999 and December 31, 1998 this fee was 0.025% per month. For the periods ended July 29, 1999 and December 31, 1998 total fees in relation to this guarantee were $13,398 and $47,663, respectively. Of these total fees, which are recorded as interest expense, $9,229 and $18,243 were recorded as accrued interest payable at July 29, 1999 and December 31, 1998, respectively. 5. MANAGEMENT INCENTIVE COMPENSATION PLAN The CCS Management Incentive Compensation Plan (the Plan) is a performance-based compensation plan for key personnel of the Partnership. The Plan authorizes the award of percentage interests in an incentive pool based on the achievement of certain performance objectives. The percentage interests vest over a period of either three or five years or, in the case of a Liquidity Event as defined in the Plan, vesting occurs immediately. F-31 CROSS COUNTRY STAFFING (A PARTNERSHIP) NOTES TO FINANCIAL STATEMENTS (CONTINUED) FOR THE PERIODS ENDED JULY 29, 1999 AND DECEMBER 31, 1998 5. MANAGEMENT INCENTIVE COMPENSATION PLAN (CONTINUED) The Plan also authorized an immediate percentage award to certain key executives based on Partnership equity value at inception, as defined by the Plan. Incremental increases in the amount of this award may occur based on increases in the value of the Partnership equity. The amount charged to income for the award and the incremental increase in equity value was $319,000 and $409,000 for the periods ended July 29, 1999 and December 31, 1998, respectively. In accordance with the terms of the Plan, cash payments are made at the earlier of occurrence of a Liquidity Event or July 1, 2001. The occurrence of a Liquidity Event also provides for a revised award computation. The Sale of CCS assets on July 29, 1999 constituted a Liquidity Event and as such, a liquidation cash payment was triggered. Grace used a portion of the Sale proceeds for such liquidation payment totaling approximately $20,200,000. 6. PARTNERS' CAPITAL (DEFICIT) Partners' capital accounts are as follows:
CCHP MRA TOTAL ------------ ------------ ----------- December 31, 1997.................................... $(12,234,662) $ 19,356,817 $ 7,122,155 1998 distributions paid and payable.................. (5,352,977) (3,011,050) (8,364,027) 1998 net income...................................... 9,403,647 5,289,552 14,693,199 ------------ ------------ ----------- December 31, 1998.................................... (8,183,992) 21,635,319 13,451,327 1999 distributions................................... (3,757,272) (2,114,949) (5,872,221) 1999 net income...................................... 7,607,391 4,279,158 11,886,549 ------------ ------------ ----------- July 29, 1999........................................ $ (4,333,873) $ 23,799,528 $19,465,655 ============ ============ ===========
At December 31, 1998, accrued distributions payable of $5,645,354 relate to CCHP. 7. COMMITMENTS AND CONTINGENCIES CCS is involved in a dispute with the Internal Revenue Service (IRS) with respect to the IRS Examination of the 1993-1995 treatment of per diem plan allowances for meals and incidental expenses paid to CCHP health care personnel who were performing temporary services while away from home. Under the terms of the Sale, Grace has assumed ongoing responsibility for any settlement or related litigation liability. In connection with the Partnership's partially self-insured workers' compensation plan, the Partnership has outstanding at July 29, 1999 a $943,594 standby letter of credit in order to guarantee the payment of workers' compensation claims to the Partnership's insurance carrier. CCS entered into an agreement to lease office space for the next 10 years beginning in February 1998. In accordance with the Sale, CCS assigned the office lease agreement to the Buyer. Rent expense related to office facilities for the periods ended July 29, 1999 and December 31, 1998 was approximately $250,000 and $269,000, respectively. F-32 CROSS COUNTRY STAFFING (A PARTNERSHIP) NOTES TO FINANCIAL STATEMENTS (CONTINUED) FOR THE PERIODS ENDED JULY 29, 1999 AND DECEMBER 31, 1998 7. COMMITMENTS AND CONTINGENCIES (CONTINUED) CCS is subject to legal proceedings and claims which arise in the ordinary course of its business. In the opinion of management, the outcome of these matters will not have a significant effect on the Partnership's financial position or results of operations. 8. SUBSEQUENT EVENTS As referred to in Note 1, the assets of CCS were sold to Cross Country Staffing, Inc. on July 29, 1999. On November 12, 1999 Cross Country Staffing, Inc. and TravCorps Corporation announced their intention to merge operations. The combined company will be owned by an affiliate of Charterhouse Group International, Inc., certain investment funds managed by Morgan Stanley Private Equity and management. The transaction was consummated on December 16, 1999. F-33 INDEPENDENT AUDITORS' REPORT To the Stockholders and Board of Directors of TravCorps Corporation and Subsidiary: We have audited the accompanying consolidated balance sheet of TravCorps Corporation and subsidiary (the "Company") as of December 15, 1999, and the related consolidated statements of income, stockholders' equity, and cash flows for the period from December 27, 1998 to December 15, 1999. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audit. The consolidated financial statements for the year ended December 26, 1998 were audited by other auditors whose report, dated March 12, 1999, expressed an unqualified opinion on those statements. We conducted our audit in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion. In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of TravCorps Corporation and subsidiary as of December 15, 1999, and the results of their operations and their cash flows for the period from December 27, 1998 to December 15, 1999, in conformity with accounting principles generally accepted in the United States. /s/ ERNST & YOUNG LLP Boston, Massachusetts March 10, 2000 F-34 INDEPENDENT AUDITORS' REPORT To the Stockholders and Board of Directors of TravCorps Corporation and Subsidiary: We have audited the accompanying consolidated balance sheet of TravCorps Corporation and Subsidiary as of December 26, 1998, and the related consolidated statement of operations, stockholders' equity, and cash flows for the year then ended. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audit. We conducted our audit in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion. In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of the companies as of December 26, 1998, and the results of its operations and its cash flows for the year then ended in conformity with accounting principles generally accepted in the United States of America. /s/ DELOITTE & TOUCHE LLP Boston, Massachusetts March 12, 1999 F-35 TRAVCORPS CORPORATION AND SUBSIDIARY CONSOLIDATED BALANCE SHEETS DECEMBER 15, 1999 AND DECEMBER 26, 1998 ASSETS
1999 1998 ----------- ----------- CURRENT ASSETS: Cash and cash equivalents................................. $ 3,594,666 $ 1,852,578 Accounts receivable, less allowance for doubtful accounts of $657,000 and $397,000 in 1999 and 1998, respectively............................................ 17,386,009 15,309,000 Prepaid rent.............................................. 488,008 862,968 Prepaid expenses and other................................ 215,396 784,979 Deferred income taxes..................................... 1,355,300 579,600 ----------- ----------- Total current assets.................................. 23,039,379 19,389,125 ----------- ----------- PROPERTY AND EQUIPMENT: Computer and software equipment........................... 6,331,352 4,777,795 Office equipment.......................................... 239,719 225,244 Furniture and fixtures.................................... 373,762 371,457 Leasehold improvements.................................... 340,142 131,166 ----------- ----------- Total property and equipment.......................... 7,284,975 5,505,662 Less accumulated depreciation and amortization............ (2,801,089) (1,628,152) ----------- ----------- Property and equipment--net........................... 4,483,886 3,877,510 ----------- ----------- DEPOSITS.................................................... 470,665 627,043 ----------- ----------- DEFERRED FINANCING COSTS--NET............................... 3,327,326 19,556 GOODWILL--NET............................................... 11,181,605 11,732,578 TOTAL....................................................... $42,502,861 $35,645,812 =========== ===========
See notes to consolidated financial statements. F-36 TRAVCORPS CORPORATION AND SUBSIDIARY CONSOLIDATED BALANCE SHEETS DECEMBER 15, 1999 AND DECEMBER 26, 1998 LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY
1999 1998 ----------- ----------- CURRENT LIABILITIES: Accounts payable.......................................... $ 2,826,601 $ 2,956,273 Accrued expenses.......................................... 2,127,221 2,660,644 Accrued payroll and withholdings.......................... 1,933,697 2,262,534 Accrued incentive compensation............................ 2,670,960 2,321,544 Current maturities of long-term obligations............... 36,273 163,742 ----------- ----------- Total current liabilities............................. 9,594,752 10,364,737 ----------- ----------- DEFERRED INCOME TAXES....................................... 1,235,538 929,800 ----------- ----------- LONG-TERM OBLIGATIONS....................................... 45,000,000 12,675,649 ----------- ----------- STOCKHOLDERS' (DEFICIT) EQUITY: Convertible preferred stock, $.01 par value per share--1,020,000 shares authorized, issued and outstanding (liquidation preference $0 and $3,804,750 in 1999 and 1998, respectively)............................ -- 2,869,229 Common stock, $.01 par value per share--1,774,385 shares authorized; 2,984,171 shares and 614,011 shares issued in 1999 and 1998, respectively; 2,984,171 shares and 476,291 shares outstanding in 1999 and 1998, respectively............................................ 29,842 6,139 Treasury stock............................................ (73,576,703) (1,377) Additional paid-in capital................................ 54,110,662 667,183 Retained earnings......................................... 6,108,770 8,134,452 ----------- ----------- Total stockholders' (deficit) equity.................. (13,327,429) 11,675,626 ----------- ----------- TOTAL....................................................... $42,502,861 $35,645,812 =========== ===========
See notes to consolidated financial statements. F-37 TRAVCORPS CORPORATION AND SUBSIDIARY CONSOLIDATED STATEMENTS OF INCOME PERIOD FROM DECEMBER 27, 1998 TO DECEMBER 15, 1999 AND THE YEAR ENDED DECEMBER 26, 1998
1999 1998 ------------ ----------- REVENUES.................................................... $112,795,230 $99,604,430 ------------ ----------- DIRECT COSTS AND EXPENSES: Professional salaries and wages........................... 58,137,810 50,660,556 Other professional expenses............................... 15,972,698 17,475,730 ------------ ----------- Total direct costs and expenses......................... 74,110,508 68,136,286 ------------ ----------- GROSS PROFIT................................................ 38,684,722 31,468,144 ------------ ----------- OPERATING EXPENSES: Selling, general and administrative expenses (includes nonrecurring transaction costs of $4,556,904 in 1999)... 35,431,054 21,282,325 Depreciation and amortization............................. 1,886,017 1,225,676 ------------ ----------- Total operating expenses................................ 37,317,071 22,508,001 ------------ ----------- INCOME FROM OPERATIONS...................................... 1,367,651 8,960,143 INTEREST EXPENSE............................................ 2,790,948 880,992 ------------ ----------- INCOME (LOSS) BEFORE PROVISION FOR INCOME TAXES............. (1,423,297) 8,079,151 PROVISION FOR INCOME TAXES.................................. 580,134 3,349,400 ------------ ----------- NET (LOSS) INCOME........................................... $ (2,003,431) $ 4,729,751 ============ ===========
See notes to consolidated financial statements. F-38 TRAVCORPS CORPORATION AND SUBSIDIARY CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY PERIOD FROM DECEMBER 27, 1998 TO DECEMBER 15, 1999 AND THE YEAR ENDED DECEMBER 26, 1998
CONVERTIBLE PREFERRED STOCK COMMON STOCK ADDITIONAL ----------------------- ---------------------- TREASURY PAID-IN RETAINED SHARES AMOUNT SHARES AMOUNT STOCK CAPITAL EARNINGS ---------- ---------- --------- ---------- ------------ ----------- ---------- BALANCE, DECEMBER 27, 1997............. 1,020,000 $2,779,979 527,674 $ 5,276 $ (1,377) $ 181 $3,493,951 Stock options exercised.............. -- -- 16,337 163 -- 2,702 -- Accretion of preferred stock dividends.......................... -- 89,250 -- -- -- -- (89,250) Purchase of treasury stock........... -- -- -- -- (190,000) -- -- Issuance of stock in connection with acquisition........................ -- -- 70,000 700 190,000 664,300 -- Net income........................... -- -- -- -- -- -- 4,729,751 ---------- ---------- --------- ---------- ------------ ----------- ---------- BALANCE, DECEMBER 26, 1998............. 1,020,000 2,869,229 614,011 6,139 (1,377) 667,183 8,134,452 Stock options exercised.............. -- -- 305,470 3,056 -- 2,023,590 -- Accretion of preferred stock dividends.......................... -- 22,251 -- -- -- -- (22,251) Conversion of preferred stock........ (1,020,000) (2,550,000) 1,020,000 10,200 -- 2,539,800 -- Distribution of preferred stock dividends.......................... -- (341,480) -- -- -- (2,550,000) -- Purchase of treasury stock........... -- -- -- -- (73,575,326) -- -- Issuance of common stock............. -- -- 1,044,690 10,447 -- 51,430,089 -- Net income (loss).................... -- -- -- -- -- -- (2,003,431) ---------- ---------- --------- ---------- ------------ ----------- ---------- BALANCE, DECEMBER 15, 1999............. -- $ -- 2,984,171 $ 29,842 $(73,576,703) $54,110,662 $6,108,770 ========== ========== ========= ========== ============ =========== ========== TOTAL ------------ BALANCE, DECEMBER 27, 1997............. $ 6,278,010 Stock options exercised.............. 2,865 Accretion of preferred stock dividends.......................... -- Purchase of treasury stock........... (190,000) Issuance of stock in connection with acquisition........................ 855,000 Net income........................... 4,729,751 ------------ BALANCE, DECEMBER 26, 1998............. 11,675,626 Stock options exercised.............. 2,026,646 Accretion of preferred stock dividends.......................... -- Conversion of preferred stock........ -- Distribution of preferred stock dividends.......................... (2,891,480) Purchase of treasury stock........... (73,575,326) Issuance of common stock............. 51,440,536 Net income (loss).................... (2,003,431) ------------ BALANCE, DECEMBER 15, 1999............. $(13,327,429) ============
See notes to consolidated financial statements. F-39 TRAVCORPS CORPORATION AND SUBSIDIARY CONSOLIDATED STATEMENTS OF CASH FLOWS PERIOD FROM DECEMBER 27, 1998 TO DECEMBER 15, 1999 AND THE YEAR ENDED DECEMBER 26, 1998
1999 1998 ------------ ------------ CASH FLOWS FROM OPERATING ACTIVITIES: Net (loss) income......................................... $ (2,003,431) $ 4,729,751 Adjustments to reconcile net (loss) income to cash (used in) provided by operating activities: Depreciation............................................ 1,108,346 781,569 Amortization............................................ 739,073 444,107 Increase (decrease) in cash from changes in: Accounts receivable................................... (2,077,009) (1,814,191) Income tax receivable................................. (1,817,733) -- Prepaid rent.......................................... 374,959 (48,326) Prepaid expenses and other............................ 569,582 (77,956) Other assets.......................................... -- (2,202) Deferred income taxes................................. (469,962) 424,300 Accounts payable and accrued expenses................. (653,337) 1,534,809 Accrued payroll withholdings and incentive compensation........................................ 20,578 1,051,983 ------------ ------------ Cash provided by (used in) operating activities..... (4,208,934) 7,023,844 ------------ ------------ CASH FLOWS FROM INVESTING ACTIVITIES: Acquisition of Cejka, net of cash acquired................ -- (11,970,454) Purchase of property and equipment........................ (1,779,340) (1,888,705) Increase in deposits...................................... 156,378 (133,495) ------------ ------------ Cash used in investing activities................... (1,622,962) (13,992,654) ------------ ------------ CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from issuance of common stock.................... 53,136,887 2,865 Redemption of preferred stock............................. (2,569,927) -- Repurchase of common stock................................ (73,576,312) (190,000) Net borrowings under revolving credit agreement........... 32,335,500 8,184,500 Deferred financing charges................................ (1,613,546) -- Principal payments on capital leases...................... -- (227,445) Principal payments on other long-term obligations......... (138,618) (17,936) ------------ ------------ Cash provided by financing activities............... 7,573,984 7,751,984 ------------ ------------ INCREASE IN CASH AND CASH EQUIVALENTS....................... 1,742,088 783,174 CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR................ 1,852,578 1,069,404 ------------ ------------ CASH AND CASH EQUIVALENTS, END OF YEAR...................... $ 3,594,666 $ 1,852,578 ============ ============ SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION-- Cash paid during the year for: Interest................................................ $ 2,857,017 $ 1,028,270 ============ ============ Income taxes............................................ $ 3,011,490 $ 2,271,687 ============ ============ SUPPLEMENTAL SCHEDULE OF NONCASH TRANSACTIONS - Stock issued in connection with the Cejka acquisition..... $ -- $ 855,000 ============ ============
See notes to consolidated financial statements. F-40 TRAVCORPS CORPORATION AND SUBSIDIARY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS PERIOD FROM DECEMBER 27, 1998 TO DECEMBER 15, 1999 AND THE YEAR ENDED DECEMBER 26, 1998 1. NATURE OF BUSINESS TravCorps Corporation ("TravCorps") and its wholly-owned subsidiary, Cejka & Company ("Cejka") (collectively, the "Company") provide flexible staffing, search, consulting and related outsourced services to health care providers throughout the United States. The Company's fiscal year typically ends on the last Saturday in December. On December 16, 1999, the Company merged with Cross Country Staffing, Inc. ("CCS") (see Note 9). These financial statements are presented on a going concern basis and do not reflect any effects on the financial statements resulting from the merger with CCS. 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES REVENUE RECOGNITION--The Company recognizes revenue from temporary staffing services as services are rendered based on hours worked by the assigned health care professionals. Retainer fees earned for search and related outsourced services are recognized over the contract term. Placement revenues are recognized upon successful completion of the search assignment. Consulting revenues are recognized as services are rendered. PRINCIPLES OF CONSOLIDATION--The consolidated financial statements include the accounts of TravCorps Corporation and subsidiary. Upon consolidation, all material intercompany accounts and transactions are eliminated. CASH AND CASH EQUIVALENTS--The Company considers all investments in highly liquid debt instruments with maturities of less than three months at the date of purchase to be cash and cash equivalents. USE OF ESTIMATES--The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Estimates included in the consolidated financial statements include allowances for uncollectible accounts and certain accrued expenses. Actual results could differ from those estimates. PROPERTY AND EQUIPMENT--Property and equipment are recorded at cost. Depreciation and amortization are provided using the straight-line method over the estimated useful lives (three to seven years) of the related assets. This caption also includes capitalized costs associated with the development of internal-use software (see below). Such costs include charges for consulting services and costs for personnel associated with programming, coding and testing such software. These costs are not depreciated until the related software is placed into service. ACCOUNTING FOR COMPUTER SOFTWARE COSTS--In March 1998, the American Institute of Certified Public Accountants issued Statement of Position (SOP) No. 98-1, ACCOUNTING FOR THE COSTS OF COMPUTER SOFTWARE DEVELOPED OR OBTAINED FOR INTERNAL USE. SOP No. 98-1 delineated the types of costs that may be capitalized in connection with the development and installation of internal-use software. The Company historically has had accounting policies that are consistent with those specified in SOP No. 98-1. Accordingly, its implementation did not have a material impact on the consolidated financial statements. F-41 TRAVCORPS CORPORATION AND SUBSIDIARY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) PERIOD FROM DECEMBER 27, 1998 TO DECEMBER 15, 1999 AND THE YEAR ENDED DECEMBER 26, 1998 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) IMPAIRMENT OF LONG-LIVED ASSETS--Long-lived assets to be held and used are reviewed for impairment whenever circumstances indicate that the carrying amount of an asset may not be recoverable. Long-lived assets to be disposed of are reported at the lower of the carrying amount or fair value, less cost to sell. GOODWILL--The excess of the purchase price of acquired companies over the fair value of net identifiable assets ("goodwill") at the date of acquisition are amortized on a straight-line basis over their estimated lives of twenty or twenty-five years. The Company periodically reviews goodwill to assess recoverability, based upon expectations of nondiscounted cash flows and operating income of the activities, that generated the goodwill balance. Impairments would be recognized in operating results if such expected cash flows were less than the carrying value of the related assets. No such impairments have been recorded through December 15, 1999. DEFERRED FINANCING COSTS--Deferred financing costs represent commitment fees and other costs incurred relating to the refinancing of the Company's revolving credit agreement and are being amortized over the life of the agreement. INCOME TAXES--Deferred income taxes are provided for differences in bases of the Company's assets and liabilities for book and tax purposes. Deferred income taxes are estimated using currently enacted tax rates. CONCENTRATION OF CREDIT RISK--The Company extends credit to its customers on an unsecured basis and requires no collateral. However, credit control policies are in place to control the Company's exposure to potential uncollectible receivables. STOCK-BASED COMPENSATION--The Company accounts for stock-based awards to employees using the intrinsic-value method. ESTIMATED FAIR VALUE OF FINANCIAL INSTRUMENTS--The carrying amounts reported in the consolidated balance sheets for cash, accounts receivable, accounts payable and accrued expenses approximate fair value because of their short maturity. The carrying amount of the long-term obligations approximates fair value because the interest rate is tied to a quoted variable index. 3. ACQUISITION On April 29, 1998, the Company acquired certain assets and assumed certain liabilities of Cejka, a company that provides permanent placement, consulting and related outsourced services for physicians and health care executives. The acquisition has been accounted for as a purchase and, accordingly, the results of Cejka are included in these consolidated financial statements from the date of acquisition. The purchase and related acquisition costs aggregated $12,826,000 and were funded with the borrowing of $11,821,000 under the Company's revolving credit agreement and the issuance of 90,000 shares of Class A common stock valued at $855,000. F-42 TRAVCORPS CORPORATION AND SUBSIDIARY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) PERIOD FROM DECEMBER 27, 1998 TO DECEMBER 15, 1999 AND THE YEAR ENDED DECEMBER 26, 1998 3. ACQUISITION (CONTINUED) The consideration involved in the acquisition, after giving effect to liabilities assumed, has been allocated to the assets acquired based on their respective fair values as follows: Assets: Cash and cash equivalents................................. $ 300 Accounts receivable....................................... 1,785,969 Prepaid rent.............................................. 28,229 Deposits.................................................. 11,396 Property and equipment.................................... 379,047 Goodwill.................................................. 11,560,000 ----------- Assets acquired............................................. 13,764,941 Less assumed liabilities.................................... 939,187 ----------- Total consideration......................................... $12,825,754 ===========
4. LONG-TERM OBLIGATIONS Long-term obligations at December 15, 1999 and December 26, 1998 consist of the following:
1999 1998 ----------- ----------- Revolving Credit Agreement......................... $45,000,000 $12,664,500 Capital lease obligations.......................... 36,273 174,891 ----------- ----------- Total.............................................. 45,036,273 12,839,391 Less current portion............................... 36,273 163,742 ----------- ----------- Total long-term obligations........................ $45,000,000 $12,675,649 =========== ===========
CREDIT AGREEMENT--At December 15, 1999, the Company has a revolving credit agreement with Chase Bank (the "Revolving Credit Agreement"), which provides for a term loan of $45 million, revolving loans of up to $10,000,000 and swingline loans up to $1,000,000, including letters of credit of up to $2,500,000, maturing May 14, 2005. Revolving loans under the Revolving Credit Agreement can be ABR loans or Eurodollar loans. Swingline loans must be ABR loans. Eurodollar rate loans must have a minimum principal balance of $1,000,000 and must be in integral multiples of $250,000. ABR Revolving loans must have a minimum principal balance of $250,000 and must be in integral multiples of $50,000. Swingline loans must have a minimum principal balance of $250,000 and must be in integral multiples of $50,000. Amounts outstanding under the term loan at December 15, 1999 totaled $45 million and are scheduled to be repaid with interest at 9.40% in quarterly installments of $250,000 from December 25, 1999 through March 2004 and $10,125,000 through May 2005. There were no Revolving or Swingline loans outstanding at December 15, 1999. ABR loans carry interest at the greatest of a) the Prime Rate, b) the Base CD Rate plus 1%, or c) the Federal Funds Effective Rate plus 1/2of 1%. Eurodollar loans carry interest at the LIBOR Rate for the interest period multiplied by b) the Statutory Reserve Rate. The interest on any ABR or F-43 TRAVCORPS CORPORATION AND SUBSIDIARY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) PERIOD FROM DECEMBER 27, 1998 TO DECEMBER 15, 1999 AND THE YEAR ENDED DECEMBER 26, 1998 4. LONG-TERM OBLIGATIONS (CONTINUED) Eurodollar loan is payable quarterly. The interest on any Swingline loan is payable on the principal due date. Letters of credit amounting to $404,099 and $399,508 at December 15, 1999 and December 26, 1998, respectively, had been issued pursuant to the Company's workers' compensation insurance program. The Agreement contains, among other things, restrictions on further indebtedness, asset sales, capital expenditures, payment of dividends, changes in the capital structure and changes in the ownership of the Company. The Agreement also has covenants which require the Company to maintain a minimum level of tangible net worth, achieve minimum levels of earnings before interest, taxes, depreciation and amortization, and achieve certain financial ratios, all as defined in the Agreement. At December 26, 1998, the Company had a revolving credit agreement with Fleet Bank NA that carried terms similar to the Chase Bank agreement. The Fleet agreement did not include a term loan. The Fleet Bank agreement was terminated and replaced with the Chase Bank agreement in connection with the leveraged recapitalization discussed in Note 7. CAPITAL LEASE OBLIGATIONS--The Company leases equipment under capital leases. The leases bear interest at rates ranging from 8.0% to 9.0% and expire in 2000. The Company intends to exercise its options to purchase the equipment. 5. COMMITMENTS AND CONTINGENCIES OPERATING ACTIVITIES--The Company has entered into various operating leases for temporary housing of its professional medical personnel, with terms of up to twelve months. The Company also leases office space for its corporate activities. Future lease payments for office space pursuant to the leases total $736,088, $440,050, $449,188, $441,166 and $0 for the years ending December 2000, 2001, 2002, 2003 and 2004, respectively. Total lease expense was approximately $12,132,185 and $10,024,495 for the period December 27, 1998 to December 15, 1999 and the year ended December 26, 1998, respectively. F-44 TRAVCORPS CORPORATION AND SUBSIDIARY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) PERIOD FROM DECEMBER 27, 1998 TO DECEMBER 15, 1999 AND THE YEAR ENDED DECEMBER 26, 1998 6. INCOME TAXES The components of the provision for income taxes for the for the period December 26, 1998 to December 15, 1999 and the year ended December 26, 1998 are as follows:
1999 1998 ---------- ---------- Current: Federal............................................ $ 831,600 $2,141,800 State.............................................. 189,200 783,300 ---------- ---------- 1,020,800 2,925,100 ---------- ---------- Deferred: Federal............................................ (363,000) 310,700 State.............................................. (77,700) 113,600 ---------- ---------- (440,700) 424,300 ---------- ---------- Total................................................ $ 580,100 $3,349,400 ========== ==========
The components of the deferred tax assets and liabilities at December 15, 1999 and December 26, 1998 are as follows:
1999 1998 ---------- ---------- Deferred tax assets--current: Accrued incentive compensation..................... $ 971,700 $ 704,550 Accrued liabilities................................ 223,900 337,650 Other.............................................. 310,000 149,400 ---------- ---------- 1,505,600 1,191,600 Deferred tax liabilities--current--prepaid expenses........................................... (150,300) (612,000) ---------- ---------- Net deferred tax assets--current..................... $1,355,300 $ 579,600 ========== ========== Deferred tax liabilities--noncurrent--depreciation... $1,235,538 $ 929,800 ========== ==========
Difference between the provision for income taxes and income taxes computed using the U.S. federal income tax rate are primarily due to state taxes and expenses not deductible for income tax purposes. 7. STOCKHOLDERS' EQUITY LEVERAGED RECAPITALIZATION--On May 14, 1999, in connection with a leveraged recapitalization transaction, the Company sold 1,044,690 of the Company's common shares to Morgan Stanley Dean Witter ("MSDW") and the Company redeemed 1,583,983 of its common shares. Immediately preceding the leveraged recapitalization, the Company's preferred shareholders converted 1,020,000 preferred shares into 1,020,000 common shares. The price for the redeemed shares was $76,869,925, which was paid in cash. After the transaction, MSDW owned 87.29% of the Company's outstanding common stock. F-45 TRAVCORPS CORPORATION AND SUBSIDIARY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) PERIOD FROM DECEMBER 27, 1998 TO DECEMBER 15, 1999 AND THE YEAR ENDED DECEMBER 26, 1998 7. STOCKHOLDERS' EQUITY (CONTINUED) The redemption was funded with $45,200,000 of new bank borrowings (see Note 4) and the proceeds from the sale of the common shares. These new borrowings and common share proceeds were also used to repay $11,081,000 of existing bank borrowings and to pay $4,036,000 of transaction expenses. For financial accounting purposes, the transaction is treated as a leveraged recapitalization, whereby the assets are not revalued and the excess purchase price of the redeemed shares over the net book value of the shares reduces the Company's equity. The characteristics of preferred and common stock of the Company prior to the recapitalization are described as follows: PREFERRED STOCK--During 1995, the Company issued 1,020,000 shares of convertible preferred stock at $2.50 per share. All (but not less than all) of the shares of convertible preferred stock were convertible at any time, at the option of the holders of the convertible preferred stock, into conversion units which consisted of one share of Class B common stock and one share of redeemable preferred stock for each share of convertible preferred stock tendered for conversion. In connection with the leveraged recapitalization described above, the holders of the convertible preferred stock elected to convert their preferred shares into Class B common shares only. The holders of convertible preferred stock were entitled to elect three representatives to the Board. On all other matters, the holders of convertible preferred stock were entitled to vote, as a single class with the common stockholders, as if their convertible preferred stock had been converted into an equivalent number of shares of common stock. The convertible preferred stock was entitled to cumulative dividends at the rate of 3.5% per year on the convertible base liquidation amount, as defined, of $2.50 per share. At December 15, 1999 and December 26, 1998, the cumulative preferred dividends in arrears totaled $0 and $319,229, respectively, as all cumulative preferred dividends were paid in connection with the leveraged recapitalization. No dividends could be paid to holders of common stock or Class B common stock until all cumulative preferred stock dividends were paid. Convertible preferred stock dividends became immediately payable upon the leveraged recapitalization. COMMON STOCK--Common stock and Class B common stock are identical, except that the holders of common stock and Class B common stock, each voting as separate classes, are entitled to each elect two representatives to the Board. The Class B common stock is convertible into an equivalent number of shares of common stock immediately prior to the closing of an Extraordinary Transaction as defined. The leveraged recapitalization qualified as an Extraordinary Transaction and, accordingly, the Class B common shares were converted into common shares. STOCK OPTIONS--The Company's 1995 Stock Option Plan (the "Plan") provides for the issuance of incentive stock options ("ISOs") and nonstatutory stock options ("NSOs") to officers, employees, directors, consultants and advisors for the purchase of up to 430,000 shares of common stock. The exercise price of ISOs may not be less than the fair market value of the Company's common stock on the date of grant and may not be less than 110% of such fair market value with respect to any ISOs granted to a participant who owns 10% or more of the Company's outstanding common stock. Options F-46 TRAVCORPS CORPORATION AND SUBSIDIARY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) PERIOD FROM DECEMBER 27, 1998 TO DECEMBER 15, 1999 AND THE YEAR ENDED DECEMBER 26, 1998 7. STOCKHOLDERS' EQUITY (CONTINUED) vest in installments over periods of up to seven years. Options granted must be exercised within ten years. The Company applies the intrinsic value method to determine compensation cost associated with its plan. The Board has determined that the fair value of common stock approximates the exercise price at the time of the grant. Accordingly, no compensation costs have been recognized for its stock option plan. The difference between net (loss) income on a pro forma basis had compensation cost for the Company's plan been determined consistent with the fair value method described in SFAS No. 123, and reported net (loss) income is immaterial: The following is a summary of stock option activity under the Plan:
WEIGHTED- AVERAGE EXERCISE PRICE PER SHARES SHARE -------- --------- Outstanding at December 27, 1997 (25,935 exercisable at a weighted-average price of $0.20)....................... 216,673 $2.93 Granted (weighted-average fair value of $3.27)......... 149,509 11.81 Forfeited.............................................. (12,310) 5.33 Exercised.............................................. (16,337) 0.18 -------- Outstanding at December 26, 1998 (51,307 exercisable at a weighted-average price of $2.83)....................... 337,535 6.91 Granted (weighted-average fair value of $25.00).......... 14,725 25.00 Forfeited.............................................. (46,790) 13.98 Exercised.............................................. (305,470) 6.26 -------- Outstanding at December 15, 1999......................... 0 ========
The fair value of each option grant was estimated on the date of grant using an option pricing model with the following assumptions:
1999 1998 -------- -------- Risk-free interest rate.................................... 4.75% 4.75% Dividend yield............................................. 0.00% 0.00% Expected life (years)...................................... 10.00 10.00
In connection with the merger with CCS (see Note 9), the options outstanding as of December 15, 1999 immediately vested and were exchanged for an equivalent number of shares in CCS. RESTRICTION ON DIVIDENDS--Pursuant to the terms of the Company's Revolving Credit Agreement in effect at December 26, 1998 (see Note 4), the Company was precluded from declaring or paying any dividends on any of its preferred or common stock and was prohibited from repurchasing any of its outstanding preferred and common stock, except that up to $190,000 of common stock could have been repurchased annually from employees whose employment had ceased. F-47 TRAVCORPS CORPORATION AND SUBSIDIARY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) PERIOD FROM DECEMBER 27, 1998 TO DECEMBER 15, 1999 AND THE YEAR ENDED DECEMBER 26, 1998 8. PROFIT-SHARING PLAN TravCorps has a 401(k) defined contribution benefit plan (the "401(k) Plan") for eligible employees. Eligible employees may make pretax savings contributions to the 401(k) Plan of up to 15% of their earnings to a certain statutory limit. TravCorps matches employee contributions up to 1% of compensation. TravCorps contributed $97,000 and $93,000 to the 401(k) Plan during the period from December 27, 1998 to December 15, 1999 and the year ended December 26, 1998, respectively, and made a discretionary profit sharing contribution of approximately $86,000 during the year ended December 26, 1998. Cejka has a separate 401(k) defined contribution benefit plan (the "Cejka plan") for eligible employees. Eligible employees may make pretax savings contributions to the Cejka plan of up to 10% of their earnings to a statutory limit. Cejka matches 50% of the employee contributions up to 6% of compensation. Cejka contributed approximately $145,000 and $250,000 to the Cejka plan and a discretionary profit-sharing plan during the period December 27, 1998 to December 15, 1999 and year ended December 26, 1998, respectively. 9. SUBSEQUENT EVENT--MERGER WITH CROSS COUNTRY STAFFING, INC. On December 16, 1999, the Company entered into a Plan of Merger with CCS, a company engaged in the business of providing temporary health care staffing services to acute and subacute care facilities nationwide. Pursuant to the Plan of Merger, all outstanding shares of the Company's common stock were exchanged for common stock in CCS. The fair value of the shares of CCS common stock issued to the stockholders of the Company, as determined by an independent valuation of the common stock in January 2000, was $32,102,000. In connection with the merger transaction, CCS assumed the Company's long-term obligation of $45,000,000. The merger was accounted for in the CCS consolidated financial statements as a purchase. Upon consummation of the merger, certain computer information systems used by the Company were replaced with CCS systems resulting in a write down of computer and software equipment approximately $1.2 million. In addition, unamortized deferred financing costs approximately $1.6 million were written off in connection with CCS's assumption of the Company's long-term obligation. These asset write downs were accounted for in the purchase accounting as part of the merger. Accordingly, the effects of these write downs are not reflected in the accompanying financial statements. F-48 REPORT OF INDEPENDENT AUDITORS The Board of Directors and Stockholders Cross Country, Inc. We have audited the accompanying consolidated statements of assets acquired and liabilities assumed of ClinForce, Inc. ("ClinForce") as of December 31, 2000 and 1999 and the related consolidated statement of operating revenues and expenses for each of the two years in the period ended December 31, 2000. These statements are the responsibility of ClinForce's management. Our responsibility is to express an opinion on the statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. The accompanying consolidated statements of assets acquired and liabilities assumed and the related consolidated statements of operating revenues and expenses were prepared for inclusion in the Registration Statement on Form S-1 of Cross Country, Inc. for purposes of complying with the rules and regulations of the Securities and Exchange Commission in lieu of the full financial statements required by Rule 3-05 for the transaction between Cross Country, Inc. and ClinForce. The statements are not intended to be a complete presentation of the financial position of ClinForce. In our opinion, the statements referred to above present fairly, in all material respects, the consolidated assets acquired and liabilities assumed of ClinForce at December 31, 2000 and 1999, and the operating revenues and expenses for each of the two years in the period ended December 31, 2000 in conformity with accounting principles generally accepted in the United States. /s/ ERNST &YOUNG LLP Raleigh, North Carolina April 26, 2001 F-49 CLINFORCE, INC. CONSOLIDATED STATEMENTS OF ASSETS ACQUIRED AND LIABILITIES ASSUMED
DECEMBER 31 ------------------------- 2000 1999 ----------- ----------- ASSETS ACQUIRED Current assets: Cash...................................................... $ -- $ 737,556 Accounts receivable, less allowance for doubtful accounts of $103,645 in 2000 and $0 in 1999...................... 4,943,894 3,367,818 Prepaid expenses.......................................... 25,201 4,290 Current deferred tax asset................................ 108,877 -- Other current assets...................................... 1,999 68,961 ----------- ----------- Total current assets........................................ 5,079,971 4,178,625 Property and equipment, net of accumulated depreciation of $842,498 in 2000 and $707,356 in 1999..................... 404,402 435,979 Goodwill, net of accumulated amortization of $2,119,322 in 2000 and $1,458,113 in 1999............................... 11,073,812 11,735,021 Other assets................................................ 30,036 14,983 ----------- ----------- Total assets acquired....................................... $16,588,221 $16,364,608 =========== =========== LIABILITIES ASSUMED Current liabilities: Cash overdraft............................................ $ 248,801 $ -- Accounts payable.......................................... 62,277 2,036 Income taxes payable...................................... 2,060,900 884,515 Accrued employee compensation and benefits................ 1,146,856 626,484 Other current liabilities................................. 4,837 21,909 ----------- ----------- Total current liabilities................................... 3,523,671 1,534,944 ----------- ----------- Long-term deferred tax liability............................ 354,998 195,435 ----------- ----------- Total liabilities assumed................................... $ 3,878,669 $ 1,730,379 =========== ===========
See accompanying notes. F-50 CLINFORCE, INC. CONSOLIDATED STATEMENTS OF OPERATING REVENUES AND EXPENSES
YEAR ENDED DECEMBER 31 ------------------------- 2000 1999 ----------- ----------- Revenue from services....................................... $28,895,276 $26,385,411 Operating expenses: Compensation and benefits................................. 20,128,675 19,066,580 Selling, general and administrative expenses.............. 4,765,833 3,906,762 Bad debt expense.......................................... 110,000 -- Depreciation.............................................. 135,141 94,199 Amortization.............................................. 659,657 659,657 ----------- ----------- Total operating expenses.................................... 25,799,306 23,727,198 ----------- ----------- Income from operations...................................... 3,095,970 2,658,213 Income tax expense.......................................... 1,227,071 1,079,950 ----------- ----------- Income from operations after tax............................ $ 1,868,899 $ 1,578,263 =========== ===========
See accompanying notes. F-51 CLINFORCE, INC. NOTES TO CONSOLIDATED STATEMENTS DECEMBER 31, 2000 1. ORGANIZATION AND BASIS OF PRESENTATION ClinForce, Inc. ("ClinForce" or the "Company") is in the business of recruiting and placing temporary and permanent clinical research professionals. The Company was a subsidiary of Edgewater Technology, Inc. (f/k/a Staffmark, Inc.), a publicly held company. ClinForce, Inc. was founded in 1991 as Clinical Trial Support Services. In 1997, the Company acquired ClinForce in Morristown, New Jersey. In August 1996, the Company merged with four other regional companies to form Staffmark, Inc. (n/k/a Edgewater Technology, Inc.). In October 1996, Staffmark became a publicly traded company. In March 1998, ClinForce acquired Temporary Tech in North Carolina. On April 1, 1999, the Company changed its name to ClinForce, Inc. During 2000, the Company opened facilities in Ft. Myers, Boston, Philadelphia, and Cincinnati. CFRC, Inc., a wholly-owned subsidiary of ClinForce, was established in fiscal year 1997. CFRC, Inc. was established primarily as an intellectual property company. The consolidated financial statements of ClinForce include the results of operations for CFRC, Inc. On December 15, 2000, the ClinForce entered into a stock purchase agreement to be acquired by Cross Country, Inc. for approximately $31,000,000. The transaction was consummated on March 16, 2001 and met the accounting criteria of a purchase. The purchase price is subject to a post-closing adjustment based on changes in the net working capital of the acquired companies between October 31, 2000 and March 16, 2001. The consolidated statements of assets acquired and liabilities assumed and related consolidated statements of operating revenues and expenses (the "statements") have been prepared solely to comply with the requirements of the Securities and Exchange Commission. These statements are not intended to be a complete presentation of the assets, liabilities, revenues and expenses of the Company because they do not include corporate allocated expenses that would have been incurred by the Company had it operated as a stand-alone business (see Note 2). USE OF ESTIMATES The preparation of the statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts in the statements and accompanying notes. Actual results could differ from those estimates. 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES These statements are not indicative of the financial condition or results of operations of this business going forward because of the change in the business and the omission of various administrative expenses. REVENUE RECOGNITION Revenues consist primarily of billing for associates' time and permanent placement fees. Revenue is recognized upon completion of services. F-52 CLINFORCE, INC. NOTES TO CONSOLIDATED STATEMENTS (CONTINUED) DECEMBER 31, 2000 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) CONCENTRATION OF CREDIT RISK Financial instruments that potentially subject the Company to concentrations of credit risk as defined by Financial Accounting Standards Board (FASB) Statement No. 105, DISCLOSURE OF INFORMATION ABOUT FINANCIAL INSTRUMENTS WITH OFF-BALANCE-SHEET RISK AND FINANCIAL INSTRUMENTS WITH CONCENTRATIONS OF CREDIT RISK, consist principally of accounts receivable. The Company's customers are clinical research organizations ("CROs") and accounts receivable represent amounts due from these CROs. The Company performs ongoing credit evaluations of its customers' financial conditions and, generally, does not require collateral. Overall, based on the large number of customers in differing geographic areas throughout the United States and its territories, the Company believes the concentration of credit risk is limited. As of December 31, 2000, approximately 48% of the outstanding accounts receivable were due from four customers. As of December 31, 1999, approximately 70% of the outstanding accounts receivable were due from four customers. PROPERTY AND EQUIPMENT Property and equipment are stated at cost, less accumulated depreciation. Depreciation is determined on a straight-line basis over the estimated useful lives of the assets, which generally range from three to seven years. Leasehold improvements are depreciated over the lives of the related leases or the useful life of an individual lease, whichever is shorter. CORPORATE ALLOCATIONS Edgewater provided substantial services to the Company, including, but not limited to, general administration, treasury, tax, financial reporting, insurance and legal functions. Edgewater has traditionally charged the Company for certain of these services through corporate allocations which were generally based on a percent of sales. The amount of corporate allocations was dependent upon the total amount of anticipated allocable costs incurred by Edgewater, less amounts charged as a specific cost or expense rather than by allocation. The amounts allocated are not necessarily indicative of amounts that would have been incurred by the Company had it operated on a stand-alone basis. GOODWILL Goodwill represents the excess of purchase price over the fair value of net assets acquired. Goodwill associated with acquisitions in 1998 and 1997 is being amortized using the straight-line method over its estimated useful life of twenty years. In accordance with FASB Statement No. 121, ACCOUNTING FOR THE IMPAIRMENT OF LONG-LIVED ASSETS AND FOR LONG-LIVED ASSETS TO BE DISPOSED OF, long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Recoverability of assets is measured by comparison of the carrying amount of the asset to net future cash flows expected to be generated from the asset. At December 31, 2000 and 1999, the Company believes that no impairment of goodwill exists. F-53 CLINFORCE, INC. NOTES TO CONSOLIDATED STATEMENTS (CONTINUED) DECEMBER 31, 2000 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) ADVERTISING The Company's advertising expense consists primarily of print media, online advertising and promotional material. Advertising costs are expensed as incurred and were approximately $16,539 and $16,759 for the years ended December 31, 2000 and 1999, respectively. INCOME TAXES The Company accounts for income taxes under FASB Statement No. 109, ACCOUNTING FOR INCOME TAXES. Deferred income tax assets and liabilities are determined based upon differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. ClinForce has always been included in a consolidated return for United States federal tax reporting purposes. The income tax provision included in the statement of operating revenues and expenses was prepared as if the Company was a stand-alone entity. ESTIMATED FAIR VALUE OF FINANCIAL INSTRUMENTS The carrying amounts reported in the consolidated balance sheets for cash, accounts receivable, accounts payable and accrued expenses approximate fair value because of their short maturity. COMPREHENSIVE INCOME The Company has adopted FASB Statement No.130, COMPREHENSIVE INCOME, which requires that an enterprise: (a) classify items of other comprehensive income by their nature in the financial statements; and (b) display the accumulated balance of other comprehensive income separately from retained earnings and additional paid-in capital in the equity section of the balance sheet. The items of other comprehensive income that are typically required to be displayed are foreign currency items, minimum pension liability adjustments and unrealized gains and losses on certain investments in debt and equity securities. There are no other components of comprehensive income or loss other than the Company's consolidated net income and net loss for the years ended December 31, 2000 and 1999, respectively. IMPACT OF RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS In June 1998, the Financial Accounting Standards Board issued SFAS No.133, "Accounting for Derivative Instruments and Hedging Activities". SFAS No.133, as amended, is required to be adopted in years beginning after June 15, 2000. The Company plans to adopt the new statement effective January 1, 2001. Because of the Company's minimal use of derivatives, management does not anticipate the adoption of the new Statement will have a significant affect on earnings or the consolidated financial position of the Company. F-54 CLINFORCE, INC. NOTES TO CONSOLIDATED STATEMENTS (CONTINUED) DECEMBER 31, 2000 3. PROPERTY AND EQUIPMENT At December 31, property and equipment consist of the following:
2000 1999 ---------- ---------- Computer equipment................................... $ 268,657 $ 251,398 Computer software.................................... 161,853 131,014 Office equipment..................................... 118,721 118,722 Furniture and fixtures............................... 558,968 556,770 Leasehold improvements............................... 138,701 85,431 ---------- ---------- 1,246,900 1,143,335 Less accumulated depreciation........................ (842,498) (707,356) ---------- ---------- $ 404,402 $ 435,979 ========== ==========
4. ACCRUED COMPENSATION AND BENEFITS At December 31, accrued employee compensation and benefits consist of the following:
2000 1999 ---------- ---------- Salaries............................................. $ 305,446 $ 222,820 Bonuses.............................................. 512,225 238,169 Accrual for payroll taxes............................ 226,855 82,063 Accrual for vacation................................. 102,330 83,432 ---------- ---------- $1,146,856 $ 626,484 ========== ==========
5. COMMITMENTS AND CONTINGENCIES The Company has entered into non-cancelable operating lease agreements for the rental of space. Future minimum lease payments associated with these agreements are as follows:
YEAR ENDING DECEMBER 31: ------------------------ 2001................................................. $ 412,214 2002................................................. 363,176 2003................................................. 365,844 2004................................................. 294,378 2005................................................. 35,352 Thereafter........................................... 23,712 ---------- $1,494,676 ==========
Rent expense related to office facilities was approximately $355,161 and $244,536 for the years ended December 31, 2000 and 1999, respectively. The Company is subject to legal proceedings and claims that arise in the ordinary course of its business. In the opinion of management, the outcome of these matters will not have a significant effect on the Company's consolidated financial position or results of operations. F-55 CLINFORCE, INC. NOTES TO CONSOLIDATED STATEMENTS (CONTINUED) DECEMBER 31, 2000 6. INCOME TAXES The Company has always been included in a consolidated return for United States federal tax reporting purposes. The income tax expense and deferred income taxes were calculated based on income from operations, and therefore are not necessarily indicative of amounts that would have been incurred by the Company had it operated as a stand-alone entity. Deferred income taxes from years prior to 1999 have not been calculated. The components of the income tax expense (benefit) are as follows:
2000 1999 ---------- ---------- Current.............................................. $1,176,385 $ 884,515 Deferred............................................. 50,686 195,435 ---------- ---------- $1,227,071 $1,079,950 ========== ==========
Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred tax assets and liabilities are as follows:
DECEMBER 31 ----------------------- 2000 1999 ---------- ---------- Deferred tax assets: Accrued expenses..................................... $ 67,953 $ -- Allowance for doubtful accounts...................... 40,924 -- ---------- ---------- 108,877 -- Deferred tax liabilities: Goodwill amortization................................ (235,764) (149,686) Depreciation......................................... (119,234) (45,749) ---------- ---------- Net deferred taxes................................... $ (246,121) $ (195,435) ========== ==========
FASB Statement No. 109 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of the evidence, it is more likely than not that some of or all of the deferred tax assets will not be realized. After consideration of all the evidence, both positive and negative, management has determined that a valuation allowance at December 31, 2000 and 1999 is not necessary. F-56 CLINFORCE, INC. NOTES TO CONSOLIDATED STATEMENTS (CONTINUED) DECEMBER 31, 2000 6. INCOME TAXES (CONTINUED) The reconciliation of income tax computed at the U. S. federal statutory rate to income tax expense is as follows:
DECEMBER 31 ----------------------- 2000 1999 ---------- ---------- Tax at U.S. statutory rate........................... $1,083,590 $ 930,375 State taxes, net of federal benefit.................. 140,039 119,221 Non-deductible items................................. 9,243 9,363 Other................................................ (5,801) 20,791 ---------- ---------- $1,227,071 $1,079,950 ========== ==========
F-57 -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- Through and including , 2001 (the 25th day after the date of this prospectus), all dealers effecting transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers' obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions. SHARES CROSS COUNTRY, INC. COMMON STOCK --------------------- P R O S P E C T U S --------------------- MERRILL LYNCH & CO. SALOMON SMITH BARNEY BANC OF AMERICA SECURITIES LLC ROBINSON-HUMPHREY CIBC WORLD MARKETS , 2001 -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- SUBJECT TO COMPLETION PRELIMINARY PROSPECTUS DATED JULY 11, 2001 The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted. PROSPECTUS SHARES [LOGO] CROSS COUNTRY, INC. COMMON STOCK ------------------ This is Cross Country, Inc.'s initial public offering. We are selling all of the shares. The international managers are offering shares outside the U.S. and Canada and the U.S. underwriters are offering shares in the U.S. and Canada. We expect the public offering price to be between $ and $ per share. Currently, no public market exists for the shares. After pricing of the offering, we expect that the shares will be quoted on the Nasdaq National Market under the symbol CCRN. INVESTING IN THE COMMON STOCK INVOLVES RISKS WHICH ARE DESCRIBED IN THE "RISK FACTORS" SECTION BEGINNING ON PAGE 9 OF THIS PROSPECTUS. ------------------------
PER SHARE TOTAL --------- -------- Public offering price....................................... $ $ Underwriting discount....................................... $ $ Proceeds, before expenses, to Cross Country, Inc............ $ $
The international managers may also purchase up to an additional shares from us at the public offering price, less the underwriting discount, within 30 days from the date of this prospectus to cover over-allotments. The U.S. underwriters may similarly purchase up to an additional shares from us. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. The shares will be ready for delivery on or about , 2001. ------------------------ MERRILL LYNCH INTERNATIONAL SALOMON SMITH BARNEY BANC OF AMERICA SECURITIES LIMITED ROBINSON-HUMPHREY CIBC WORLD MARKETS ------------------------ The date of this prospectus is , 2001. ALT-1 UNDERWRITING We intend to offer the shares outside the U.S. and Canada through the international managers and in the U.S. and Canada through the U.S. underwriters. Merrill Lynch International, Salomon Brothers International Limited, Banc of America Securities Limited, The Robinson-Humphrey Company, LLC and CIBC World Markets plc. are acting as lead managers for the international managers named below. Subject to the terms and conditions described in an international purchase agreement between us and the international managers, and concurrently with the sale of shares to U.S. underwriters, we have agreed to sell to the international managers, and the international managers severally have agreed to purchase from us, the number of shares listed opposite their names below.
NUMBER OF SHARES INTERNATIONAL UNDERWRITER ---------------- Merrill Lynch International................................. Salomon Brothers International Limited...................... Banc of America Securities Limited.......................... The Robinson-Humphrey Company, LLC.......................... CIBC World Markets plc...................................... ------ Total............................................. ======
We have also entered into a U.S. purchase agreement with the U.S. underwriters for sale of the shares in the U.S. and Canada for whom Merrill Lynch, Pierce, Fenner & Smith Incorporated, Salomon Smith Barney Inc., Banc of America Securities LLC, The Robinson-Humphrey Company, LLC and CIBC World Markets Corp. are acting as U.S. representatives. Subject to the terms and conditions in the U.S. purchase agreement, and concurrently with the sale of shares to the international managers pursuant to the international purchase agreement, we have agreed to sell to the U.S. underwriters, and the U.S. underwriters severally have agreed to purchase shares from us. The initial public offering price per share and the total underwriting discount per share are identical under the international purchase agreement and the U.S. purchase agreement. The international managers and the U.S. underwriters have agreed to purchase all of the shares sold under the international and U.S. purchase agreements if any of these shares are purchased. If an underwriter defaults, the international and U.S. purchase agreements provide that the purchase commitments of the nondefaulting underwriters may be increased or the purchase agreements may be terminated. The closings for the sale of shares to be purchased by the international managers and the U.S. underwriters are conditioned on one another. We have agreed to indemnify the international managers and the U.S. underwriters against certain liabilities, including liabilities under the Securities Act, or to contribute to payments the international managers and the U.S. underwriters may be required to make in respect of those liabilities. The international manager are offering the shares, subject to prior sale, when, as and if issued to and accepted by them, subject to approval of legal matters by their counsel, including the validity of the shares, and other conditions contained in the purchase agreements, such as the receipt by the underwriters of officer's certificates and legal opinions. The international manager reserve the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part. COMMISSIONS AND DISCOUNTS The lead managers have advised us that the international managers propose initially to offer the shares to the public at the initial public offering price on the cover page of this prospectus and to dealers at that price less a concession not in excess of $ per share. The international managers may allow, and the dealers may reallow, a discount not in excess of $ per share to other dealers. After the initial public offering, the public offering price, concession and discount may be changed. ALT-2 The following table shows the public offering price, underwriting discount and proceeds before expenses to Cross Country. The information assumes either no exercise or full exercise by the international managers and the U.S. underwriters of their over-allotment options.
PER SHARE WITHOUT OPTION WITH OPTION --------- -------------- ----------- Public offering price..................... $ $ $ Underwriting discount..................... $ $ $ Proceeds, before expenses, to Cross Country................................. $ $ $
The expenses of the offering, not including the underwriting discount, are estimated at $ and are payable by Cross Country. OVERALLOTMENT OPTIONS We have granted an option to the international managers to purchase up to additional shares at the public offering price less the underwriting discount. The international managers may exercise this option for 30 days from the date of this prospectus solely to cover any overallotments. If the international managers exercise this option, each will be obligated, subject to conditions contained in the purchase agreements, to purchase a number of additional shares proportionate to that international manager's initial amount reflected in the above table. We have also granted an option to the U.S. underwriters, exercisable for 30 days from the date of this prospectus, to purchase up to additional shares to cover any overallotments on terms similar to those granted to the international managers. INTERSYNDICATE AGREEMENT The international managers and the U.S. underwriters have entered into an intersyndicate agreement that provides for the coordination of their activities. Under the intersyndicate agreement, the international managers and the U.S. underwriters may sell shares to each other for purposes of resale at the initial public offering price, less an amount not greater than the selling concession. Under the intersyndicate agreement, the international managers and any dealer to whom they sell shares will not offer to sell or sell shares to persons who are U.S. or Canadian persons or to persons they believe intend to resell to persons who are U.S. or Canadian persons, except in the case of transactions under the intersyndicate agreement. Similarly, the U.S. underwriters and any dealer to whom they sell shares will not offer to sell or sell shares to non-U.S. persons or non-Canadian persons or to persons they believe intend to resell to non-U.S. or non-Canadian persons, except in the case of transactions under the intersyndicate agreement. RESERVED SHARES At our request, the international managers have reserved for sale, at the initial public offering price, up to shares offered by this prospectus for sale to some of our [directors, officers, employees, distributors, dealers, business associates and related persons]. If these persons purchase reserved shares, this will reduce the number of shares available for sale to the general public. Any reserved shares that are not orally confirmed for purchase within one day of the pricing of this offering will be offered by the underwriters to the general public on the same terms as the other shares offered by this prospectus. NO SALES OF SIMILAR SECURITIES We and our executive officers and directors and all existing stockholders have agreed, with exceptions, not to sell or transfer any common stock for 180 days after the date of this prospectus ALT-3 without first obtaining the written consent of Merrill Lynch. Specifically, we and these other individuals have agreed not to directly or indirectly: - offer, pledge, sell or contract to sell any common stock; - sell any option or contract to purchase any common stock; - purchase any option or contract to sell any common stock; - grant any option, right or warrant for the sale of any common stock; - lend or otherwise dispose of or transfer any common stock; - request or demand that we file a registration statement related to the common stock; or - enter into any swap or other agreement that transfers, in whole or in part, the economic consequence of ownership of any common stock whether any such swap or transaction is to be settled by delivery of shares or other securities, in cash or otherwise. This lockup provision applies to common stock and to securities convertible into or exchangeable or exercisable for or repayable with common stock. It also applies to common stock owned now or acquired later by the person executing the agreement or for which the person executing the agreement later acquires the power of disposition. QUOTATION ON THE NASDAQ NATIONAL MARKET We expect the shares to be approved for quotation on the Nasdaq National Market, subject to notice of issuance, under the symbol "CCRN." Before this offering, there has been no public market for our common stock. The initial public offering price will be determined through negotiations among us and the U.S. representatives and lead managers. In addition to prevailing market conditions, the factors to be considered in determining the initial public offering price are: - the valuation multiples of publicly traded companies that the U.S. representatives and the lead managers believe to be comparable to us; - our financial information; - the history of, and the prospects for, our company and the industry in which we compete; - an assessment of our management, its past and present operations, and the prospects for, and timing of, our future revenue; - the present state of our development; and - the above factors in relation to market values and various valuation measures of other companies engaged in activities similar to ours. An active trading market for the shares may not develop. It is also possible that after the offering the shares will not trade in the public market at or above the initial public offering price. The international managers do not expect to sell more than 5% of the shares in the aggregate to accounts over which they exercise discretionary authority. UK SELLING RESTRICTIONS Each international manager has agreed that - it has not offered or sold and will not offer or sell any shares of common stock to persons in the United Kingdom, except to persons whose ordinary activities involve them in acquiring, holding, ALT-4 managing or disposing of investments (as principal or agent) for the purposes of their businesses or otherwise in circumstances which do not constitute an offer to the public in the United Kingdom with the meaning of the Public Offers of Securities Regulations 1995. - it has complied and will comply with all applicable provisions of the Financial Service Act 1986 with respect to anything done by it in relation to the common stock in, from or otherwise involving the United Kingdom; and - it has only issued or passed on and will only issue or pass on in the United Kingdom any document received by it in connection with the issuance of common stock to a person who is of a kind described in Article 11(3) of the Financial Services Act 1986 (Investment Advertisements)(Exemptions) Order 1996 as amended by the Financial Services Act of 1986 (Investment Advertisements)(Exemptions) Order 1997 or is a person to whom such document may otherwise lawfully be issued or pass on. NO PUBLIC OFFERING OUTSIDE THE UNITED STATES No action has been or will be taken in any jurisdiction (except in the United States) that would permit a public offering of the shares of common stock, or the possession, circulation or distribution of this prospectus or any other material relating to our company, or shares of our common stock in any jurisdiction where action for that purpose is required. Accordingly, the shares of our common stock may not be offered or sold, directly or indirectly, and neither this prospectus nor any other offering materials or advertisements in connection with the shares of common stock may be distributed or published, in or from any country or jurisdiction except in compliance with any applicable rules and regulations of any such country or jurisdiction. Purchasers of the shares offered by this prospectus may be required to pay stamp taxes and other charges in accordance with the laws and practices of the country of purchase in addition to the offering price on the cover page of this prospects. NASD REGULATIONS More than ten percent of the proceeds of the offering will be applied to pay down debt obligations owed to affiliates of Merrill Lynch International, Salomon Brothers International Limited, Banc of America Securities Limited and The Robinson-Humphrey Company, LLC. Because more than ten percent of the net proceeds of the offering will be paid to members or affiliates of members of the National Association of Securities Dealers, Inc. participating in the offering, the offering will be conducted in accordance with NASD Conduct Rule 2710(c)(8). This rule requires that the public offering price of an equity security be no higher than the price recommended by a qualified independent underwriter which has participated in the preparation of the registration statement and performed its usual standard of due diligence with respect to that registration statement. CIBC World Markets Corp. has agreed to act as qualified independent underwriter for the offering. The price of the shares will be no higher than that recommended by CIBC World Markets Corp. The underwriters will not confirm sales of shares to any account over which they exercise discretionary authority without the prior written specific approval of the customer. PRICE STABILIZATION, SHORT POSITIONS AND PENALTY BIDS Until the distribution of the shares is completed, SEC rules may limit underwriters and selling group members from bidding for and purchasing our common stock. However, the U.S. representatives may engage in transactions that stabilize the price of the common stock, such as bids or purchases to peg, fix or maintain that price. ALT-5 The underwriters may purchase and sell our common stock in the open market. These transactions may include short sales, stabilizing transactions and purchases to cover positions created by short sales. Short sales involve the sale by the underwriters of a greater number of shares than they are required to purchase in the offering. "Covered" short sales are sales made in an amount not greater than the underwriters' option to purchase additional shares from the issuer in the offering. The underwriters may close out any covered short position by either exercising their option to purchase additional shares or purchasing shares in the open market. In determining the source of shares to close out the covered short position, the underwriters will consider, among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase shares through the over-allotment option. "Naked" short sales are any sales in excess of such option. The underwriters must close out any naked short position by purchasing shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the common shares in the open market after pricing that could adversely affect investors who purchase in the offering. Stabilizing transactions consist of various bids for or purchases of common shares made by the underwriters in the open market prior to the completion of the offering. The underwriters may also impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discount received by it because the representatives have repurchased shares sold by or for the account of such underwriter in stabilizing or short covering transactions. Similar to other purchase transactions, the underwriters' purchases to cover the syndicate short sales may have the effect of raising or maintaining the market price of our common stock or preventing or retarding a decline in the market price of the common shares. As a result, the price of our common stock may be higher than the price that might otherwise exist in the open market. Neither we nor any of the underwriters makes any representation or prediction as to the direction or magnitude of any effect that the transactions described above may have on the price of the common stock. In addition, neither we nor any of the underwriters makes any representation that the U.S. representatives or the lead managers will engage in these transactions or that these transactions, once commenced, will not be discontinued without notice. OTHER RELATIONSHIPS Some of the underwriters and their affiliates have engaged in, and may in the future engage in, investment banking and other commercial dealings in the ordinary course of business with us. They have received customary fees and commissions for these transactions. Affiliates of Salomon Brothers International Limited acted as the arranger and affiliates of Salomon Brothers International Limited and The Robinson-Humphrey Company, LLC acted as administrative agent, collateral agent, issuing bank and swingline lender under our credit facility. In addition, affiliates of Merrill Lynch International, Salomon Brothers International Limited, Banc of America Securities Limited and The Robinson-Humphrey Company, LLC are lenders under our credit facility. INTERNET DISTRIBUTION Merrill Lynch will be facilitating internet distribution for the offering to some of its internet subscription customers. Merrill Lynch intends to allocate a limited number of shares for sale to its online brokerage customers. An electronic prospectus is available on the website maintained by Merrill Lynch. Other than the prospectus in electronic format, the information on the Merrill Lynch website relating to the offering is not a part of this prospectus. ALT-6 -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- Through and including , 2001 (the 25th day after the date of this prospectus), all dealers effecting transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers' obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions. SHARES CROSS COUNTRY, INC. COMMON STOCK --------------------- P R O S P E C T U S --------------------- MERRILL LYNCH INTERNATIONAL SALOMON SMITH BARNEY BANC OF AMERICA SECURITIES LLC ROBINSON-HUMPHREY CIBC WORLD MARKETS , 2001 -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- ALT-7 PART II INFORMATION NOT REQUIRED IN PROSPECTUS ITEM 13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION The following table sets forth the expenses expected to be incurred in connection with the issuance and distribution of common stock registered hereby, all of which expenses, except for the Securities and Exchange Commission registrant fee, the National Association of Securities Dealers, Inc. filing fee, and the Nasdaq National Market listing application fee, are estimated. Securities and Exchange Commission registration fee......... $ 35,938 National Association of Securities Dealers, Inc. filing fee....................................................... 14,875 Nasdaq National Market listing application fee.............. * Printing and engraving fees and expenses.................... * Legal fees and expenses..................................... * Accounting fees and expenses................................ * Blue Sky fees and expenses.................................. * Transfer Agent and Registrar fees and expenses.............. * Miscellaneous expenses...................................... * ---------- Total................................................... $ * ==========
* To be completed by amendment. ITEM 14. INDEMNIFICATION OF DIRECTORS AND OFFICERS Section 102 of the General Corporation Law of Delaware allows a corporation to limit a director's personal liability to the corporation or its stockholders from monetary damages for breach of fiduciary duty as a director, with certain exceptions. The Company's Certificate of Incorporation, as amended, provides such limitation to the fullest extent permitted by the General Corporation Law of Delaware. Section 145 of the General Corporation Law of Delaware permits a corporation, subject to the standards set forth therein, to indemnify any person in connection with any action, suit or proceeding brought or threatened by reason of the fact that such person is or was a director, officer, employee or agent of the corporation or is or was serving as such with respect to another entity at the request of the corporation. The Company's Certificate of Incorporation, as amended, and the Company's By-Laws, as amended, provide for full indemnification of its directors and officers to the extent permitted by Section 145. Our amended and restated certificate of incorporation limits the liability of our directors to us and our stockholders to the fullest extent permitted by Delaware law. Specifically, our directors will not be personally liable for money damages for breach of fiduciary duty as a director, except for liability - for any breach of the director's duty of loyalty to us or our stockholders; - for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law; - under Section 174 of the Delaware General Corporation Law, which concerns unlawful payments of dividends, stock purchases, or redemptions; and - for any transaction from which the director derived an improper personal benefit. Our amended and restated certificate of incorporation and amended and restated by-laws will also contain provisions indemnifying our directors and officers to the fullest extent permitted by Delaware law. The indemnification permitted under Delaware law is not exclusive of any other rights to which such persons may be entitled. II-1 In addition, we maintain insurance on behalf of our directors and officers insuring them against liabilities asserted against them in their capacities as directors or officers or arising out of such status, except when we have directly indemnified the directors and officers. ITEM 15. RECENT SALES OF UNREGISTERED SECURITIES Since its inception, Cross Country has issued and sold the following securities: On July 29, 1999, we issued and sold 2,040,503 shares of Common Stock for gross proceeds of $71.8 million. On July 29, 1999, in connection with our acquisition of substantially all the assets of Cross Country Staffing, we issued 170,445 shares of Common Stock to Cross Country Staffing. On July 29, 1999, pursuant to an Amended and Restated Subscription and Stockholders Agreement, we issued to Joseph Boshart, Emil Hensel, Jonathan Ward and Vickie Anenberg an aggregate of 49,716 shares of Common Stock for gross proceeds of $1.8 million. On July 29, 1999, we issued 65,527 shares of Common Stock to The Northwestern Mutual Life Insurance Company in connection with its purchase of $10.0 million of our 12% Senior Subordinated Pay-in-Kind Notes, due on January 1, 2006. On July 29, 1999, we issued 131,053 shares of Common Stock to DB Capital Investors in connection with the purchase by BT Investment Partners of $20.0 million of our 12% Senior Subordinated Pay-in-Kind Notes, due on January 1, 2006. On December 9, 1999, we granted to certain of our and our subsidiaries' employees an aggregate of 22,754 shares of Common Stock in consideration for the receipt of $0.01 per share. On December 16, 1999, in connection with our acquisition of TravCorps, we issued 1,520,000 shares of Common Stock to certain holders of stock of TravCorps. In addition, as of March 31, 2001, the Company has granted options to purchase a total of 540,919 shares of Common Stock to employees, including certain senior managers, at a weighted average exercise price of approximately $ per share. The issuances described above in this Item 15 were deemed exempt from registration under the Securities Act in reliance on either: (1) Rule 701 promulgated under the Securities Act as offers and sales of securities pursuant to certain compensatory benefit plans and contracts relating to compensation in compliance with Rule 701; or (2) Section 4(2) of the Securities Act, including Regulation D thereunder, as transactions by an issuer not involving any public offering. II-2 ITEM 16. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES (a) Exhibits The following exhibits are filed with this registration statement.
NO. DESCRIPTION --- ----------- 1.1* Form of U.S. Underwriting Agreement 1.2* Form of International Underwriting Agreement 2.1 Cross Country Staffing Asset Purchase Agreement, dated June 24, 1999, by and among W. R. Grace & Co.-Conn., a Connecticut corporation, Cross Country Staffing, a Delaware general partnership, and the Registrant, a Delaware corporation 2.2 Agreement and Plan of Merger, dated as of October 29, 1999, by and among the Registrant, CCTC Acquisition, Inc. and Certain Stockholders of Cross Country Staffing, Inc and TravCorps Corporation and the Stockholders of TravCorps Corporation 2.3 Stock Purchase Agreement, dated as of December 15, 2000, by and between Edgewater Technology, Inc. and the Registrant 3.1* Amended and Restated Certificate of Incorporation of the Registrant 3.2* Amended and Restated By-laws of the Registrant 4.1* Form of specimen common stock certificate 4.2* Stockholders Agreement, dated as of October 29, 1999, among the Registrant, a Delaware corporation, the CEP Investors and the MSDWCP Investors 4.3 Registration Rights Agreement, dated as of July 29, 1999, among the Registrant, a Delaware corporation and The Northwestern Mutual Life Insurance Company and DB Capital Investors, L.P. as Investors 4.4 Registration Rights Agreement, dated as of October 29, 1999, among the Registrant, a Delaware corporation and the Charterhouse Investors and the MSDW Investors. 5.1* Opinion of Proskauer Rose LLP as to the legality of the common stock being registered 10.1 Employment Agreement, dated as of June 24, 1999, between Joseph Boshart and the Registrant 10.2 Employment Agreement, dated as of June 24, 1999, between Emil Hensel and the Registrant 10.3 Employment Agreement termination, dated as of December 21, 2000, between Bruce Cerullo and the Registrant 10.4 Lease Agreement, dated April 28, 1997, between Meridian Properties and the Registrant 10.5 Lease Agreement, dated October 31, 2000, by and between Trustees of the Goldberg Brothers Trust, a Massachusetts Nominee Trust and TVCM, Inc. 10.6 222 Building Standard Office Lease between Clayton Investors Associates, LLC and Cejka & Company 10.7 1999 Stock Option Plan of the Registrant 10.8 Equity Participation Plan of the Registrant 10.9 Second Amended and Restated Credit Agreement, dated as of March 16, 2001, among the Registrant, the Lenders Party thereto, Salomon Smith Barney, Inc., as Arranger, Citicorp USA, Inc. as Administrative Agent, Collateral Agent, Issuing Bank and Swingline Lender, Bankers Trust Company, as Syndication Agent, and Wachovia Bank, N.A., as Documentation Agent
II-3
NO. DESCRIPTION --- ----------- 10.10 Waiver and Amendment No. 1 dated as of May 3, 2001, to the Credit Agreement dated as of July 29, 1999, as amended and restated as of December 16, 1999 and March 16, 2001 by and among the Registrant, the Lenders Party thereto, Salomon Smith Barney, Inc., as Arranger, Citicorp USA, Inc. as Administrative Agent, Collateral Agent, Issuing Bank and Swingline Lender, Bankers Trust Company, as Syndication Agent, and Wachovia Bank, N.A., as Documentation Agent. 10.11 Form of Subsidiary Guarantee Agreement, dated as of December 16, 1999, among the Registrant's subsidiary guarantors and Citicorp USA, Inc., as collateral agent for the Obligees 10.12 Form of Security Agreement, dated as of July 29, 1999, as amended and restated as of December 16, 1999 among the Registrant and Citicorp USA, Inc. as collateral agent for the Obligees 10.13 Form of Pledge Agreement, dated as of July 29, 1999, as amended and restated as of December 16, 1999, among the Registrant and Citicorp USA, Inc., as collateral agent for the Obligees 10.14 Form of Indemnity, Subrogation and Contribution Agreement, dated as of December 16, 1999, among the Registrant, the subsidiaries of the Registrant and Citicorp USA, Inc., as collateral agent for the Obligees 21.1 List of subsidiaries of the Registrant 23.1 Consents of Ernst & Young LLP 23.2 Consent of PricewaterhouseCoopers LLP 23.3 Consent of Deloitte & Touche LLP 23.4* Consent of Proskauer Rose LLP (contained in Exhibit 5.1) 24.1 Power of Attorney (included on signature page of the Registration Statement)
------------------------ * To be filed by amendment. (b) Financial Statement Schedules SCHEDULE II
VALUATION AND QUALIFYING ACCOUNTS (FOR CONTINUING OPERATIONS) ------------------------------------------------------------------------------- BALANCE AT CHARGED TO BALANCE AT BEGINNING COSTS AND OTHER END DESCRIPTION OF PERIOD EXPENSES WRITEOFF'S RECOVERIES CHANGES OF PERIOD ----------- ---------- ---------- ---------- ---------- ---------- ---------- ALLOWANCE FOR DOUBTFUL ACCOUNTS Period July 30-December 31, $1,159,039 $ 511,341 $ (273,142) $ -- $ 746,872 (a) $2,144,110 1999............................ Year ended December 31, 2000...... 2,144,110 431,397 (563,436) 75,676 -- 2,087,747 Three months ended March 31, 2,087,747 419,926 (150,104) -- 52,499 (b) 2,410,068 2001............................
-------------------------- (a) - Allowance for doubtful accounts for receivables acquired in TravCorps acquisition (b) - Allowance for doubtful accounts for receivables acquired in ClinForce acquisition All schedules not identified above have been omitted because they are not required, are not applicable or the information is included in the selected consolidated financial data or notes contained in this Registration Statement. II-4 ITEM 17. UNDERTAKINGS (a) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by the director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. (b) The undersigned registrant hereby undertakes that: (1) For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective. (2) For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. (c) The undersigned registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement, certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser. II-5 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Boca Raton, Florida, on the 11th day of July, 2001. CROSS COUNTRY, INC. By: /s/ JOSEPH BOSHART ----------------------------------------- Joseph Boshart PRESIDENT AND CHIEF EXECUTIVE OFFICER
Each person whose signature appears below hereby constitutes and appoints Joseph A. Boshart and Emil Hensel, and each of them, his true and lawful attorneys-in-fact and agents with full power of substitution and resubstitution, for him and in his name, place, and stead, in any and all capacities, to sign any and all (1) amendments (including post-effective amendments) and additions to this Registration Statement and (2) Registration Statements, and any and all amendments thereto (including post-effective amendments), relating to the offering contemplated pursuant to Rule 462(b) under the Securities Act of 1933, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, and hereby grants to such attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or their substitute or substitutes may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following persons on the 11th day of July, 2001.
SIGNATURE TITLE --------- ----- /s/ JOSEPH A. BOSHART President, Chief Executive Officer and ------------------------------------------- Director Joseph A. Boshart (Principal Executive Officer) /s/ EMIL HENSEL Chief Financial Officer, Chief Operating ------------------------------------------- Officer and Director (Principal Financial Emil Hensel Officer and Principal Accounting Officer) /s/ KAREN H. BECHTEL ------------------------------------------- Director Karen H. Bechtel /s/ BRUCE A. CERULLO ------------------------------------------- Director Bruce A. Cerullo /s/ THOMAS C. DIRCKS ------------------------------------------- Director Thomas C. Dircks
II-6
SIGNATURE TITLE --------- ----- /s/ A. LAWRENCE FAGAN ------------------------------------------- Director A. Lawrence Fagan /s/ ALAN FITZPATRICK ------------------------------------------- Director Alan Fitzpatrick /s/ FAZLE HUSAIN ------------------------------------------- Director Fazle Husain /s/ LORI LIVERS ------------------------------------------- Director Lori Livers
II-7